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1 Abstract
Cytomegaloviruses (CMVs) infect different cell types, such as epithelial cells. Epithelial cells
are of particular importance for CMV infections, since they are exposed first to infectious virus
and therefore are first targets for CMV. Cytomegaloviruses are transmitted by bodily fluids that
are secreted by epithelial cells. The broad cell tropism of CMV results from the acquisition
of cell tropism factors. Viral factors that determine the tropism of mouse CMV (MCMV) for
endothelial cells or macrophages have been described. Viral factors that determine the tropism
of MCMV for epithelial cells, however, remain to be identified. CMVs induce cell rounding that
causes the formation of characteristic plaques in the cell monolayer. This cytopathic effect is
only poorly characterised for MCMV.
The present study aimed to identify factors of MCMV that determine the tropism for epithe-
lial cells and the induction of cell rounding during infection. To this end, a library of MCMV
mutants was generated. Genes were deleted that are dispensable for viral growth in fibrob-
lasts. Subsequently, the growth properties of the MCMV deletion mutants were investigated
in epithelial cells and fibroblasts. In parallel, the infected fibroblasts were screened for a loss
of cell rounding.
A virus mutant, lacking the gene region of m106 to m108, yielded strongly reduced titres
in epithelial cells compared to those of the wild type MCMV. By contrast similar titres were
measured in fibroblasts. Therefore, the presence of tropism factors for epithelial cells in this
region of the MCMV genome was assumed. The analysis of additional mutants excluded the
m106 gene and a stable intron RNA as potential epithelial tropism factors. The prevention
of potential m107 or m108 protein synthesis did not, however, inhibit the growth of the
respective mutants in epithelial cells. These results demonstrated that neither proteins nor
RNA account for the impaired growth of the m106-m108 deletion virus. DNA sequences within
the m106-m108 region of the MCMV genome that are as yet undetermined possibly bind
epithelial cell-specific transcription factors and are a prerequisite for the productive infection
of epithelial cells. The analysis of the morphology of infected fibroblasts revealed that M25-
deficient MCMV mutants lost their ability to induce cell rounding. This could be restored
with inserting M25 in the mutant genome. M25 induced cell rounding in the absence of other
MCMV genes. The synthesis of M25 mRNAs and their translation into proteins correlated
with the kinetics of MCMV-induced cell rounding. In this study, M25 was identified as the
MCMV gene that is necessary for the induction of cell rounding.
mouse cytomegalovirus, cell tropism, cytopathic effect
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Zusammenfassung
Zytomegaloviren infizieren verschiedene Zelltypen, darunter auch Epithelzellen. Epithelzellen
spielen ein besondere Rolle fu¨r die Zytomegalovirus-Infektion. Sie sind vermutlich die ersten
Zellen, die infiziert werden und Zytomegaloviren werden in Ko¨rperflu¨ssigkeiten u¨bertragen die
von Epithelzellen sezerniert werden. Der breite Zelltropismus der Zytomegaloviren beruht
auf dem Erwerb von Zelltropismusfaktoren. Bisher konnten fu¨r das murine Zytomegalovirus
(MCMV) Gene fu¨r den Endothelzell- und den Makrophagentropismus gefunden werden. Gene,
die den Epithelzelltropismus des MCMV bestimmen, sind hingegen unerforscht. CMV-infizierte
Zellen runden sich ab was zu einem charakteristischen Plaque im Zellrasen fu¨hrt. Dieser zyto-
pathische Effekt ist fu¨r MCMV bisher wenig charakterisiert.
Das Ziel der Arbeit war die Identifizierung von viralen Genen, die den Epithelzelltropismus des
MCMV bestimmen und das Abrunden der Zellen wa¨hrend der MCMV-Infektion induzieren. Zu
diesem Zweck wurde eine Bibliothek von MCMV-Mutanten hergestellt, in denen Gene deletiert
wurden, die nicht essentiell fu¨r das Wachstum in Fibroblasten sind. Die Deletionsmutanten
wurden anschliessend auf ihre Wachstumseigenschaften in Epithelzellen und Fibroblasten hin
u¨berpru¨ft. Die infizierten Fibroblasten wurden ausserdem auf einen Verlust der Zellabrundung
hin untersucht.
Fu¨r das Virus, in dem die Gene m106-m108 deletiert sind, wurden stark reduzierte Titer in
Epithelzellen im Vergleich zu denen des Wild-Typ MCMV festgestellt. Die Titer der beiden
Viren in Fibroblasten waren hingegen vergleichbar. Daraus wurde geschlossen, dass in der
m106-m108 Gen-Region Faktoren fu¨r den Epithelzelltropismus kodiert sind. Mit Hilfe von
weiteren Deletionsmutanten konnten das m106-Gen und eine stabile Intron RNA als mo¨gliche
Epithelzelltropismusfaktoren ausgeschlossen werden. Auch die Verhinderung einer mo¨glichen
Synthese der m107- oder m108-Proteine schra¨nkte das Wachstum der Viren auf Epithelzellen
nicht ein. Diese Ergebnisse zeigten, dass weder Proteine noch RNA in der m106-m108 Region
des Genomes Tropismusfaktoren fu¨r Epithelzellen darstellen. Mo¨glicherweise funktionieren
noch nicht identifizierte DNA-Sequenzen in dieser Region als Bindeelemente fu¨r epithelzell-
spezifische Transkriptionsfaktoren und sind somit eine Vorraussetzung fu¨r die effiziente Ver-
mehrung des MCMV in Epithelzellen.
Die U¨berpru¨fung der Morphologie der infizierten Fibroblasten zeigte, dass ein Fehlen des
M25-Gens im Virusgenom zu einem Verlust der Zellabrundung fu¨hrt. Diese Eigenschaft konnte
mit der Insertion des M25-Gens in die Mutante wiederhergestellt werden. Die Funktion des
M25-Gens war unabha¨ngig von anderen MCMV-Genen. Die Synthese von M25 mRNAs und
deren Translation in Proteine korrelierte zeitlich mit dem MCMV-induzierten Zellabrunden.
Somit wurde M25 wurde als das MCMV-Gen identifiziert, welches fu¨r die Abrundung von
MCMV-infizierten Zellen notwendig ist.
Murines Zytomegalovirus, Zelltropismus, Zytopathischer Effekt
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5
Contents
6
2 Introduction
2.1 The Biology of Cytomegaloviruses
The Herpesviridae are categorised into three subfamilies, Alpha- , Beta-, and Gammaherpes-
virinae [Pellett and Roizman, 2007]. Alphaherpesviruses infect reptiles, birds and mammals
whereas betaherpesviruses and gammaherpesviruses only infect mammals. The further clas-
sification within a herpesvirus subfamily is based on the similarity of the DNA sequence, the
genome arrangement and the expression of characteristic proteins. Cytomegaloviruses (CMVs)
belong to the subfamily of betaherpesviridae. Members of the betaherpesviruses are species-
specific, i.e. they productively replicate only in cells of one species. All herpesviruses establish
a latent infection in their host.
Human CMV (HCMV) infects the human population worldwide [Britt, 2008, Mocarski et al.,
2007]. Evidence of a previous HCMV infection is present in nearly 100% of children and adults
from developing countries in Africa, Asia and South America whereas less than 30% of adults
in some areas of North America and Northern Europe have been infected with HCMV.
The clinical symptoms and the severity of disease caused by an acute HCMV infection depend
on the immune status of the host. In the healthy, immune competent host HCMV manifests,
if at all, in low-grade fevers, fatigue and headache. Rarely, HCMV infection in the immune
competent host leads to severe disease such as encephalitis, myocarditis, or ocular disease.
Transplant patients, who are immune suppressed, or people suffering from Aquired Immune
Deficiency Syndrome (AIDS) develop more severe diseases. HCMV is the most common viral
infection after transplantation and is one of the first opportunistic pathogens identified in
patients with AIDS. HCMV infection in these immune suppressed patients often manifests as
hepatitis, retinitis, pneumonia or enteritis.
Attempts to investigate the course and the pathogenesis of HCMV employ animal models
such as the mouse model of CMV [Mercer and Spector, 1986, Balthesen et al., 1993, Collins
et al., 1994]. Mouse CMV (MCMV) infection is characterised by an acute phase with the
highest amounts of virus (titres) typically found in liver and spleen around day four and day
sixteen after infection [Mercer and Spector, 1986]. Thereafter, the virus persists at low titers in
these organs. In the salivary glands, the organs in which MCMV replicates to the highest titres,
the peak virus titres occur around day eight after infection declining thereafter indicating the
switch to the persistent phase. At day thirty-nine after infection, infectious virus can still be
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measured in the salivary glands whereas the titres remain under the detection limit in spleen
and liver. Virus can still be detected in the salivary glands after four months of infection
but is not detectable in spleen, liver and salivary glands around six month after infection
indicating latency [Balthesen et al., 1993]. During latency, viral gene expression is thought to
be restricted to genes that ensure the maintenance of the viral genome. MCMV latency is
further characterised by a reduced viral genome number in comparison to the acute infection
and the absence of CMV-specific antigens [Balthesen et al., 1993].
During an acute infection, CMV is continuously shed into bodily fluids such as saliva,
breast milk or genital secretions. Transmission of CMV between individuals occurs by close
contact with these fluids. Primary CMV infection often takes place at a young age, via breast
milk or during childhood via the saliva of acutely infected children. Most infants that have
been exposed to infectious bodily fluids such as breast milk from mothers with an acute
HCMV infection become infected with HCMV [Dworsky et al., 1983]. Virus shed from acutely
infected children also represents a source of infection for HCMV negative adults. In sexually
active adolescents, infection is presumed to occur via exposure to genital secretions bearing
infectious virus particles. Other routes of infection that do not include direct human-to-human
contact are blood transfusions or organ transplants from HCMV-positive donors.
Most HCMV infections are thought to occur as a result of exposure of the epithelium at
mucosal surfaces to infectious HCMV. Studies in primates have demonstrated that infection
of the oral mucosa leads to dissemination of the virus and subsequent infection of organs such
as the liver and spleen [Lockridge et al., 1999]. Oral or intravenous inoculation of rhesus
macaques with rhesus CMV both lead to virus dissemination and infection of liver and spleen.
However, dissemination after oral inoculation was delayed suggesting that the virus replicates
in the mucosal epithelium before it then spreads to secondary organs such as liver and spleen
[Lockridge et al., 1999]. Studies in mice are consistent with this mode of spread in the
host. MCMV is first detected in blood leukocytes after intraperitoneal inoculation of mice
with MCMV, representing the first viremia. The virus is then disseminated to liver and spleen
where it again replicates to high titres thereby causing the second viremia [Collins et al., 1994].
These organs may serve as reservoirs for infectious virus during acute infection allowing the
spread to other organs. The salivary gland has been shown to be a site of persistent infection
where the virus continuously replicates to high titres after the virus has been cleared from
liver and spleen [Jonjic et al., 1989]. MCMV replicates in a specialised cell type of the salivary
gland, the acinar glandular epithelial cell. This cell type provides a niche for CMV, delaying
its elimination by immune cells, predominately mediated by CD4+ T cells [Jonjic et al., 1989].
The salivary gland is also the first organ from which MCMV was isolated and propagated in
cell culture [Smith, 1954] and the reason why CMV is also called salivary gland virus.
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2.2 The Mouse Model of CMV Infection
Cytomegaloviruses are species-specific, thus human CMV pathogenesis can not be studied in
other animals. In order to analyse various aspects of CMV infection one has to make use of
animal CMV models such as the mouse model of CMV infection. MCMV and HCMV have
colinear genomes meaning that their genomic organisation is very similar [Rawlinson et al.,
1996]. The MCMV and HCMV genomes contain a core of gene blocks that are conserved
in order and gene content among all herpesviruses (Fig.2.2). These conserved gene blocks
are flanked with genes that have homologs in all CMVs. However, there are also differences
between the two viruses as their genomes contain genes that are unique for MCMV or HCMV
[Rawlinson et al., 1996]. Despite their genetic differences, the similar courses of infection in
their respective hosts with respect to the cell types, tissues and organs infected makes MCMV
a valuable animal model for HCMV.
The CMV mouse model has been useful in studying CMV-directed immune responses and
CMV dissemination [Holtappels et al., 2008, Bale and O’Neil, 1989, Collins et al., 1994, Noda
et al., 2006, Saederup et al., 2001, Sacher et al., 2008]. The fact that CD8+ T cells are antiviral
effector cells which prevent virus dissemination and organ disease during MCMV infection was
concluded from in vivo mouse experiments [Holtappels et al., 2008]. The adoptive transfer
of CMV-specific CD8+ effector and memory T cells not only limited CMV infection but also
prevented the manifestation of CMV-infection in tissues. These results were fundamental
for the establishment of clinical trials using CMV-specific CD8+ T cells and supported the
establishment of a T cell based immunotherapy in CMV-disease [Riddell et al., 1991].
Leukocytes are believed to be the source of CMV dissemination within the human or murine
host. All leukocyte subsets isolated from peripheral blood of immunocompromised patients
with acute CMV infection were positive for HCMV DNA, arguing that these cells play a role
in CMV dissemination [Gerna et al., 1992]. The role of leukocytes during CMV infection
was investigated in the mouse model. The detection of infectious virus or viral DNA in
blood leukocytes isolated from both immune competent and immune deficient mice indicated
that leukocytes may also be the major source for dissemination of MCMV, thereby further
emphasising the biological similarities between MCMV and HCMV [Bale and O’Neil, 1989,
Collins et al., 1994]. Virus dissemination using leukocytes is actively stimulated by the virus
itself, exploiting host adaptive immune cells. A MCMV-secreted viral chemokine, MCK-2,
attracts and recruits leukocytes to sites of infection [Saederup et al., 2001, Noda et al., 2006].
A MCK-2 deletion virus showed less infiltration of leukocytes into the infected tissue and an
impaired dissemination to the salivary glands.
In order to shed light on CMV dissemination, the contribution of virus spread from infected
hepatocytes was investigated in transgenic mice using a genetically modified MCMV. Sacher et
al. constructed a MCMV virus with a marker gene which is exclusively expressed in hepatocytes
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following activation by Cre-recombinase [Sacher et al., 2008]. Viruses that infected hepatocytes
and also progeny viruses expressed the marker protein, GFP, in order to follow virus spread from
the liver to other organs. The authors could show that hepatocytes are among the first cells
in which the virus grows to high titers during the course of infection. Surprisingly, however,
these cells are not the main source of MCMV dissemination since MCMV did not spread from
the liver to other organs.
In general, to study CMV pathogenesis, the use of mice is advantageous over other animals
such as guinea pigs, rats, or primates, in that a wide variety of genetically modified mice
that are applicable in CMV research are available. In addition, a humanised mouse model
has been established in order to study HCMV replication in human implants. SCID-hu mice,
severe combined immunodeficient (SCID) mice carrying a human tissue implant, were used
to investigate human CMV replication in vivo [Mocarski et al., 1993]. Implanted human fetal
liver or thymus tissue allowed the in vivo growth of HCMV in these mice. The restricted host
range of CMV was maintained since virus was only found in the implanted tissues. In addition,
virus replication could also be controlled in these implants by applying antiviral treatment and
thus provided a tool to study the efficacy of antiviral therapeutics. Further, the model system
was also used to study the growth properties of low-passaged or high-passaged HCMV isolates
in human implants [Brown et al., 1995]. However, this humanised mouse model is of limited
use since HCMV pathogenesis or any other question related to the immune response directed
against HCMV cannot be studied.
2.3 The Herpesvirus Life Cycle
Viral productivity and fitness is a function of the ability of the virus to enter, replicate and
exit from a cell in an efficient way. The architecture of the mature virion is common to
all members of the herpesviruses [Pellett and Roizman, 2007]. The size of a herpesvirus
virion varies between 120 and 260 nm, and consists of an icosahedral (20 faces) nucleocapsid
containing the capsid with the viral dsDNA, the tegument which is an amorphous protein layer
surrounding the capsid, and the lipid envelope containing viral glycoproteins.
In HCMV infection, the envelope glycoprotein complexes consisting of gB or gM/gN or
gH/gL bind to cell surface receptors such as integrins or heparan sulfate proteoglycans (HS)
(Fig.2.1, (1)) [Feire et al., 2004, Wang et al., 2005, Compton et al., 1993]. For viral entry, viri-
ons either fuse with the plasma membrane thereby releasing virus capsids into the cytoplasm or
virions are endocytosed (Fig.2.1, (2)). The cellular transport machinery is exploited to deliver
the herpes genome towards the nucleus [Radtke et al., 2006]. In fact, microtubules are required
for efficient transport of HCMV capsids towards the nucleus (Fig.2.1, (3)) [Ogawa-Goto et al.,
2003]. The release of HCMV viral capsids from endocytic vesicles into the cytoplasm occurs
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Figure 2.1: Summary diagram of the herpesvirus life cycle. Details of the different steps are described in
the text. Modified from Mettenleiter et. al, 2006
via low pH-dependent fusion of the viral envelope with the endosomal membrane (Fig.2.1, (4))
[Ryckman et al., 2006]. The viral DNA is released into the nucleus after the viral capsids have
reached the nuclear pore. Viral gene expression, viral replication and packaging of the newly
replicated viral genomes into preformed capsids, takes place in the nucleus (Fig.2.1, (5-6)).
The analysis of herpesvirus capsids by cryo-electron microscopy and 3D image reconstitution
revealed that herpesvirus capsids have a unique structure [Zhou et al., 1994, Butcher et al.,
1998, Trus et al., 2001]. The capsid shell consists of protein complexes called capsomers
that are formed by 150 hexons and 12 pentons which are connected by proteins organised in
triplexes. The HCMV capsid proteins that assemble into these capsomers are the major capsid
protein (MCP, UL86) the triplex monomer and triplex dimer protein (TR1, UL46, TR2, UL85),
and the smallest capsid protein (SCP, UL48/49) [Gibson, 2006]. The CMV nucleocapsid has
a diameter of approximately 130 nm in which the viral genome is tightly packaged [Butcher
et al., 1998].
The current model for the egress and the release of herpesviral viral particles at the plasma
membrane is the two-step envelopment process [Mettenleiter et al., 2006, Mocarski et al.,
2007]: Primary envelopment describes mature nucleocapsids that bud through the inner nuclear
membrane into the perinuclear cleft.
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The primary envelope fuses with the outer nuclear membrane thereby releasing the viral
capsid into the cytoplasm (Fig.2.1, (7)).
The tegumentation of nucleocapsids takes place in the cytoplasm and is initiated at two sites,
the virus capsid and outer tegument proteins assemble at vesicles for final envelopment (Fig.2.1,
(8)) [Mettenleiter et al., 2006]. The surface of the capsid provides anchor points for tegument
proteins and the binding of additional tegument proteins requires specific and direct interaction
with capsid proteins as was revealed from electron cryomicroscopy of herpesviral capsids and
image reconstitution [Trus et al., 1999]. Close-up views of reconstituted images of herpesviral
capsids demonstrate binding of tegument proteins to pentons and hexons [Chen et al., 1999].
Thus, the viral capsid provides a surface to which tegument proteins are consecutively added
in a defined order via protein-protein interactions.
Tegument proteins constitute the layer that surrounds the nucleocapsid and play a role
during entry or maturation of the virion. They are involved in the assembly of the virion or the
uncoating of the virus particle during entry and are packaged into the virion to ensure their
presence upon infection of a new host cell [Mocarski et al., 2007]. Other tegument proteins
alter the host cell cycle and stimulate the host cell metabolism to produce optimal conditions
for replication. As many as fifty-nine viral proteins were found in purified HCMV virions by
mass-spectrometry [Varnum et al., 2004]. The functions or predicted functions of a total of
17 tegument proteins have been described, fourteen of which have been identified in purified
virions [Gibson, 2006]. Among the most abundant proteins purified from HCMV-infected
cell cultures are the major tegument protein pp65 (UL83), and the basic phosphoprotein
BPP (pp150, UL32) which is also a tegument protein. The latter protein has the highest
immunogenic potential, since the strongest reactivity in human sera was found directed against
pp150 [Jahn et al., 1987]. The UL32 and UL82 homologs in MCMV, M32 and M82, have been
identified in purified MCMV virions among other tegument proteins with unknown function
such as M25 [Kattenhorn et al., 2004]. Six HCMV envelope glycoproteins have been identified
that are conserved among all herpesviruses and are essential for viral replication in cell culture
[Eickmann et al., 2006, Britt, 2007]. These glycoproteins form the gI (gB), gII (gM/gN) and
gIII (gH/gL/gO) membrane-anchored glycoprotein complexes.
The site in the cytoplasm at which the nucleocapsid and the surrounding tegument become
enveloped is not well defined. Electron microscopy analysis of herpesvirus assembly showed that
nucleocapsids obtained their membranous envelope by budding into cytoplasmic vesicles [Tooze
et al., 1993, Mettenleiter et al., 2006]. Based on the findings that envelope glycoproteins are
recycled from the plasma membrane to the trans-golgi-network in HCMV-infected cells and
that nucleocapsids bud into the cisternae of the trans-golgi-network, the capsid envelopment
is thought to occur in an intermediate compartment consisting of vesicles of early/recycling
endosomal vesicles and cisternae of the trans-golgi-network (Fig.2.1, (9)) [Schmelz et al.,
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1994, Homman-Loudiyi et al., 2003, Tooze et al., 1993]. The final egress of mature virions
resembles the exocytosis of secretory vesicles as the release of herpesvirus particles occurs via
fusion at the plasma membrane (Fig.2.1, (10)) [Mettenleiter et al., 2006].
In addition to infectious viral particles, non-infectious enveloped viral particles are released in
superior numbers during HCMV infection (Fig.2.1, (11)). These particles do not contain viral
DNA and have either no capsid at all (dense bodies) or have an immature capsid (non-infectious
enveloped particles) [Irmiere and Gibson, 1983]. In both types of non-infectious particles, the
tegument composition is different from that of the infectious particles and their presence
indicates that neither the packaging of the viral genome nor capsid assembly is required for
secondary envelopment. During infection in vivo, it is possible that these particles impede
the immune response by binding to immune effector cells thereby allowing the infectious viral
particles to reach their targets.
2.4 Organisation of the MCMV Genome
MCMV, as do all herpesviruses, possesses a linear double stranded DNA genome that circu-
larises immediately upon its release from capsids into the nuclei of infected cells [Pellett and
Roizman, 2007]. Sequence analysis of the MCMV Smith strain revealed a genome length of
230 kbp that is similar to that of HCMV (230 kbp) but larger than the genome size of the
alphaherpesvirus herpes simplex virus type-1 (152 kbp) and the gammaherpesvirus Karposi′s
sarcoma-associated herpesvirus (170 kbp) [Rawlinson et al., 1996, Pellett and Roizman, 2007].
A total of 170 ORFs were predicted for MCMV, based on the analysis of the genomic
sequence of the Smith strain [Rawlinson et al., 1996]. However, this prediction of ORFs had
limiting criteria such as a minimum length of 300 bp and less then 60% overlap with adjacent
ORFs. Thus, the prediction excluded ORFs that might encode proteins but that are shorter
in length. In addition, this was only a prediction based on the genomic sequence and did not
include an analysis of viral gene expression. Lowering the criteria for an ORF to a minimum
length of 150 bp led to the prediction of 14 additional ORFs within the MCMV sequence and
further analysis of viral gene expression in cells confirmed the existence of the majority of all
predicted ORFs [Tang et al., 2006]. Sequence analysis of the Smith strain without restriction
to the degree of overlap between putative protein-coding regions and with a focus on ORFs
with more than 60 bp predicted several additional ORFs [Brocchieri et al., 2005]. The newly
annotated ORFs, such as m106.1, m106.2, m107.1, m107.2 and m107.3 are partly located
inside previously predicted ORFs.
The MCMV genome contains genes that are conserved across the herpesviruses and which
are clustered in seven core gene blocks in the central part of the MCMV genome (Fig.2.2). The
block arrangement and the gene order differs across the herpesvirus families but is conserved
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Figure 2.2: Organisation of the MCMV genome. The core of genes that are conserved among all her-
pesviruses is located in the center of the MCMV genome. This region is flanked by genes that are common
within the betaherpesvirus family. MCMV-specific genes are located at the termini of the genome. A kbp
scale is given for the orientation of the gene regions within the genome.
within a subfamily [Pellett and Roizman, 2007]. Thus, the position and the orientation of the
MCMV gene blocks are identical to those of HCMV. The core of conserved genes contains the
genes from M44 to M115 that encode mainly proteins that are essential for the viral replication
machinery and for the assembly of the virus particle. It also encompasses the origin of lytic
replication, orilyt, which is required for replication of the viral DNA [Masse et al., 1997]. In
addition to the core conserved genes, MCMV contains genes that are HCMV homologs and
are distributed within the central part of the genome. In contrast, genes present in the left
and right termini of the sequence are unique to MCMV [Rawlinson et al., 1996].
The comparison of the genomic sequences of different MCMV isolates identified the highest
variability across the genome in these termini [Mocarski et al., 2007, Smith et al., 2008].
The left and right termini of the MCMV genome consist of 31 bp direct repeats that contain
cis-acting signals for the cleavage and packaging of viral DNA during viral replication. The
presence of viral genes that show homology to cellular genes suggests that herpesviruses have
captured cellular genes during co-evolution with their host. These genes are likely to be
insertions of a cDNA copy from cellular mRNA or pre-mRNA species [Davison and Bhella,
2007]. These cellular homologs are predominately located towards the genomic termini and
between the core gene blocks [Pellett and Roizman, 2007]. MCMV ORFs with homolo-
gy to cellular genes include the M33 and the m144 genes that have been shown to have
sequence homology to G protein-coupled receptors and to a class I MHC heavy-chain homolog,
respectively [Davis-Poynter et al., 1997, Chapman and Bjorkman, 1998].
2.5 Cytomegalovirus Gene Expression
Herpesviral gene expression is a regulated process [Stinski and Meier, 2007, White and Spector,
2007, Anders et al., 2007]. Viral proteins of different kinetic classes are synthesised during
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infection. After the viral genome is released into the nucleus the transcription of viral genes
takes place. Transcription of viral genes is dependent on the cellular RNA polymerase II. In
addition, the virus exploits the cellular basic transcription machinery and cellular translation
factors [Mocarski et al., 2007]. The application of inhibitors of protein synthesis alone or
in combination with inhibitors of DNA synthesis prior to viral infection and the subsequent
analysis of viral gene expression revealed that herpesvirus gene expression can be divided into
three phases. Viral genes are expressed with immediate early (IE), early (E) or late kinetics
(L) [Honess and Roizman, 1974].
The immediate early genes are the first genes transcribed after infection. In contrast to
the early or late genes, their transcription does not require de novo viral protein synthesis.
Transcripts of MCMV immediate early genes can be detected immediately after infection within
a period of four hours [Keil et al., 1984, Messerle et al., 1991]. Early viral gene transcripts
are detected from two hours until ten hours post infection showing peak levels at four hours
after infection [Bu¨hler et al., 1990]. Late transcripts are detected around sixteen hours post
infection and reached maximum levels at 20 to twenty-four hours post infection [Keil et al.,
1984]. Late viral gene expression is concomitant with viral DNA replication and the first new
MCMV virions are released 24 hours after infection.
The best characterised immediate early genes in MCMV or HCMV are the ie1, ie2 and
ie3 genes, expressed under the control of the major IE promoter, MIEP. The IE1 and IE3
proteins affect viral gene expression and viral replication and thus are critical determinants of
productive virus infection. A MCMV ie3 deletion mutant is unable to grow in cultured cells
due to a block in early and late gene expression indicating the significance of a transactivating
role of the corresponding IE3 protein [Angulo et al., 2000]. The MCMV IE1 protein has been
shown to interact with cellular factors in the nuclei of infected cells that otherwise repress the
transcription of viral genomes [Tang and Maul, 2003]. The MIEP region is located outside of
the core region and is a complex regulated unit. HCMV IE gene expression can be activated
by binding of the tegument protein pp71 to the enhancer region of the MIEP [Liu and Stinski,
1992]. An autoregulatory function of ie3 or the HCMV equivalent ie2, by repression of the
major IE promoter of MCMV and HCMV, respectively, has been described [Messerle et al.,
1992, Pizzorno and Hayward, 1990].
Early and late gene expression in herpesviruses requires de novo protein synthesis. For
example, the MCMV IE3 protein not only autoregulates its own promoter but also activates
the promoters regulating the expression of early genes [Messerle et al., 1992]. Many of the
viral genes that are expressed with late kinetics encode structural proteins for virus assembly
or egress [Anders et al., 2007].
The kinetic expression profile of HCMV genes was investigated by the detection of viral
transcripts in the presence of protein synthesis or DNA synthesis inhibitors. This revealed that
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genes that are expressed with early or late kinetics are distributed over the HCMV genome
whereas genes expressed with IE kinetics are clustered in few loci on the genome and further,
most HCMV genes are expressed during the early phase of infection [Chambers et al., 1999].
2.6 Cytomegalovirus Cell Tropism
The ability of a virus to productively infect a certain cell type is referred to as its cell tropism
[Mahy and van Regenmortel, 2008]. The broad cell tropism of MCMV and HCMV enables
the establishment of a systemic infection in the host, targeting multiple organs. Fibroblasts,
epithelial cells, endothelial cells and smooth muscle cells are the main target cells of HCMV
according to immunohistological stainings of various organ tissues from acutely infected pa-
tients [Sinzger et al., 1995]. Explanations for this broad cell tropism are the expression of
CMV receptors on the surface of various cell types and also permissiveness to viral replication.
The cell surface receptors discovered to date for CMV attachment or entry are glycosamino-
glycans, i.e. heparan sulfate and integrins such as alpha-V-beta3 and also the platelet-derived
growth factor-α receptor (PDGF-α) [Compton et al., 1993, Feire et al., 2004, Wang et al.,
2005, Soroceanu et al., 2008]. Heparin competition or enzymatic digestion with heparinase
block virus attachment and viral gene expression whereas antibodies specific for integrins such
as αV and β3 inhibit virus entry but not virus binding [Feire et al., 2004]. Recently, HCMV
entry was found to depend on the surface expression of the growth factor receptor PDGF-α.
Virus particle internalisation and viral gene expression is absent in PDGF-α null cells and the
authentic PDGF-α ligand decreases HCMV entry [Soroceanu et al., 2008]. Thus, HCMV is
most likely to attach to heparan sulfates before its subsequent binding to integrins and/ or
growth factor receptors. All of the identified HCMV-receptors are suggested or have been
shown to bind either glycoprotein gB or gH.
However, virus replication only occurs if a cell is permissive. Based on cross-species exper-
iments, it is assumed that viral factors interact with other cellular factors at the post-entry
step to promote productive infection. A number of studies have shown that cells of species
other than mouse or human are susceptible for MCMV or HCMV, respectively, but only few
are permissive [Fioretti et al., 1973, Lafemina and Hayward, 1988, Nowlin et al., 1991, Jurak
and Brune, 2006]. The replication of MCMV in cells of other species is not productive, partly
due to infection-induced programmed cell death [Jurak and Brune, 2006]. In general, inside
the cell, the interference with cellular defense mechanisms is critical for the virus to be able
to replicate and spread efficiently. Due to their slow replication cycles, CMVs are particu-
lary reliant on suppressing cellular defence mechanisms including cell death and the interferon
response [Goldmacher, 2005, Zimmermann and Hengel, 2006].
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Viral cell tropism factors are suggested to interact with intracellular factors thereby ensuring
replication of the virus. The identification of cell tropism genes of CMVs was pioneered by
Brune et al. who showed that productive infection of endothelial cells is only possible in the
presence of M45 [Brune et al., 2001]. A number of viral genes of different CMV species have
since then been identified that determine the tropism for endothelial cells, epithelial cells or
macrophages [Brune et al., 2001, Me´nard et al., 2003, Dunn et al., 2003, Hahn et al., 2004,
Lilja et al., 2008]. To date, modes of action have only been identified for the MCMV M36
and M45 proteins. In the absence of the M36 protein infected macrophages and hepatocytes
undergo apoptosis, whereas the effect is less pronounced in fibroblasts. The survival of CMV-
infected macrophages and hepatocytes is obviously necessary for viral fitness since the ∆M36
virus does not reach comparable titres to the wild type MCMV in the salivary glands. The M36
protein interferes with Fas-associated death domain (FADD) function and thereby inhibits the
death receptor mediated pathway of apoptosis [Cicin-Sain et al., 2008]. The M45 protein binds
to the cellular receptor-interacting protein RIP1 and prevents the TNFalpha-induced death of
endothelial cells [Mack et al., 2008, Upton et al., 2008]. The finding that mutant viruses
that do not express M45 are avirulent in immunodeficient mice and do not replicate in their
target organs highlights the relevance of endothelial cells for MCMV pathogenesis [Lembo
et al., 2004]. The cell type-dependent sensitivity to cell death in the absence of M45 has been
suggested to depend on the cellular expression level of RIP1.
The majority of the identified CMV cell tropism factors exert their functions after the virus
has entered the cell. Even in the absence of cell tropism factors gene expression under the
control of the major IE promoter is observed [Brune et al., 2001, Lilja et al., 2008] implying that
cellular permissiveness to a virus is determined by cell tropism factors acting at a post-entry
step. However, the tropism of HCMV for endothelial and epithelial cells is determined prior to
viral gene expression. Laboratory-adapted HCMV strains have lost their tropism for epithelial
and endothelial cells due to mutations in the UL128-131 locus of the viral genome [Hahn
et al., 2004]. The formation of a complex consisting of the glycoproteins gH/gL together
with the UL128-UL131 gene products on the surface of HCMV virions is required for entry
in epithelial and endothelial cells via pH-dependent fusion at endocytic vesicles prior to viral
gene expression [Wang and Shenk, 2005a, Ryckman et al., 2008]. In contrast, the glycoprotein
complex gH/gL/gO mediates entry into fibroblasts via fusion at the plasma membrane.
The two cell types that were used in the present study for the investigation of MCMV cell
tropism and the induction of cell rounding are epithelial cells and fibroblasts. Fibroblasts are
commonly used for the propagation of CMV in cell culture since CMV produces high amounts
of progeny virus in this cell type [Kim and Carp, 1971, Smee et al., 1989, Furukawa et al.,
1973]. Fibroblasts and smooth muscle cells belong to the family of connective tissue cells and
are dispersed throughout the body [Alberts et al., 2002]. It can be speculated that this cell
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type is also a source for the production of progeny virus and virus spread in vivo. Several
studies, examining the growth properties of MCMV deletion viruses, demonstrate that the
tropism of MCMV for fibroblasts is not determined by ORFs that are located outside of the
herpesviral core region [Zhan et al., 2000, Me´nard et al., 2003, Brune et al., 2001, 2006].
This indicates that the core of conserved genes are sufficient for the productive infection of
fibroblasts.
Infection of Epithelial Cells
Epithelial cells of mucosal surfaces are exposed first to infectious virus and therefore have been
suggested to be the first targets for CMV. During the course of infection CMV is disseminated
to sites that have been postulated to support persistent infection in vivo. These include the
salivary gland and breast secretory epithelium, prostatic epithelium and renal tubule epithelium
[Britt, 2007]. Further, HCMV persistence in retinal epithelial cells of immunocompromised
individuals has been reported [Scholz et al., 2003]. Glandular epithelial cells are the main
secretory cells of the salivary and the mammary glands [Welsch, 2006]. Consistent with the
fact that CMV is transmitted via bodily fluids such as saliva virus particles have been found in
acinar glandular epithelial cells of the salivary gland in persistently infected mice [Jonjic et al.,
1989]. Further, glandular or ductal epithelial cells in kidney, breast milk duct and genital
organs are thought to be major sites for shedding of infectious virus into urine, mothers breast
milk and cervical secretions [Britt, 1996].
Viral factors that are necessary for the productive infection of epithelial cells have only been
identified to date for HCMV and rhesus CMV [Hahn et al., 2004, Lilja et al., 2008]. The rhesus
CMV Rh01-deletion mutant grows to reduced titres in epithelial cells compared to those in
fibroblasts whereas similar titres of the wild type CMV were obtained from both cell types
[Lilja et al., 2008]. Although the mechanism remains unknown, the failure to produce similar
titres must be due to a post entry-step since epithelial cells infected with the mutant expressed
similar levels of all kinetic classes of viral proteins.
The impact of epithelial cells for the dissemination and pathogenesis of CMV has not been
studied to date. The identification of epithelial cell tropism factors of MCMV could be useful
for answering this question. Their deletion and the analysis of the in vivo growth properties
of the respective mutants in the in vivo mouse model would be suitable to clarify the role of
epithelial cells during MCMV infection.
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Figure 2.3: CMV-induced plaque for-
mation. CMV infection results in
cell rounding leading to the forma-
tion of holes in the cell monolayer,
so called plaques. Arrows point to
CMV-infected primary fibroblasts.
2.7 Cytomegalovirus-Induced Cell Rounding as a
Cytopathic Effect
Cell rounding is a cytopathic effect induced by CMV [Furukawa et al., 1973, Fioretti et al.,
1973, Ihara et al., 1982, Albrecht et al., 1983, 1980]. During the early stages of infection
the morphology of fibroblasts changes from a typical fibroblast shape to a round cell shape.
Characteristic holes in the cell monolayer, so-called plaques, are formed during CMV infection
and are caused by rounded CMV-infected cells (Fig.2.3). Although CMV replication is species-
specific, cell rounding can be induced in cells of other species. MCMV and HCMV can enter
human cells and guinea pig cells respectively and express a set of genes that are sufficient to
induce cell rounding [Jurak and Brune, 2006, Fioretti et al., 1973].
The onset of cell rounding is observed at 5-6 hours after infection in single HCMV-infected
fibroblasts and most infected cells are rounded at 24 hours after infection [Furukawa et al.,
1973, Fioretti et al., 1973, Ihara et al., 1982, Albrecht et al., 1983, 1980]. The application
of inhibitors affecting protein synthesis, transcription, or DNA synthesis in combination with
HCMV infection and UV-irradiation of virus particles indicates that viral induced cell rounding
is not induced by a constituent of the virion but requires de novo synthesis of an early virus
protein. Cell rounding was completely inhibited when the protein synthesis inhibitor cyclo-
heximide or the transcription inhibitor actinomycin D were added before or within two hours
of HCMV-infection, indicating that early viral protein synthesis is required for this process
[Furukawa et al., 1973]. Further, the inhibition of viral DNA replication does not inhibit the
induction of cell rounding [Albrecht et al., 1983]. The requirement of de novo gene expression
and protein synthesis for the induction of cell rounding is further confirmed by the fact that
UV-irradiated virus particles are unable to induce cell rounding [Hirai et al., 1977].
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Possible explanations of HCMV-induced cell rounding include virus-induced integrin sig-
nalling, cellular Ca2+ accumulation and ATP depletion. The latter was attributed to a single
HCMV-gene whereas MCMV-induced cell rounding has not been characterised to date nor has
the responsible gene been identified. The reduction of the cellular adhesion molecule integrin
α1/β1 correlates with the onset of cell rounding in HCMV infected cells, indicating that the
early events that induce the morphological changes also influence integrin signalling or vice
versa [Warren et al., 1994]. HCMV-induced cell rounding is inhibited in smooth muscle cells by
calcium influx blockers suggesting that virus-induced cell rounding resembles a contractile-like
process and that an influx of cations triggered through an early viral protein causes this initial
contraction of actin filaments [Albrecht et al., 1983]. Recently, a single HCMV gene, vMIA,
has been implicated in HCMV-induced cell rounding [Poncet et al., 2006]. This gene was
initially described encoding an inhibitor of apoptosis and is expressed with immediate early
kinetics [Goldmacher et al., 1999]. However, the influence on cell rounding is not related to
its anti-apoptotic function but to the inhibition of the phosphate supply for the generation of
ATP, thereby reducing cellular ATP levels [Poncet et al., 2006].
Since the cytoskeleton is required for the maintenance of the spatial organisation and the
structural framework of a cell, cell rounding must correlate with cytoskeletal reorganisation.
Cellular proteins that regulate the microtubule architecture or the actin cytoskeleton might
represent potential targets for viral proteins to induce cell rounding. Regulatory proteins of
the actin cytoskeleton, Rho, Rac and Cdc42 are members of the guanosine triphosphatase
(GTP) family. GTPases control the assembly and the organisation of the actin cytoskeleton
and are required for the maintenance of cell polarity and cell contraction [Etienne-Manneville
and Hall, 2002]. Activation of Rho in NIH 3T3 fibroblasts leads to the contraction of actin-
myosin filaments (Fig. 2.4) [Hall, 1998]. The formation of lamellipodia and membrane ruﬄes
is induced when Rac is activated, for example by platelet-derived growth factor and activated
Cdc42 induces actin-rich surface protrusions called filopodia. The effects of Rho, Rac or Cdc42
activation are not restricted to fibroblasts but have been observed in other cell types including
epithelial and endothelial cells and macrophages [Hall, 1998].
Microbial pathogens exploit the involvement of Rho GTPases in multiple cellular functions
in order to induce cytopathic and cytotoxic effects [Aktories and Barbieri, 2005]. The Gram-
positive bacterium Clostridium difficile effects morphological changes in its target cells resulting
in cell rounding concomitant with the induction of apoptosis. The Clostridium difficile toxin A
and toxin B glycosylate and thereby inactivate Rho/Rac proteins. This modification induces
the cytopathic effect as well as the cytotoxic effect in infected cells [Gerhard et al., 2008,
Halabi-Cabezon et al., 2008].
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Figure 2.4: Rho, Rac, and Cdc42 control the assembly and organisation of the actin cytoskeleton. (A)
Quiescent fibroblasts contain very few organised actin filaments. (C) Rho activation leads to the formation
of actin stress fibers effecting a morphology with prominent focal adhesions. Microinjection of constitutively
active Rac induces lamellipodia (E), whereas active Cdc42 leads to the formation of filopodia (G). In (A),
(C), (E), and (G), actin filaments were visualised with rhodamine phalloidine; in (B), (D), (F), and (H),
the adhesion complexes were visualised with an antibody to vinculin. Scale: 1 cm = 25 µm, taken from
Hall, 1998.
In two members of the alphaherpesviruses, pseudorabies virus and Marek′s disease virus, the
viral US3 protein kinase has been identified as manipulating the actin cytoskeleton [Van Min-
nebruggen et al., 2003, Schumacher et al., 2005]. An impressive actin stress fibre breakdown
is observed in cells at six hours after infection with pseudorabies virus. This actin stress fibre
breakdown is dependent on the presence of the US3 protein kinase [Van Minnebruggen et al.,
2003]. Although the exact mechanism remains elusive, it is speculated that the nuclear lo-
calised US3 kinase interferes with Cdc42/Rac signalling. The US3 protein kinase of Marek′s
disease virus contributes only partially to actin stress fibre breakdown since this effect is also
observed in ∆US3-infected cells indicating that additional viral proteins are involved [Schu-
macher et al., 2005]. The US3-induced stress fibre breakdown leads to morphological changes
but does not disrupt cell-to-cell contacts and so is unable to produce totally rounded cells as
observed during CMV infection. Thus, actin stress-fibre breakdown alone does not lead to cell
rounding and other additional factors must be required to drive these morphological changes.
The US3 protein kinase is also present in HSV-1 and HSV-2. The importance of US3 for
HSV-induced cell rounding has so far only been investigated in a cell line expressing HSV-2 US3
[Murata et al., 2000]. Here, cell rounding is observed upon the expression of US3. Notably,
the finding that co-expression of dominant active forms of Cdc42/Rac inhibit cell rounding is
indicative of an interference of US3 with GTPase-signaling. No US3 homologs were found in
HCMV or MCMV [McGeoch et al., 1988, Chee et al., 1990, Rawlinson et al., 1996]. Thus, it
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is possible that cell rounding during MCMV infection is induced by another viral kinase.
Cells that are transformed with rous sarcoma virus virus exhibit a loss of contact between
neighbouring cells and a round cell morphology [Rohrschneider and Reynolds, 1985]. This
transformation is ascribed to the interaction of the virally expressed kinase v-src and the Rho
protein [Mayer et al., 1999]. Expression of a constitutively active Rho-protein in trans, in
rous sarcoma virus-transformed fibroblasts, partly restored the typical fibroblast shape with
the formation of stress fibres and focal adhesions. This suggested that the cytoskeletal re-
arrangements in rous sarcoma virus-transformed cells are induced through phosphorylation of
the cytoskeletal regulator protein Rho.
The in vivo relevance of virally-induced cell rounding, if any, is unclear. Manipulation of the
cytoskeleton by cytomegaloviruses may facilitate the dissemination of the virus. Circulating
CMV-infected endothelial cells (CCIC) are found in blood from immunocompromised patients
with symptomatic or asymptomatic CMV-disease [Percivalle et al., 1993, Salzberger et al.,
1997]. In one study increased numbers of CCIC corresponded to peak levels of antigenemia
and viremia [Percivalle et al., 1993]. The findings support the view that endothelial cells detach
from the vessel wall as a result of HCMV-induced cytopathic effect. These cells then enter
the blood stream leading to dissemination of the virus in peripheral blood. Notably, CCIC
that are in close contact to surrounding leukocytes has been reported [Salzberger et al., 1997]
suggesting virus transmission between these cells.
Bentz et al. reported of increased expression of cell surface adhesion molecules in endothelial
cells after HCMV infection [Bentz et al., 2006]. This was shown to be sufficient for the
adherence of na¨ıve monocytes to the endothelial surface and virus transmission. Further,
CMV-induced morphological alterations in endothelial cells lead to a permeable endothelium
that enables traversing of infected monocytes and hence virus dissemination.
Thus, the identification of the MCMV gene that induces cell rounding during infection and
the examination of a mutant virus lacking the ability to induce cell rounding may exhibit an
excellent tool to study the relevance of cell rounding for the infection process. The elucidation
of the mechanism of CMV-induced cell rounding may further provide insights into cellular
processes that are as yet poorly understood e.g. cell rounding during mitosis.
2.8 Genetic Manipulation of Cytomegaloviruses
Manipulation of the large CMV genomes with the aim of the identification of viral gene func-
tions was first achieved by mutagenesis of isolated virus using UV-irradiation [Hirai et al., 1977,
Ihara et al., 1978]. Mutagenesis by UV-irradiation of virus particles generates mutants that
show temperature-sensitive viral replication [Ihara et al., 1978]. However, the identification
of point mutations is laborious and only few mutated gene regions of HCMV temperature-
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sensitive mutants can be mapped and associated with open reading frames [Ihara et al., 1994].
More recently viral genes have been cloned into plasmids and thus made accessible for ma-
nipulation in bacteria. This approach has been applied in particular to examine the function of
already known viral genes [Manning and Mocarski, 1988]. Mutated fragments are transfected
into cells together with the wild type CMV and homologous recombination replaces a genome
fragment with the mutated sequence. However, homologous recombination is a rare event
in eukaryotic cells, and without any selection for the mutated viral genomes reconstitution of
the wild type CMV would be dominant. Therefore, selection markers were provided with the
mutated viral fragments that were inserted into the viral genome.
The use of viral cosmids to reconstitute the mutated viral genome in the absence of the wild
type CMV genome facilitated the isolation of mutant genomes [Kemble et al., 1996, Ehsani
et al., 2000]. Viral genomes have been cloned in several fragments as a set of overlapping
cosmid clones. After transfection of all the cosmid clones into eukaryotic cells, the wild type
CMV genomes are reconstituted via multiple homologous recombination events. A mutation
can be introduced in one of these fragments. Several viral fragments with mutations have been
constructed by generating a cosmid library using transposon mutagenesis [Zhan et al., 2000].
After transfection and homologous recombination of the single cosmid clones the mutated
genome is reconstituted in the absence of the wild type genome. However, the efficiency of
this method is poor. Further, additional mutations can occur in the viral genome since the
reconstitution of the virus out of the several cosmid clones relies on several recombination
events in the cell.
With the cloning of CMV genomes as bacterial artificial chromosomes (BAC) in E. coli,
manipulation of CMV genomes using bacterial genetics became possible and thus new op-
portunities were opened for the investigation of viral gene functions [Messerle et al., 1997].
After reconstitution from the BAC, the genomic sequence of the virus is indistinguishable from
that of the isolated wild type CMV due to the self-excision of the BAC vector sequences in
eukaryotic cells [Wagner et al., 1999]. Site-directed mutagenesis or random transposon muta-
genesis of the viral genome can be used to generate libraries of virus mutants [Brune et al.,
2006, 1999]. The transposon library has been used to screen for essential and non-essential
herpesvirus genes by random insertions into the viral genome [Brune et al., 1999] whereas the
library of mutants generated by the site-directed mutagenesis technique aims at the manip-
ulation of the viral genome on a selected gene-by-gene basis. Site-directed mutagenesis of
the viral genomes is achieved by homologous recombination between linear DNA fragments or
shuttle plasmids and the viral BAC in E.coli. The site-directed mutagenesis technique using
linear PCR fragments is probably the most frequently used method for the functional analysis
of a specific viral gene. Mutant genomes with introduced deletions, insertions or point muta-
tions can be efficiently generated [Borst et al., 2007]. The reconstituted mutants can then be
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Figure 2.5: Site-directed BAC mutagenesis using linear PCR fragments. The MCMV Smith strain was
previously cloned as a BAC [Messerle et al., 1997]. For this, the viral DNA and recombination plasmids
containing the BAC were transfected into eukaryotic cells to generate a recombinant virus. A selection
marker i.e. the kanamycin resistance cassette (KnR, green bar) flanked by FRT-sites (back bars) was am-
plified by PCR using primers with additional homology to the sequences directly upstream and downstream
of the gene or gene region of interest (blue box). The linear PCR product was electroporated into E.coli
containing the viral BAC and the plasmid pKD46 expressing the recombination enzymes exo, bet, gam. The
recombination enzymes mediate homologous recombination between the PCR product and the BAC. Only
those bacteria containing the mutated BAC are able to grow under selection pressure. The Flp recombinase
is expressed from the pCP20 plasmid and mediates the excision of the selection marker leaving a single
FRT site in the BAC (black bar). The mutated BAC is then transfected into eukaryotic cells to reconstitute
mutant virus. The scheme is not drawn to scale.
screened for the appearance of a searched for phenotype in an appropriate assay. A scheme of
the site-directed mutagenesis using linear PCR fragments is shown in Fig. 2.5. In this way the
functions of several CMV genes have been identified, such as for cell tropism, the inhibition of
apoptosis, the immunomodulation and capsid maturation [Brune et al., 2001, Me´nard et al.,
2003, Hahn et al., 2004, Lilja et al., 2008, Bubic et al., 2004, Hasan et al., 2005, Loewendorf
et al., 2004, Mack et al., 2008, Upton et al., 2008, Borst et al., 2008].
A growing number of HCMV and MCMV strains, have been cloned as BACs to date [Brune
et al., 2006] allowing the maintenance of clonal reference genomes of individual viruses. Fur-
ther, several herpesvirus genomes were cloned as BACs and used to study viral gene functions
[Zhou et al., 2002, Chang and Barry, 2003, Smith and Enquist, 2000, Nagel et al., 2008].
When examining viral gene function, by applying mutagenesis techniques, the observation of
a phenotype upon deletion of a selected gene requires a close investigation of the phentotype-
genotype connection. It is always possible that the phenotype is not caused by the deletion
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of a gene but rather by the deletion of sequence elements that influence adjacent genes.
A suitable tool to prove whether a viral gene is responsible for the observed phenotype is
cis-complementation via integration of the missing gene into the mutant BAC [Borst et al.,
2001].
2.9 Aims of the Study
Among the characteristic features of a cytomegalovirus infection are the broad cell tropism
and the induction of cell rounding [Mocarski et al., 2007, Sinzger et al., 2008, Furukawa
et al., 1973, Fioretti et al., 1973, Ihara et al., 1982, Albrecht et al., 1983, 1980]. Genes
have been identified that determine the tropism of different CMV species for endothelial cells,
macrophages or epithelial cells [Brune et al., 2001, Me´nard et al., 2003, Hahn et al., 2004,
Lilja et al., 2008]. Most of the so-called cell tropism factors interact with cellular factors at a
post-entry step. This raised the hypothesis that cell tropism factors are required in addition
to attachment and entry receptors for the productive infection of a specific cell type. Viral
genes that determine the tropism of MCMV for epithelial cells have not been found yet.
Possible explanations of HCMV-induced cell rounding have been described [Albrecht et al.,
1983, Warren et al., 1994, Poncet et al., 2006] whereas MCMV-induced cell rounding is only
poorly characterised.
The aim of this study was the identification of MCMV epithelial cell tropism factors and
viral genes that induce cell rounding during MCMV-infection.
To this end, the construction of a library of MCMV mutants was intended. The MCMV
genome was previously cloned as a bacterial artificial chromosome in E.coli making it accessible
for mutagenesis exploiting bacterial genetics. Site-directed mutagenesis would be the method
of choice to specifically target single or multiple viral genes for deletion. A cell tropism assay
should be established and used to compare the growth and spread of mutants and wild type
MCMV in epithelial cells and fibroblasts. Further, the mutants would be examined for their
ability to induce cell rounding by analysing the cellular morphology of infected cells.
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3.1 Chemicals and Reagents
The standard chemicals and reagents were purchased from Sigma Aldrich, Steinheim; Roth,
Karlsruhe and Merck, Darmstadt. Plastic labware for tissue culture was purchased from Greiner
Bio-One, Frickenhausen and Sarstedt AG & Co., Nu¨mbrecht. Further, the following chemicals,
reagents and materials were used:
5′-/3′-RACE kit Roche Diagnostics GmbH, Mannheim
1kb Plus DNA ladder Invitrogen, Karlsruhe
100 bp DNA ladder GeneRuler Fermentas, St. Leon-Rot
Riboruler High Range RNA marker Fermentas
40% Acrylamide/ Bisacrylamide (19:1) Qbiogen, Irvine, USA
Bacto-Agar BD Biosciences, Heidelberg
Agarose Invitrogen, Karlsruhe
Ampicillin Roth
Ammoniumpersulfate (APS) Merck, Darmstadt
Aqua Poly Mount Polysciences Inc. Warrington, USA
L-(+)-Arabinose Sigma Aldrich
Bovine Serum Albumine Sigma Aldrich
Benzonase Sigma Aldrich
Carboxymethylcellulose Sigma Aldrich
Chloramphenicol Roth
Calf Intestine Phosphatase (CIP) New England Biolabs, Frankfurt a.M.
Cycloheximide Roth
Electroporation Cuvettes PeqLab, Erlangen
DecaLabel DNA labeling kit Fermentas
Deoxynucleotide mix Invitrogen
DMSO (Dimethylsulfoxid) Roth
DNA-free Kit Ambion, AppliedBiosystems, Darmstadt
Dulbeccos modified Eagles Medium (DMEM)- Sigma Aldrich
high glucose
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DMEM-high glucose Biochrom AG, Berlin
DMEM 10 x Sigma Aldrich
ECL Western Blotting detection reagent Amersham Biosciences, Freiburg
Ethidiumbromid Roth
Folic acid Sigma Aldrich
Formamide Roth
Formaldehyde Merck
Fetal bovine serum (FBS) Biochrom AG
FBS Gold PAA Laboratories GmbH, Co¨lbe
HEPES PAA Laboratories GmbH
High Fidelity Phusion DNA polymerase Finnzymes, Espoo, FIN
Icafectin Eurogenetec, Ko¨ln
jetPEI Polyplus-transfection, Illkirch, France
Kanamycin Roth
Kodak X-omat-AR X-ray films Kodak, Stuttgart
T4 Ligase Fermentas
Lipofectamine2000 Invitrogen
β-Mercaptoethanol Sigma Aldrich
Milk powder Roth
MOPS Roth
BD Microlance 3, needles 0,3 x 13 mm BD Biosciences
Newborn calf serum (NCS) Biochrom AG
Nitrocellulose membrane Hybond-ECL, Amersham Biosciences
Nonidet P40 (NP-40) Sigma Aldrich
Nucleobond PC 100 Macherey-Nagel, Du¨ren
Biodyne B nylon transfer membrane PALL, Fl, USA
Opti-MEM Invitrogen
Phenol/Chloroform/Isoamylalcohol Roth
Phosphonoacetic acid Sigma Aldrich
Paraformaldehyde Sigma Aldrich
Phosphate buffered saline (PBS) PAA Laboratories GmbH
PBS (cell culture) CytoGen, Sinn
Penicillin/Streptomycin/Glutamine PAA Laboratories GmbH
Protease Inhibitor Cocktail Set III Calbiochem, SanDiego, USA
Proteinase K Sigma Aldrich
Full range Rainbow marker GE Healthcare, Mu¨nchen
(225, 150, 102, 76, 52, 38, 31, 24, 12 kDa)
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Spectra Multicolor Broad Range Protein Ladder Fermentas
(260, 140, 100, 70, 50, 40, 35, 25, 15, 10 kDa)
QiaShredder Qiagen, Hilden
Quick PCR purification kit Qiagen
Restriction Enzymes NEB
RNase A Sigma Aldrich
RNase inhibitors Promega, Mannheim
RNeasy kit Qiagen
SDS Roth
Sodium bicarbonate Gibco, Invitrogen, Karlsruhe
Salmon sperm DNA Invitrogen
Spin columns S200 MoBiTec, Go¨ttingen
TEMED (Tetramethylethylendiamin) Serva, Heidelberg
TRITC-Phalloidin Sigma Aldrich
Trypsin/EDTA Biochrom AG
Bacto-Tryptone BD Biosciences
Tween-20 Roth
UltraCleanTM15 Mo Bio Laboratories Inc., Carlsbad, USA
VenorGeM Minerva, Berlin
Yeast Extract Roth
3.2 Cells and Bacteria
NIH 3T3, adherent mouse fibroblasts purchased from ATCC, CRL-1658
C127I, adherent mouse mammary gland derived epithelial cells purchased from ATCC,
CRL-1616
293T cells, adherent human kidney epithelial cells purchased from ATCC, CRL-11268
MEF, adherent primary mouse embryonic fibroblasts prepared from 2 weeks old BALB/c mice
embryos, provided by Lars Steinbru¨ck
E. coli, DH10B: used for the maintenance and cloning of BACs. Genotype: F-mcrA
∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 endA1 araD139 ∆(ara leu) 7697 galU
galK rpsL nupG λ- (Invitrogen)
E.coli, PIR 1: used for the cloning of plasmid pOri6k derivatives. Express the bacteriophage
λ pi protein. Genotype: F- ∆lac169 rpoS(am) robA1 creC510 hsdR514 endA recA1 uidA
(∆Mlu I)::pir-116 (Invitrogen).
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3.3 Antibodies, Probes and Antibiotics
Antibodies
Peroxidase-conjugated goat anti-rabbit IgG DAKO
Peroxidase-conjugated sheep anti-mouse IgG Amersham
Alexa 568 conjugated goat anti-rat IgG Invitrogen
Alexa 568 conjugated goat anti-mouse IgG (H+L) Invitrogen
Monoclonal mouse CROMA101 provided by S. Jonjic, Rijeka,
against the MCMV IE1 protein Croatia
Monoclonal mouse CROMA 103 against MCMV E1 provided by S. Jonjic
Monoclonal mouse 20/352/4, provided by B. Bu¨hler
(against a yet uncharacterised late MCMV protein)
Rat monoclonal anti-HA (subtype IgG1), Roche Diagnostics, Mannheim
(clone 3F10)
Rabbit polyclonal anti-HA, Sigma Aldrich
(recognises the amino acid residues 98-106 of the
human influenza hemagglutinin (HA))
Rabbit monoclonal anti-GAPDH (clone 14C10) Cell Signalling Technologies,
Danvers, MA, USA
probe GFP, corresponds to the cDNA of eGFP obtained from Jens Bohne,
MHH, Hannover
Antibiotics
Chloramphenicol: 170 µg/ml (high copy plasmids), 17 µg/ml (low copy plamids)
Kanamycin: 50 µg/ml (high copy plasmids), 25 µg/ml (low copy plamids)
Ampicillin: 100 µg/ml (high copy plasmids), 50 µg/ml (low copy plasmids)
3.4 BACs and Plasmids
pSM3fr: low copy; BAC plasmid containing the full-length sequence of the MCMV Smith
strain. CamR, [Wagner et al., 1999]
pSM3fr-GFP: low copy; BAC plasmid containing the full-length MCMV sequence of the
Smith strain. The gene expressing the enhanced green fluorescent protein was inserted into
the IE2 locus of the viral genome. CamR (provided by M.Messerle, MHH, Hannover; described
in [Mathys et al., 2003]).
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pIRES2AcGFP1: high copy; Plasmid containing an internal ribosome entry site (IRES) be-
tween an multiple cloning site and the AcGFP1 gene. KnR. Clontech Laboratories Inc.,
Saint-Germain-en-Laye, France.
pACYC177 HindIII A: low copy; Plasmid containing the MCMV HindIII A fragment (pro-
vided by M.Messerle, MHH, Hannover).
pGP704-kan: Plasmid containing the kanamycin resistance cassette flanked by FRT-sites.
Grows only in the presence of the replication factor Pi expressed from the bacteriophage λ pir
gene. KnR [Borst and Messerle, 2005].
pCP20: low copy; Plasmid expressing the Flp recombinase. Temperature sensitive replication
mode at 30◦C. AmpR, CamR. [Cherepanov and Wackernagel, 1995]
pOri6klinker : Plasmid contains a multiple cloning site and the kanamycin resistance cassette
fused to a FRT-site. Grows only in the presence of the λ pi protein. KnR. (provided by E.M.
Borst, MHH, Hannover)
pKD46: low copy; Plasmid expressing the bacteriophage λ recombination enzymes exo, bet,
gam encoded by the genes red α, β, γ under the control of an L-arabinose inducible promoter.
Temperature sensitive replication mode at 30◦C, AmpR [Datsenko and Wanner, 2000].
3.5 Laboratory Equipment
Avanti J-25 Centrifuge BeckmanCoulter, Fullerton, CA, USA
BioPhotometer Eppendorf
Centrifuge 5415D, 5415R Eppendorf, Hamburg
CO2 Cell Incubator Sanyo, Wood Dale, IL, USA
Gel documentation Alpha Innotech Corp., San Leandro, GB
Gene Pulser Xcell System Biorad, Mu¨nchen
Hereaus Megafuge 1.0 ThermoScientific, Waltham, MA, USA
Hereaus Multifuge 3SR+ ThermoScientific
Hoefer SE600 Ruby electrophoresis unit Amersham Biosciences
JA-10, JA-20.1, Type-19, SW40 rotors BeckmanCoulter
LAS-3000 Imager FujiFilm, Du¨sseldorf
Mini-Protean Electrophoresis System Biorad
Mini Trans-Blot Cell Biorad
Nikon Eclipse T5100 Nikon GmbH, Du¨sseldorf
PerfectBlueTM Mini/Maxi S gel system PeqLab, Erlangen
Sterile Hood Hereaus HeraSafe Kendro, Rodenbach
T3 Thermocycler Biometra, Go¨ttingen
TE 62 Transfer Unit Amersham Biosciences
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TL 100 Ultracentrifuge BeckmanCoulter
UV-Stratalinker 2400 Stratagene, LaJolla, CA, USA
Zeiss Axio Observer Microscope Zeiss MicroImaging GmbH, Go¨ttingen
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4.1 Eukaryotic Cell Culture
Cell Culture
BALB/c mouse embryonic fibroblasts (MEF) and C127I were propagated in Dulbecco′s modi-
fied Eagle′s Medium supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/ml
of penicillin and 100 µg/ml of streptomycin sulfate. NIH 3T3 fibroblasts were propagated like-
wise MEF but with 5% newborn calf serum. 293T cells were grown in DMEM supplemented
with 10% FBS gold, 2 mM glutamine, 20 mM HEPES, 100 U/ml of penicillin and 100 µg/ml
of streptomycin sulfate. Cells were monthly tested for mycoplasma contamination by PCR
using Venor R©GeM mycoplasma detecton kit. Cells were grown in a humid atmosphere in an
incubator at 37◦C and 5% CO2.
Cryoconservation of Cells
Cells of a confluent culture dish (ø 10 cm) were trypsinized and resuspended in complete
growth medium. Cells were pelleted by centrifugation in 15 ml centrifugation tubes at 300
x g for 3 min and were resuspended in 2.4 ml DMEM without additives. 800 µl of the cell
suspension were provided in a cryoconservation tube. Freezing medium (DMEM supplemented
with 40% FCS, 20% DMSO) was added dropwise and cells were frozen in a polystyrene box
at -80◦C for 1 week before longterm storage in liquid nitrogen.
Cells were thawed at 37◦C in a water bath and transferred into a 15 ml centrifugation
tube. 5 ml complete growth medium was added dropwise and cells were pelleted at 300 x g for
3 min before they were resuspended in complete growth medium and seeded in a cell culture
dish.
4.2 Mutagenesis of BACs using linear PCR Fragments
MCMV genomes were mutated using E.coli DH10β containing the pSM3fr BAC or the pSM3fr-
GFP BAC. Homologous recombination between linear PCR fragments and the MCMV BAC
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was mediated by the bacteriophage λ recombination enzymes expressed by the genes red α,
-β, and -γ on the plasmid pKD46.
For this, 2-5 ng of plasmid pKD46 were electroporated into bacteria containing the MCMV-
BAC. The bacterial culture was incubated at 30◦C for 1 h and streaked onto an agar plate
containing 17 µg/ ml chloramphenicol and 25 µg/ ml ampicillin. The plate was incubated
overnight at 30◦C. A 100 ml liquid culture of these bacteria was grown to an OD600 of 0.5 to 0.6
under the same selection conditions. The expression of the recombination enzymes was induced
in the presence of 0.1% L-arabinose for 1 h and electrocompetent bacteria were generated from
these cultures. Purified PCR fragments (300 ng) were electroporated into electrocompetent
bacteria (see DNA methods) and recombination of the PCR product into the MCMV BAC
was allowed to happen by incubation for at least 1.5 h at 37◦C with shaking. The transformed
bacteria were streaked out on agar plates containing 17 µg/ ml chloramphenicol and 25 µg/
ml kanamycin. The plasmid pKD46 was eliminated by subsequent overnight incubation at
43◦C. The integrity of the mutant BACs was analysed by small scale preparation of BAC-DNA
followed by restriction analysis.
Generation of linear PCR Fragments for BAC mutagenesis
For the generation of PCR fragments 2-5 ng of plasmid pGP704-kan were used as a template.
Primers that were designed for the generation of the mutant genomes are listed in the appendix.
The primers have a 50 bp homology directly upstream and downstream to the gene or the
gene region of interest and a 20 bp homology to the kanamycin resistance cassette. For a
50 µl PCR reaction a final concentration of 0.2 µM of each primer, 0.01 U of the Phusion
polymerase in HF buffer and 200 µM dNTPs were used. The PCR was carried out using
the follwing cycling conditions: Initial denaturation, 98◦C, 2 min; 35 cycles of (Denaturation,
98◦C, 20 sec; Annealing, 55◦C, 30 sec; Extension, 72◦C, 10 min); Final extension, 72◦C, 10
min; hold, 4◦C.
The PCR product was analysed on a 1 % agarose gel and purified using a spin column
purification kit (Quick PCR purification kit) according to the manufacturers instructions and
eluted in 30 µl TE buffer (10 mM Tris/Cl pH 8.0, 1 mM EDTA).
Excision of the Kanamycin Resistance Cassette
The Flp recombinase mediates recombination between FRT-sites, removing the marker gene
and leaving a single FRT-site in the genome.
5 ng of pCP20, expressing the Flp recombinase, were electroporated into bacteria con-
taining the mutated MCMV BAC. The bacterial culture was incubated at 30◦C for 1 h and
streaked onto an agar plate containing 17 µg/ ml chloramphenicol and 25 µg/ ml ampicillin.
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The plate was incubated overnight at 30◦C. A few colonies were streaked onto an agar plate
containing 17 µg/ ml chloramphenicol only and incubated overnight at 43◦C to eliminate the
pCP20 plasmid. Single colonies (up to 50) were picked on a plate containing kanamycin and
in parallel on a plate containing chloramphenicol only and were incubated overnight at 37◦C.
The BAC DNA of kanamycin-sensitive clones was analyzed by restriction analysis.
4.3 Culture of Bacteria
Cryoconservation of Bacteria
1 volume of a bacterial culture (e.g. from a liquid culture from a large scale DNA preparation)
was mixed with 1 volume of 50% (v/v) glycerol and stored at -80◦C.
Preparation of Electrocompetent Bacteria
A 100 ml bacterial culture grown to an OD600 of 0.5 - 0.8 was chilled on ice for 15 min. The
bacteria were harvested by centrifugation at 4000 rpm for 10 min at 4◦C using the 2704 rotor
in a Hereaus Megafuge 1.0, washed twice with abundant ice-cold sterile ddH2O. The bacteria
were washed once in 10% (v/v) ice-cold glycerol, resuspended in a volume equivalent to the
pellet volume of 10% (v/v) cold glycerol and stored in aliquots at -80◦C. Bacteria were thawed
on ice.
4.4 Virological Methods
Preparation of Virus Stocks
For the preparation of virus stocks, MEF were grown in ten tissue culture dishes (ø 14.5
mm) to 70-80% confluence. MEF were infected with approximately 0.01 PFU/cell and were
cultured until complete cytopathic effect was observed. Cells were harvested together with
the supernatants and intracellular virions were released by at least one freeze-thaw cycle. The
mixture of cells and supernatant was transferred into 500 ml sterile centrifuge buckets. Cellular
debris was separated from medium by centrifugation in a Beckmann JA-10 rotor at 6000 rpm
for 20 min at 4◦C. The supernatant was transferred into sterile centrifuge buckets and virus
was pelleted by centrifugation in a Beckmann Type 19 rotor for 3 h at 13,000 rpm at 4◦C.
The virus-containing pellet was left with a small amount of residual medium on ice over night
at 4◦C. The pellet was resuspended in the residual medium and dounced 20 times on ice. The
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suspension was loaded onto a 2 ml cushion of ice-cold 15% sucrose/virus standart buffer (50
mM Tris/Cl pH 7.8, 12 mM KCl, 5 mM EDTA pH , 15% (w/v) sucrose) in a sterile SW 40
ultracentrifuge tube and centrifuged in a Beckmann Type SW40Ti rotor for 1 h at 20,000
rpm, 4◦C. The supernatant was decanted and the virus-containing pellet was resuspended in 2
ml ice-cold 15% sucrose/VSB and dounced 20 times on ice. The virus suspension was divided
into 50 µl aliquots and stored at -80◦C.
Plaque Assay
Supernatants or virus stocks were titrated on confluent MEF. For this, dilutions were prepared
in 96-well plates. Frozen samples were quickly thawed in a 37◦C water bath and diluted
in ice cold DMEM without serum and antibiotics. Usually, a dilution-series from 1:10 to
1:100,000 was prepared and dilutions from 1:100 to 1:10,000 were prepared and tested. Only
when titers were expected to be low, dilutions of 1:2 to 1:16 were tested. Samples were
titrated in triplicates on confluent MEF seeded in 48-well plates. 100 µl of diluted sample was
applied to the cells and virus was allowed to the cells incubation for 2 h at 37◦C, 5% CO2
before the virus inoculum was removed and cells were covered with 500 µl titration medium
( 0.75% (w/v) carboxymethylcellulose, 5% FBS, 10% 10 x DMEM, 2 mM glutamine, 100
U/ml penicillin, 100 µg/ml streptomycin sulfate, 3.5 g/l D-glucose, 4 mg/l folic acid, 0.37 %
sodium bicarbonate). Plaques were counted four days later using fluorescence microscopy for
pSM3fr-GFP derived MCMV or phase contrast microscopy for pSM3fr-derived MCMV. The
number of plaque-forming units (PFU) per milliliter of sample was calculated.
Reconstitution of Virus
Electroporation of BAC DNA into NIH 3T3 Cells
Mutant viruses used for the cell tropism assays were reconstituted by electroporation of BAC
DNA into NIH 3T3 fibroblasts. Confluent NIH 3T3 fibroblasts of a cell culture dish (ø 10 cm)
were trypsinized and washed once with PBS. Cells were pelleted by centrifugation at 300 x g
for 3 min at RT, resuspended in 800 µl Opti-MEM and transferred into 4 mm electroporation
cuvettes. Approximately 1 µg of BAC DNA was added to the cell suspension. The DNA
was electroporated into cells using the Gene Pulser Xcell System with the following settings:
250 V and 1500 µF. The cells were immediately resuspended in pre-warmed complete growth
medium and seeded into cell culture dishes. The medium was changed the next day. When
total cytopathic effect occurred the supernatant was harvested and used to infect a cell culture
dish (ø 10 cm) with confluently grown MEF. The supernatant from MEF harvested after total
CPE was titrated by plaque assay and used in cell tropism assays.
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Transfection of BAC DNA into MEF
BAC DNA from a medium-scale DNA preparation was transfected into sub-confluent MEF in
a 6-well tissue culture plate. For this, 10 µl (approximately 1 µg) DNA was diluted in 40 µl
150 mM NaCl solution and 2 µl jetPEI were diluted in 48 µl 150 mM NaCl solution. The 50
µl jetPEI solution was then added to the 50 µl DNA solution all at once. The solution was
mixed without vortexing and incubated for 25 min. Before adding the solution dropwise to the
cells, the medium was aspirated and 1 ml of new medium was provided. After the addition of
the solution the tissue culture plate was centrifuged for 20 min at 300 x g. The next day, 1
ml of medium was added to the transfected cell cultures.
Viral Growth Kinetics
For the analysis of virus growth kinetics, NIH 3T3 fibroblasts or MEF were seeded at a density
of 1 x 105cells/well in 12-well plates. Cells were infected at a MOI of 0.1 or at a MOI of 0.3 with
centrifugation enhancement for 20 min at 300 x g resulting in an approximately 10-fold increase
of infection. Supernatants from infected cultures were harvested at different time points after
infection and titrated by plaque assay on MEF. Cells were pelleted by centrifugation of 5 min
at 6000 rpm and the supernatant was transferred into fresh tubes and stored at -80 ◦C until
all samples were collected.
4.5 DNA Methods
Preparation of DNA from Virus Particles
A cell culture dish (ø 10 cm) with sub-confluently grown MEF or 3T3 was infected at a
MOI of 0.1 or less. When total cytopathic effect was achieved cells were scraped into 15
ml centrifugation tubes and were frozen with the supernatant at -80◦C. Cell associated virus
was released by thawing the samples at 37◦C in a water bath. Cellular debris was pelleted
by centrifugation at 923 x g for 10 min at 4◦C. The supernatant was transferred into SW 40
ultracentrifugation tubes and virus particles were pellet at 25,000 rpm for 1 h at 4◦C using an
Beckmann Type SW40Ti rotor. For degradation of cellular DNA the pellet was resuspended
in 500 µl Benzonase buffer (50 mM Tris/Cl pH 8.0, 1 mM MgCl2, 100 µg/ml BSA) and
incubated with Benzonase (100 U) for 1 h at RT. Enzyme activity was deactivated by adding
20 µl 0.5 M EDTA, pH 8.0. Viral capsids were solubilized by adding 500 µl 1% SDS. Cellular
and capsid proteins were degraded in the presence of Proteinase K (final concentration 400
µg/ml) at 65◦C for 2-3 h thereby releasing the viral DNA.
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Viral DNA was extracted once with phenol/chloroform. For this, 1 volume of
phenol/chloroform/isoamylalkohol (25:24:1) was added to the aqueous solution and mixed
by inverting the sample for 2 min. Subsequent centrifugation at 14,000 rpm for 5 min at 4◦C
in a 5417R Eppendorf table centrifuge led to the separation into three phases. The aqueous
upper phase contained the viral DNA and was collected. After the addition of 1 µl of a glyco-
gen solution (35 mg/ml) and 1/10 volume 3 M NaAc pH 5.2 the viral DNA was precipitated
with 0.8 vol. of isopropanol at 14,000 rpm for 30 min at 4◦C in a 5417R Eppendorf table
centrifuge. The DNA pellet was washed once with 70% EtOH and dissolved in 100 µl 20
µg/µl RNase A/TE buffer (10mM Tris/Cl pH 7.5, 1 mM EDTA). The DNA was analysed by
restriction analysis of 10-30 µl of the dissolved viral DNA.
RNase A stock solution: 10 mg/ ml in 10 mM Tris/Cl pH 7.5/ 15 mM NaCl
Preparation of Plasmid or BAC DNA
Small-scale Preparation
In the following protocol the volumes for the preparation of plasmid DNA are given without
parentheses and the volumes for the preparation of BAC DNA are given in parentheses. A
single bacterial colony was used to inoculate 3 ml (10 ml) LB medium (1% tryptone, 0.5%
yeast extract, 1% NaCl) and were grown overnight with the respective antibiotics. Bacteria
were harvested by centrifugation at 4000 rpm for 10 min at 4◦C and resuspended in 100 µl
(200 µl) Solution I (50 mM glucose, 10 mM EDTA, 25 mM Tris/Cl pH 8.0). For cell lysis the
suspension was mixed and incubated with 100 µl (200 µl) of Solution II (0.2 M NaOH, 1 %
SDS) not longer than 5 min. 200 µl (300 µl) of ice-cold Solution III (3 M potassium acetate,
pH 4.8) was used to precipitate proteins and cellular debris on ice for 5 min. The precipitate
was pelleted by centrifugation at 14,000 rpm for 5 min at 4◦C. The supernatant was collected
and DNA was precipitated by addition of 0.8 vol. isopropanol and centrifugation at 14,000
rpm for 5-10 min at 4◦C. The DNA pellet was washed once with 70% EtOH and dissolved
in 50 µl (50 µl) 20 µg/µl RNase A/TE buffer (10 mM Tris/Cl pH 7.5, 1 mM EDTA). The
DNA pattern was analysed by restriction analysis of 0.5-2 µl (45 µl) of the dissolved plasmid
or BAC DNA .
Medium-scale Preparation
Glycerol stocks or pre-cultures of the bacteria containing the plasmid or the viral BAC were
used to inoculate 100 ml of LB medium. Cultures were grown overnight in the presence of
the respective antibiotics. Bacteria were harvested by centrifugation at 4000 rpm for 10 min
at 4◦C. The DNA was purified using the Nucleobond PC 100 DNA purification protocol for
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low copy plasmids was used according to the manufacturers instructions. The DNA pellet
was dissolved in 100 µl (100 µl) 20 µg/µl RNase A/TE buffer (10 mM Tris/Cl pH 7.5, 1
mM EDTA). The DNA pattern was analysed by restriction analysis of 1-5 µl (10 µl) of the
dissolved DNA.
Electroporation of Bacteria
2-5 ng of plasmid DNA were used to transform a 50 µl aliquot of electrocompetent bacteria
by electroporation in 2 mm electroporation cuvettes using the Gene Pulser Xcell System with
the following settings: 2500 V, 15µF and 300 µΩ. The bacteria were resuspended in 500 µl of
LB medium, incubated at the required temperatures for 1 h and streaked onto an agar plate
with the required antibiotics.
Transfection of Plasmids into Cells
For transfection 5 x 105 NIH 3T3 cells/well or 8 x 105 293T cells/well were seeded into a
6-well plate. 2.5 µg plasmid DNA was transfected using 6.5 µl Icafectin according to the
manufacturers instructions. Medium was exchanged 12 h after transfection, and cells were
harvested for Western Blotting 24 h post transfection.
NIH 3T3 fibroblasts were transfected in 6-well plates with the pIRESM25 constructs or the
empty vector using 2 µg DNA and 10 µl Lipofectamine transfection reagent according to the
manufacturers instructions.
Restriction Analysis of Plasmid DNA
The integritiy of plasmid DNA was controlled by digesting 0.5 - 2 µl of 50 µl dissolved DNA
from a small-scale DNA preparation using 5 - 10 U of enzyme in the appropriate buffer for
1 h at 37◦C. The sample was supplemented with DNA loading buffer and fragments were
separated in a 1 - 2% agarose gel in 1 x TAE buffer (40 mM Tris base, 40 mM acetic acid,
1 mM EDTA) at 100 V for 45 min using the PerfectBlueTM Mini S gel system. Gels were
stained with ethidium bromide to visualize the DNA fragments.
Restriction Analysis of BAC DNA
To analyse the integrity of the viral BACs after mutagenesis, 45 µl of 50 µl of dissolved BAC
DNA from a small-scale preparation, 10 µl of 100 µl of dissolved BAC DNA from a medium-
scale preparation or 10 µl of 100 µl of dissolved viral DNA from a virus DNA preparation were
treated with 20 U of the restriction enzyme in the appropriate buffer for 1.5-3 h at 37◦C.
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Agarose Gel Electrophoresis
The DNA sample was supplemented with DNA loading buffer (50 % (v/v) glycerol, 0.37 mM
Bromphenolblue, 10 mM EDTA pH 8.0) and fragments were separated in a 0.6 % agarose
gel in 1 x TBE buffer (90 mM Tris/Cl pH 8.3, 90 mM boric acid, 2 mM EDTA) at 80 V for
12-16 h using the PerfectBlueTM Maxi S gel system. Gels were stained with ethidium bromid
to visualize the DNA fragments.
Extraction of DNA from Agarose Gels
DNA was extracted from agarose gels using the UltraCleanTM15 DNA purification kit according
to the manufacturers instructions. The DNA pellet was dissolved in 30 µl elution buffer.
Phosphatase Treatment of Vector DNA
To prevent religation of linearized vector DNA the 5′-phosphate groups can be removed from
vector DNA using the alkaline phosphatase (CIP). For this, the vector is treated with alkaline
phosphate (0.5 U/µg DNA) in the appropriate buffer at 37◦C for 1 h.
Ligation
Ligation was carried out using a 1:1 up to 3:1 molar ratio of insert DNA to vector DNA. 1-2 U
T4 DNA Ligase were used in the appropriate buffer and supplemented with PEG 4000 solution
if necessary (for blunt end ligation). The mixture was incubated in a waterbath overnight at
16◦C.
Cloning of the pIRESM25CHA and pIRESM25NHA vectors
The pIRESM25CHA vector was constructed by PCR amplification of the full length M25
ORF using primers M25CHA-EcoRI and M25CHA-PstI and wild type BAC DNA as template.
Primer M25CHA-EcoRI contains an EcoRI restriction site and primer M25CHA-PstI contains
the sequence of the hemaglutinin (HA) tag and a PstI restriction site. The HA-tag was
added to the M25 C-terminus for later M25 protein detection with an HA-specific antibody.
The product was then digested with EcoRI and PstI and ligated into EcoRI/PstI digested
pIRES2AcGFP1 between the HCMV major immediately early promoter (MIEP) and the IRES
giving rise to pIRESM25CHA. The M25-HA construct was ligated via EcoRI/PstI downstream
of the HCMV major immediate early promoter (MIEP) and upstream of the IRES in order to
produce the pIRESM25-tagged constructs.
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The M25CHA vector construct contains 51 nt spanning the region between the transcript
start and M25 translation start codon ATG. This sequence represents the 5′ untranslated region
(UTR) or leader sequence and should ensure proper recognition of the ATG by ribosomes
[Kozak, 1987]. The C-terminal HA-tag could theoretically have a negative influence on M25
protein function by altering the folding of the protein.
Considering this possibility, a second plasmid was constructed in which an HA-tag was
added to the M25 N-terminus. The M25 ORF contains more than 10 ATGs in frame. Transla-
tion initiation is to some extent determined by the nucleotide context around the ATG [Kozak,
1999]. For adding an HA-tag to the N-terminus, the 5th ATG was chosen since this particular
ATG was claimed to be the initiation codon according to Dallas et al., possibly because it is
surrounded by a strong context [Dallas et al., 1994]. Primers HANM25-EcoRI and HANM25-
PstI were used to amplify the ORF M25 providing 48 nt spanning the 5′ UTR. Here, the
sequence for the HA-tag is provided with the primer HANM25-EcoRI. The integrity of the
M25 sequence and the HA-tag was confirmed by sequencing.
Quick Mutagenesis of Plasmids by PCR
This protocol is based on the method for the site-directed mutagenesis of double-stranded DNA
by PCR [Weiner et al., 1994]. It relies on amplification of full-length plasmid using primers
facing opposite directions. The method allows easy and quick introduction of point-mutations,
deletions and insertions into plasmids. The plasmid pIRESM25CHA containing the complete
predicted M25 ORF [Rawlinson et al., 1996] was used as a template to shorten the M25 ORF
by PCR. 60 ng of template DNA were used in a 50 µl reaction and 200 µM of each forward
primer ATG N◦ 2 to ATG N◦ 10 were used with the reverse primer HMIEP N◦1. Forward and
reverse primers were ordered with phosphorylated 5′ends for subsequent circularization of the
linear PCR fragments by ligation. The Phusion polymerase (0.5 U/50 µl reaction) was used
for amplification according to the manufacturers protocol with the following PCR conditions:
Initial denaturation, 98◦C, 1 min; 35 cycles of (Denaturation, 98◦C, 10 sec; Annealing, 62◦C,
30 sec; Extension, 72◦C, 3 min); Final extension, 72◦C, 10 min; hold, 4◦C.
The size of the PCR products was analysed by separating 5 µl of each reaction on a 1%
agarose gel. The remaining 45 µl of the PCR reaction were separated on a 1 % agarose gel
and DNA fragments with the correct size were excised and purified from agarose using the
UltraCleanTM15 kit and eluted in 30 µl ddH20. For removal of methylated template DNA,
DpnI was added to the eluted PCR products and was incubated at 37◦C for 1 h. The PCR
products were purified using the Quick PCR purification kit and the DNA concentration was
determined by measuring the OD260. An OD260=1 is equivalent to 50 µg/ ml of DNA. The
linear plasmids were circularized using T4 ligase in the appropriate buffer overnight at 16 ◦C
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Figure 4.1: Quick mutatgenesis of Plasmids by PCR A standard reverse primer (HMIEP.rev) was used in all
reactions and annealed downstream of the major IE promoter sequence amplifying the promoter sequence
and the following vector sequence in the negative orientation. The individual forward primers amplified
the plasmid in positive orientation. Primer annealing took place in front of the individual ATG ensuring
approximately 50 nt between transcription start and initiation of translation. A 5′-leader sequence of at
least 20 nt is required for efficient translation of the 1st ATG in vertebrates [Kozak, 1987]. The scheme is
not drawn to scale.
and electroporated in DH10B bacteria for the generation of new plasmids. The presence of
the correct DNA fragments was controlled by restriction enzyme digest of plasmid DNA. The
integrity of the M25 sequence was checked by sequencing.
Generation of the M25R virus
For the construction of the M25R virus, the kanamycin resistance gene was excised from
the ∆M24-m25.2 BAC by Flp-mediated recombination. A 4.3 kbp fragment of the plasmid
pOriM25 consisting of the M25 ORF and containing 840 bp of the sequences upstream of
the M25 start codon and 748 bp downstream of the M25 stop codon, predicted to provide
suitable promoter elements and the polyadenylation signal was excised with StuI/PstI from
the pACYC177 vector containing the complete HindIII A fragment of the pSM3fr BAC. The
fragment was ligated to HpaI/PstI digested pOri6klinker vector giving rise to the pOriM25.
The pOri6klinker vector contains of a kanamycin resistance cassette with a single FRT-site.
The complete 5.9 kb pOri6M25 construct integrated into the ∆M24-m25.2 ∆KnR BAC using
FLP-mediated recombination, giving rise to the M25R BAC. Infectious virus was reconstituted
in MEF.
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Sequencing
Plasmids and PCR fragments were sequenced on ABI 3730XL 96-Capillary Sequencers at
EUROFINS MWG Operon, Ebersberg. BAC-DNA and products from the 5′/3′ RACE were sent
to Sequiserve, Vaterstetten and were sequenced on ABI Prism 3730 48-Capillary Sequencers.
4.6 RNA Methods
RNA Preparation
3T3 cells were seeded at a density of 5 x 105cells/well in a 6-well plate the day before the
experiment. A total of 1.5 x 106 cells was infected with purified virus stock at a MOI of 0.3
with centrifugal enhancement at 300 x g for 20 min. Total RNA was extracted using the
RNeasy kit according to the manufacturers protocol. Cells were directly lysed in the wells
using the β-mercaptoethanol - containing lysis buffer RLT. Lysates were homogenized using
QIAshredder homogenizers according to the manufacturers instructions.
The quality of the RNA was determined by measuring the OD260 and OD280 and calculating
the 260/280 ratio. Pure RNA is determined by a ratio between 1.8 - 2.0. An OD260 of 1 is
equivalent to 40 µg/ml of RNA.
Northern Blotting
10 µg of purified total RNA were denaturated in 20 µl deionised formamide/ 6 µl formaldehyde/
2 µl 20x MOPS for 10 min at 65◦C and separated by size at 125 V in a 1% agarose gel (1%
agarose, 11.35% (v/v) formaldehyde in DEPC-treated ddH2O) in running buffer (1x MOPS/
7.5 % formaldehyde in DEPC-treated ddH2O). The gel was washed 3 x 10 min in DEPC-
treated ddH2O and was equilibrated together with the nylon transfer membrane for 20 min in
20x SSC. Subsequently, RNAs were transferred onto a nylon membrane in 20x SSC overnight
using capillary transfer and were immobilised with 1200 Joules in a UV-light cross-linker. Gene-
specific probes were raised by PCR on MCMV wild-type BAC DNA using gene-specific primers.
Probes (25 ng) were radiolabeled with 32P-dCTP (2 MBq/probe) using the DecaLabel DNA
labeling kit and were separated from unincorporated nucleotides using MoBiTec spin columns.
The membrane was pre-hybridised for 2 h at 42◦C in hybridisation buffer (6 x SSC/ 5 x
Denhard′s solution/ 50% (v/v) deionised formamide/ 1% (w/v) SDS/ 0.5 mg salmon sperm
DNA) before the labelled probes were added. Hybridisation of the membrane was carried out
overnight at 42◦C. The membrane was rinsed once and washed for 15 min in pre-warmed 2x
SSC followed by three additional washing steps for 15 min each in pre-warmed washing buffers
containing lowered concentrations of SSC (2x SSC/ 0.1% SDS; 1x SSC/ 0.1% SDS; 0.1x
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SSC/ 0.1% SDS) and were sealed and exposed to X-ray films.
20x MOPS: 400 mM MOPS, 200 mM sodium acetate, 20 mM EDTA in ddH2O
20x SSC: 3 M NaCl pH 7.2, 0.3 M sodium citrate in ddH2O
50x Denhard′s solution: 1% Ficoll, 1% polyvinylpyrrolidone, 1% bovine serum albumin.
Transcript Mapping using Rapid Amplification of cDNA Ends
For mapping of viral transcripts, infected cells were harvested at different time points and
RNA was prepared as described in this section, RNA Preparation. To avoid the binding of the
primer to remaining DNA, purified RNA samples were treated with the DNA-free kit. The
sample was adjusted to 100 µg RNA/ml and the contaminating DNA was degraded using
DNAse I in the presence of RNAse inhibitors. Mapping of the transcription start site (5′-end)
and 3′-end of the M25 transcript was carried out with the 5′-/3′-RACE kit according to the
manufacturers instructions. (See Fig. 4.2)
In brief, for determination of the 5′-end, first strand cDNA was synthesized from 1 µg
total RNA using a gene-specific primer 5′-SP1. The mRNA template was degraded by the
RNase H activity of the Reverse Transcriptase. The cDNA was purified from unincorporated
nucleotides and primers and was then used for addition of a homopolymeric A-tail to the 3′-end
of the cDNA. Tailed cDNA was then amplified by PCR using a gene-specific primer 5′-SP2
and an Oligo(dT)-anchor primer. First-strand cDNA synthesis for the determination of the
3′-end of the transcript was initiated at the poly(A)-tail of the mRNA using the Oligo(dT)-
anchor primer. The mRNA template was degraded by the RNase H activity of the Reverse
Transcriptase. Amplification of the resulting cDNA was then performed using the PCR anchor
primer that binds to the Oligo(dT)-anchor primer sequence and a gene-specific primer 5′-SP3.
The PCR conditions were optimised by raising the annealing temperature from standard 55
◦C to 65 ◦C to avoid unspecific primer binding. PCR products were separated by agarose-gel
electrophoresis. A fraction of the PCR sample was sent for sequencing. When DNA fragments
were excised from the agarose-gel, they were purified from agarose using the UltraCleanTM15
DNA purification kit according to the manufacturers instructions and were sequenced.
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Figure 4.2: 5′/3′ Rapid amplification of cDNA ends. Overview of the 5′ RACE. (A) Synthesis of the first
strand cDNA with the gene specific primer SP5′-1. (B) Degradation of the mRNA template by the RNase
H activity of Transcriptor Reverse Transcriptase. (C) Tailing of the purified cDNA. (D) Amplification of
the tailed cDNA by PCR using the Oligo (dT)-anchor primer and a second gene specific primer SP5′-2.
Overview of the 3′RACE. (A) cDNA synthesis using the Oligo (dT)-anchor primer. (B) Degradation of
the mRNA by the RNase H activity of Transcriptor Reverse Transcriptase. (C) Amplification of the cDNA
by PCR using a gene specific primer SP3′-1 and the PCR anchor primer. Scheme is modified from Roche
Applied Science.
4.7 Protein Methods
Immunoblotting
Preparation of Cell Lysates
For the kinetics of M25 protein expression 1 x 106cells NIH 3T3 cells were infected in 6-well
plates (5 x 105cells/well) for every investigated time point. A MOI of 0.5 was used followed
by centrifugation of the plates for 20 min at 300 x g leading to an approximately 10-fold
increase of infection. Cells were scraped and transferred together with the supernatant into
15 ml centrifugation tubes. Cells were pelleted at 300 x g for 3 min and resuspended in 1
ml ice-cold PBS to determine the number of cells. The cell suspension was transferred into
1 ml centrifuge tubes. Cells were pelleted again and 1 x 106 cells were lysed in 100 µl lysis
buffer (125 mM NaCl, 20 mM Tris/Cl pH 7.4, 1% NP-40) containing 1% protease inhibitors
per 1 x 106 cells followed by 5 min incubation on ice. Cellular DNA was sheared using needles
and cellular debris was pelleted at 14,000 rpm for 5 min using the 5417R Eppendorf table
centrifuge. Cell lysates were frozen at -20 ◦C or directly used for immunoblotting.
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SDS-PAGE
Proteins were separated by size in either small (8 cm wide) 10% or large (18 cm wide) 7.5%
polyacrylamide gels. For the 10% resolving gel, 2.5 ml 40% acrylamide mix, 2.5 ml 1.5 M
Tris/Cl pH 8.8, 100 µl 10% SDS and 4.8 ml H20 were mixed. The polymerisation was started
by adding 4 µl TEMED and 100 µl 10% ammonium persulfate. For the 7.5% resolving gel, 4.7
ml 40% acrylamide mix, 6.3 ml 1.5 M Tris/Cl pH 8.8, 250 µl 10% SDS and 13.5 ml H20 were
mixed. The polymerisation was started by adding 25 µl TEMED and 250 µl 10% ammonium
persulfate. The solutions were casted into vertical electrophoresis units and were overlaid with
2-isopropanol and allowed to polymerise. The Mini-Protean Electrophoresis system was used
for the small gels and the Hoefer SE 600 Ruby electrophoresis system was used for the large
gels. For the 5% stacking gel a solution was prepared of 0.4 ml 40% acrylamide mix, 0.38 ml
1.5 M Tris/Cl pH 6.8, 30 µl 10% SDS, 2.2 ml H20, 3 µl TEMED and 30 µl 10% ammonium
persulfate for small gels and 1.25 ml 40% acrylamide mix, 1.25 ml 1.5 M Tris/Cl pH 6.8, 100
µl 10% SDS, 7.3 ml H20, 15 µl TEMED and 100 µl 10% ammonium persulfate for the large
gels and casted onto the polymerised resolving gel.
Cell lysates were diluted 1:1 in protein loading buffer (500 µl protein sample buffer, (2%)
β-Mercaptoethanol) and were boiled for 5 min at 99◦C and loaded onto polyacryamide gels.
The protein samples were loaded onto a polyacrylamide gel and separated by size using a
Mini-Protean Electrophoresis system in running buffer A (25 mM Tris base, 250 mM Glycine,
0.1% SDS) at 50-100 V or a Hoefer SE 600 Ruby electrophoresis system in running buffer B
(25 mM Tris base, 192 mM Glycine, 0.1 % SDS) at 100 mA.
Protein sample buffer: 100 mM Tris/Cl pH 6.8, 4% SDS (w/v), 0.2% (w/v) Bromphenolblue,
20% (v/v) glycerol
Western Blotting
Proteins were transferred from the polyacryamide gels onto nitrocellulose membranes in trans-
fer buffer A (20% methanol, 40 mM Tris base, 119 mM Glycine) using a Mini Trans-Blot Cell
apparatus at 0.35 mA for 1 h or in case of the 7.5 % gels in transfer buffer B (10% Methanol,
48 mM Tris base, 380 mM Glycine, 0.1% (w/v) SDS) using a water-cooled TE 62 transfer
unit at 100 mA for 16 h.
Immunostaining
Unspecific binding sites were blocked by incubating the membrane for 1 h in blocking buffer
(2%milk powder in PBS/ 0.1% Tween) at RT. The membrane was incubated for 1.5 h with the
first antibody diluted in 2% milk powder in PBS/ 0.1% Tween under weak agitation. Excess
antibody was removed by rinsing the membrane with PBS/ 0.1% Tween followed by 1 x 15
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min and 3 x 5 min washing before incubation for 1.5 h with the horseradish peroxidase-linked
second antibody diluted in PBS/Tween 0.1%. After the incubation period the membrane was
rinsed once with PBS/ 0.1% Tween and washed 1 x 15 min and 3 x 5 min, treated with ECL
Western Blotting detection reagent and developed using a LAS-3000 imager.
Stripping
Primary and secondary antibodies were removed from the membranes by incubation in stripping
buffer (100 mM β-Mercaptoethanol, 2 % SDS, 62.5 mM Tris/Cl pH 6.7) for 30 min at 50◦C.
The membranes were washed twice for 10 min with large volumes of wash buffer ( PBS/ 1%
Tween) at RT followed by repeating the immunostaining protocol.
Immunofluorescence
Cells were seeded on coverslips (ø 10 mm) at a density of 1 x 104 - 1 x 105 cells/well in a
24-well plate one day before infection. A MOI of 0.1 was used, followed by centrifugation of
the plates for 20 min at 300 x g thereby increasing the infection approximately 10-fold. Cells
were briefly washed in PBS and fixed with PBS/ 3% paraformaldehyde (PFA) for 20 minutes at
different time points after infection. Remaining PFA was inactivated by incubating the cells in
PBS/ 50 mM NH4Cl for at least 10 min. Incubation with PBS/ 0.2% Triton-X 100 for exactly
5 min was used to permeabilize the plasma membrane. To minimize background staining free
binding sites were blocked with PBS/ 0.5% (w/v) BSA at RT for 30 min. Cells were then
incubated with the appropriate dilution of the primary antibody, washed 3 x 5 min in PBS, and
then incubated with secondary antibody directly coupled to a fluorescent dye. First and second
antibodies were diluted in PBS/ 0.5% (w/v) BSA. After incubation with the second antibody
cells were washed 3 x 5 min with PBS. Cells were dipped in ddH2O to eliminate excess BSA
and PBS before they were mounted with Aqua Poly Mount and analyzed using a Zeiss Axio
Observer laser scanning microscope. Images were further processed using Adobe Photoshop
CS 3. Filamentous actin was labelled using TRITC-Phalloidin. This is a toxin of the mushroom
Amantia phalloides that binds to and stabilises actin filaments. Fluorophore-coupled Phalloidin
is commonly used to visualise actin filaments by fluorescence microscopy.
4.8 Cell Tropism Assay
MEF and C127I were seeded in 6-well plates at a density of 1 x 105 cells/well 16-20 h before
the experiment. Each virus was tested in triplicate cultures. MEF and C127I were infected
at a MOI of 0.01. For the initial screening of the growth properties of the MCMV mutants
47
4 Methods
supernatants of infected cultures were used for infection. Virus stocks or supernatants were
quickly thawed in a 37◦C water bath and kept on ice. Virus was diluted in pre-warmed complete
growth medium and 1 ml/ well was used for inoculation. Virus was allowed to bind to the cells
by incubation of the plates for 2 h at 37◦C, 5% CO2 before the virus inoculum was replaced
by 2 ml of new growth medium. Cells were then further incubated at 37◦C, 5% CO2. On day
six after infection 200 µl supernatants were harvested form each well. Cells were pelleted at
6000 rpm in a 5417R Eppendorf table centrifuge for 5 min at RT and the supernatants were
transferred into fresh tubes, frozen in liquid nitrogen and stored at - 80◦C until all samples were
obtained. Viral titers were determined by plaque assay on MEF. Virus spread was documented
on day two and day six after infection using fluorescence microscopy.
4.9 Infection of Cells for the Screening of the Cellular
Morphology
Cells were infected in 6-well plates at a MOI of 0.3 with centrifugal enhancement for 20 min
at 300 x g leading to an approximately 10-fold increase of infection. For this, virus was diluted
in 1 ml of complete growth medium. The growth medium was removed from the cells and the
virus inoculum was pipetted onto the cells. After centrifugation, the cells were incubated for
2 h in a humid atmosphere in an incubator at 37◦C and 5% CO2. 1 ml of complete growth
medium was added after the 2 h incubation. Cellular morphology was analysed at 48 h after
infection using fluorescence microscopy.
4.10 Analysis of the Cellular Morphology after
Transfection of the pIRES vectors
NIH 3T3 fibroblasts were transfected with the pIRESM25CHA, pIRESM25NHA or the empty
pIREsAcGFP1 plasmids as described above. At 48 hours after infection the number of trans-
fected outstreched or round cells was determined in four to five random fields of view from
one well of cells transfected with an individual plasmid using a fluorescence microscope. The
percentage of round cells of total counted cells from a single field of view was calculated. The
value of the mean percentage and its standard deviation was determined from all analysed
frames of one plasmid.
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4.11 Bioinformatic Tools
The following prediction programs were used. For the alignment of two protein sequences
and the similarity searches of a protein or a nucleotide sequence, the Basic Local Alignment
Tool (BLAST) (http : //blast.ncbi.nlm.nih.gov/Blast.cgi) was used [Altschul et al., 1990,
Tatusova and Madden, 1999]. PSORT II predicts subcellular localization sites of proteins from
their amino acid sequence [Nakai and Horton, 1999]. SOSUI discriminates between soluble
and membrane proteins by analysing helices hydrophobicity and protein length based on known
soluble and membrane proteins [Mitaku and Hirokawa, 1999]. NetPhos, predicts serine, thre-
onine and tyrosine phosphorylation sites in a given protein sequence [Blom et al., 1999]. The
molecular weight of a protein was predicted using Compute pI/MW (http://expasy.org/tools/).
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The productive infection of epithelial cells and the induction of cell rounding are hallmarks
of cytomegalovirus infection. A library of mouse cytomegalovirus mutants was generated, in
order to study viral gene function required for the productive infection of epithelial cells and
the induction of cell rounding.
5.1 Generation of a Library of Mouse Cytomegalovirus
Mutants
The MCMV deletion mutants were generated using the BAC mutagenesis technique. The
MCMV Smith strain was previously cloned as a bacterial artificial chromosome (BAC) in E. coli
thereby making it accessible for manipulation using the methods of bacterial genetics [Messerle
et al., 1997]. This method uses homologous recombination between linear DNA fragments
obtained by PCR and the BAC-cloned MCMV genome employing the recombination enzymes
of bacteriophage λ. As an example, a scheme of the construction of the ∆M24-m25.2 mutant
is shown in Fig.5.1.
In principle, a selection marker, e.g. the kanamycin resistance gene, is amplified by PCR
using primers with a 20 bp homology to the kanamycin resistance cassette and a 50 bp ho-
mology at either end of the target gene. The amplified linear DNA fragment is electroporated
into the bacteria which contain the MCMV BAC and a plasmid expressing the recombination
enzymes exo, bet and gam. The recombination enzymes mediate the homologous recombi-
nation between the linear DNA fragment and the MCMV BAC. The bacteria containing the
mutant BAC are then identified by antibiotic selection. The mutant BAC is isolated and the
integrity of the BAC DNA is analysed by restriction enzyme analysis.
All mutants that were generated in this study were analysed for genome integrity by cutting
BAC DNA with at least two restriction enzymes. In addition, viral DNA was prepared from
infected fibroblasts and the correct DNA pattern was assured by restriction analysis of the
DNA.
The restriction patterns of the wild type MCMV BAC and three BAC mutants, ∆M24-
m25.2, ∆m139-m141 and ∆m42-M43, after treatment with EcoRI, are shown in Fig.5.2.
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Figure 5.1: BAC mutagenesis using
linear DNA fragments (A) The
kanamycin resistance gene, flanked
by FRT-sites was amplified by PCR
using primers with a 20 bp homology
to the template DNA and a 50 bp
homology to the sequence within the
ORF M24 or to the sequence within
the ORF m25.2 on the MCMV BAC.
(B) In the presence of the recom-
bination enzymes exo, bet and gam
the linear PCR fragment recombines
with the homologous regions of the
BAC to replace the sequence be-
tween the ORFs M24 to m25.2. (C)
In some mutants the kanamycin re-
sistance cassette was excised. The
Flp recombinase was expressed and
mediates DNA excision between the
two directly orientated FRT-sites,
leaving only a single FRT-site in the
mutant BAC.
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Figure 5.2: Analysis of MCMV BAC mutants. (A) BAC DNA from wild type MCMV or MCMV mutants
was cut with EcoRI or HindIII restriction enzymes and DNA fragments were separated on an 0.6 % agarose
gel. Arrows point to the new fragments generated in the mutant BAC genomes that are not present in the
wild type BAC DNA (wt). Size markers are indicated to the left. (B) Schematic illustration of selected DNA
fragments after cutting the wild type MCMV BAC (wt), the ∆M24-m25.2 BAC (1), the ∆m139-m141 BAC
(2) and the ∆m42-M43 mutant BAC (3) with EcoRI. Genomic positions of the EcoRI sites are indicated
in bp and the sizes of the DNA fragments are given in kb. The dashed lines indicate the insertion of the
kanamycin resistance cassette. The scheme is not drawn to scale.
The wild type MCMV BAC contains two EcoRI restriction sites upstream of the M24 and
downstream of the M26 genes (Fig.5.2B, panel 1, upper line). The intervening fragment has
a size of 13.6 kb and was replaced to produce the ∆M24-m25.2 BAC. This gave rise to two
new fragments of 3.5 and 6.1 kb (Fig.5.2B, panel 1, lower line). The genes m139 to m141
of the wild type MCMV BAC are flanked by two EcoRI sites leading to a 4.7 kb fragment
(Fig.5.2B, panel 2, upper line). The ∆m139-m141 virus mutant was generated by partially
deleting this region thereby disrupting the 4.7 kb fragment. The insertion of the kanamycin
resistance cassette produced two new fragments of 2.0 and 8.0 kb (Fig.5.2B, panel 2, lower
line). Treatment of the wild type MCMV BAC with EcoRI generates a 8.7 kb fragment
containing the m42 and M43 genes. Deletion of the m42 and M43 genes and insertion of the
kanamycin resistance cassette disrupted the 8.7 kb fragment and produced two fragments of
1.1 and 6.0 kb (Fig.5.2B, panel 3). Taken together, the fragments produced after cutting with
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EcoRI indicated that the mutant genomes had the expected integrity.
The electroporation of BAC DNA of each mutant genome into NIH 3T3 cells led to the
reconstitution of infectious virus that was able to produce plaques in fibroblasts.
The BAC mutagenesis technique allowed the manipulation of MCMV genomes and was
used for the generation of a library of 18 MCMV mutants. The individual deletions from the
MCMV genome encompassed between 1 and 19 genes. In total, 105 genes were covered,
referring to the published genomic sequence of the MCMV Smith strain [Rawlinson et al.,
1996]. For the generation of the mutant viruses sequences of ranging from 1 to 14 kb were
deleted from the wild type MCMV BAC. Genes that are MCMV-specific as well as genes that
are common among all CMV were targeted for deletion (Fig.5.3). Most of the targeted genes
have previously been shown to be non-essential for viral replication in fibroblasts [Brune et al.,
2006]. Genes that are located in the region that is conserved among all herpesviruses and
thought to comprise the essential genes for the replication in cell culture e.g. in fibroblasts
were not targeted for deletion. The function of the proteins encoded by the majority of the
genes targeted for deletion is not known or has not been studied in detail. Manipulating the
MCMV genome allows the study of viral gene functions in the context of the viral life cycle.
In summary, a library of mouse cytomegalovirus mutants was constructed, which then served
as a basis to study viral gene function. In particular, the aim was to identify viral factors of
MCMV that are critical for the productive infection of epithelial cells and for virus-induced cell
rounding.
5.2 Searching for Viral Factors determining the Epithelial
Cell Tropism of MCMV
Cytomegaloviruses infect cells of various origin and with various functions such as monocytes
and macrophages, smooth muscle cells, fibroblasts, endothelial and epithelial cells. Epithelial
cells are of particular interest, firstly because they are among the first cells to become infected
by CMV in the oral epithelium of the mucosa and therefore may influence the course of an
infection. Secondly, epithelial cells of the salivary gland are major producers of infectious
virus and therefore play an important role for the transmission of the virus in the population.
To identify viral factors that permit viral growth in epithelial cells, a cell tropism assay was
established that allows to investigate the growth of CMV mutants in epithelial cells.
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Figure 5.3: Overview of the constructed MCMV deletion viruses. The vertical bars represent the ORFs
in the genome of the Smith strain [Rawlinson et al., 1996]. Black bars indicate the ORFs which are specific
for MCMV. The blue bars indicate ORFs which are common for CMVs and the green bars represent ORFs
located in the region that is conserved throughout all herpesviruses. MCMV ORFs with homologs in HCMV
are indicated by uppercase prefixes (M45), whereas ORFs without sequence similarity with HCMV ORFs are
indicated by lowercase prefixes (m01). The horizontal black lines show the deletions that were introduced
and the names of the corresponding virus mutants are mentioned underneath. For an orientation, the
HindIII fragments of the MCMV genome are annotated in grey. The scheme is not drawn to scale.
5.2.1 Establishment of a Cell Tropism Assay and Screening of a
Library of MCMV Mutants
The cell tropism assay was designed in such a way that the growth of a virus in fibroblasts
could be compared with the growth of the same virus in epithelial cells. For this, primary
mouse embryonic fibroblasts (MEF) and epithelial cells (C127I) were infected with wild type
MCMV or mutant viruses. C127I cells are derived from a mouse mammary gland epithelial
tumor and both MEF and C127I are permissive for MCMV infection [Kim and Carp, 1971,
Smee et al., 1989]. MCMV can infect and replicate in these cells, leading to typical plaque
formation, and produces progeny virus. The wild type MCMV represents the standard for viral
growth in fibroblasts or epithelial cells and viral growth of the mutants was therefore analysed
and compared with regard to the growth properties of the wild type MCMV. The titres of sets
of virus mutants and of the wild type MCMV were determined in parallel before the viruses
were used in the cell tropism assay (Fig.5.6, diagrams 1-4). In this way, it was assured that
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Figure 5.4: Outline of the Cell Tropsim Assay. Fibroblasts (MEF) and epithelial cells (C127I) were infected
using a MOI of 0.01 with wild type MCMV (wt) or various MCMV mutants (M1-5). All viruses express the
green fluorescent protein, allowing the identification of infected cells. Wild type MCMV productively infects
both, fibroblasts and epithelial cells. Two days post infection (p.i) only a few cells are infected but at day
6 p.i. the virus has spread to most cells. Infection with the mutant viruses leads to a similar number of
infected cells at day 2 p.i. All virus mutants are expected to grow in fibroblasts and most virus mutants will
grow in epithelial cells. However, if a viral gene is deleted that expresses an epithelial cell tropism factor,
the respective virus mutant will not grow in epithelial cells (e.g. M1, M5). Viral growth is analysed by
determination of the viral titres and cell-to-cell spread by fluorescence microscopy on day 6 p.i.
the inoculation doses of the viruses were as similar as possible.
A low multiplicity of infection (MOI) of 0.01 was used. A low MOI enables the virus to
replicate and to infect neighbouring cells in such a way that the spread of the virus could
be monitored. All mutant viruses and the wild type MCMV expressed the enhanced green
fluorescent protein EGFP. EGFP emits bright green light when exposed to UV-light, making
it possible to identify infected cells by fluorescence microscopy.
Viral titres were determined from supernatants of infected cells harvested at day six after
infection. In general, MCMV titres in fibroblasts increase from day 2 to 4 exponentially and
reach the stationary phase on day 5 to 6. MCMV growth in epithelial cells in general is slower.
Thus, six days after infection represents a suitable time point for the comparison of viral titres
of the wild type MCMV with those of different virus mutants. In addition, cell-to-cell spread
was documented by taking images from the infected cells with a fluorescence microscope at
two and six days after infection. The cell tropism assay is outlined in Fig.5.4.
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The cell tropism assay was employed to investigate the viral cell-to-cell spread and growth
of all the generated virus mutants. Fibroblasts and epithelial cells were infected in parallel with
wild type MCMV or the virus mutants at an MOI of 0.01. Viral spread was documented two
days and six days after infection by fluorescence microscopy.
Infected cells could be identified at two days after infection. As an example the viral spread
of two selected virus mutants and of the wild type MCMV is shown in Fig.5.5. Single MCMV-
infected GFP-positive fibroblasts or epithelial cells infected with either wild type MCMV, the
∆m39-m40 or the ∆m106-m108 virus mutants were found. Six days after infection GFP
expression was not only visible in single cells but also in neighbouring fibroblasts (Fig.5.5A).
This and the formation of plaques indicated that all viruses were able to productively infect
fibroblasts.
Infection of neighbouring epithelial cells and plaque formation was observed in wild type
MCMV infected cultures (Fig.5.5B) and for most virus mutants. However, the ∆m106-m108
mutant as well as five additional virus mutants, ∆m29-M31, ∆M28-M31, ∆M35-M37 and
∆M45 failed to spread in epithelial cells. The presence of single infected cells and small plaques
in epithelial cells indicated that these virus mutants infected epithelial cells but did not spread
efficiently in these cells.
At six days after infection the viral titres were analysed. To this end, supernatants from in-
fected fibroblasts or epithelial cells were harvested and the viral titres were determined (Fig.5.6).
In fibroblasts, five virus mutants∆M33, ∆m39-m40,∆m128-m138,∆m139-m141 and∆m01-
m17 yielded similar titres compared to those of the wild type MCMV. Thirteen virus mutants
(∆m18-m23.1, ∆M116, ∆m106-m108, ∆m159-m170, ∆m29-M31, ∆m42-M32, ∆m117-
m120, ∆M28-M31, ∆M24-m25.2 ∆M35-M37, ∆M45, ∆m121 and ∆m144-m158) yielded
maximally two orders of magnitude lower titres compared to the titre of the wild type MCMV.
This indicated that the deletion of genes from the virus genome or possibly the insertion of
non-viral DNA, i.e. the kanamycin resistence cassette, influenced already the viral growth in
fibroblasts.
In epithelial cells, the ∆m42-M43, ∆m139-m141 and the ∆m01-m17 virus mutants yielded
similar or even higher titres compared to those of the wild type MCMV and 15 virus mu-
tants grew to lower titres than wild type MCMV. The titres of 10 virus mutants, ∆m18-
m23.1, ∆M116, ∆m39-m40, ∆M33, ∆m121, ∆m128-m138, ∆m144-m158, ∆M24-m25.2,
were slightly lower compared to the titre determined for wild type MCMV in epithelial cells
(maximally one order of magnitude). Two virus mutants, ∆m29-M31 and ∆m106-m108, grew
to titres that were up to three orders of magnitude lower compared to the titre from wild type
MCMV infected epithelial cells. The titres of three virus mutants, ∆M28-M31, ∆M35-M37,
∆M45, remained below the detection limit. The data obtained from the analysis of the viral
titres were consistent with the results obtained from viral spread. Whenever lower titres were
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C127I
Figure 5.5: Viral spread of MCMV mutants in fibroblasts and epithelial cells. MEF (A) and C127I (B)
were infected in parallel using a MOI of 0.01 with wild type MCMV (wt) or the virus mutants ∆m39-m40
or ∆m106-m108. MCMV infected cells expressing GFP were monitored at 2 days and 6 days after infection
by fluorescence microscopy.
determined, the respective virus did not spread in epithelial cells as efficient as the wild type
MCMV. The overall lower titres determined from infected epithelial cells suggest that MCMV
grows more slowly on the epithelial cell line C127I as in primary fibroblasts.
In order to identify a virus mutant that is impaired to grow in epithelial cells, the titres of
individual virus mutants obtained from epithelial cells were compared to the respective titre of
the wild type MCMV. Virus mutants that did not grow at all in epithelial cells or that grew to
at least 1.5 orders of magnitude lower titres compared to those of the wild type MCMV were
selected. Five virus mutants were identified. Infection of epithelial cells with the ∆m29-M31
virus yielded 1.5 orders of magnitude lower titres or with the ∆m106-m108 viruses three orders
of magnitude lower titres (Fig.5.6, D2, see arrow), respectively, compared to those of the wild
type MCMV. The titres of the ∆M35-M37, ∆M45 or ∆M28-M31 viruses in epithelial cells
remained below the detection limit. However, the virus mutants ∆M28-M31, ∆m29-M31,
58
5.2 Searching for Viral Factors determining the Epithelial Cell Tropism of MCMV
MEF C127I
D1 D2
D3 D4
Figure 5.6: Viral growth of MCMV mutants in fibroblasts or epithelial cells. MEF and C127I were
infected with wild type (wt) or MCMV mutants using a MOI of 0.01 in triplicate. Supernatants were
harvested on day six and viral titres (PFU/ml) were determined by plaque assay on MEF. Data show the
results of one representative experiment out of three independent experiments. The dashed line shows the
detection limit of the virus plaque assay. Error bars indicate standard deviation of the mean value. Virus
mutants were investigated independently as sets of viruses indicated in diagrams D1-D4.
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∆M35-M37 and ∆M45 already failed to grow to high titres in fibroblasts. The titres of these
viruses in fibroblasts were at least 1.5 orders of magnitude lower compared to those of the
wild type MCMV. This is possibly due to an overall impaired growth caused by the deleted
genes and was thus not considered to be unique for the growth in epithelial cells. In contrast,
the ∆m106-m108 mutant yielded only slightly lower titres in fibroblasts compared to the titre
of the wild type MCMV (maximally one order of magnitude). Therefore, this mutant was
considered to lack a viral factor required primarily for the growth in epithelial cells and thus
the following work focused on the analysis of the m106 to m108 region of the MCMV genome.
5.2.2 Analysis of the ∆m106-m108 Virus Mutant
In order to define the reason for the lack of growth of the ∆m106-m108 virus mutant in
epithelial cells, additional virus mutants were generated. Three ORFs, m106, m107 and
m108, are predicted in the targeted region [Rawlinson et al., 1996]. Additional smaller ORFs
m106.1, m106.2, m106.3, m106.4, m106.5, m107.1 m107.2 and 107.3 have also been predicted
[Brocchieri et al., 2005]. The m106 gene overlaps with the newly annotated ORFs m106.1 and
m106.2 whereas the ORFs m107 and the m108 show a >60 % overlap due to the localisation
of the ORF m108 on the complementary strand (Fig.5.7). The newly annotated ORFs m107.1,
107.2 and m107.3 overlap with the ORFs m107 and m108. The ORFs m106.3, m106.4 and
m106.5 are located in the region between the ORFs m106 and m107. In addition, a 7.2 kb
stable, non-coding intron RNA was reported to be produced from the region between the
ORFs m106 and m107 [Kulesza and Shenk, 2006]. The expression of RNA from the predicted
ORFs m106, m107 and m108 was also examined using microarray-based oligonucleotide-cDNA
hybridisation [Tang et al., 2006]. RNA expression could be confirmed for the ORFs m106 and
m108, but the array analysis provided no evidence for the presence of a m107 transcript.
The functions of the transcripts mentioned above, have not been elucidated and no proteins
encoded from these ORFs have yet been found.
To investigate the role of the ORFs m106, m107 and m108 additional virus mutants were
generated using the BAC mutagenesis technique. The generated virus mutants are illustrated
in Fig.5.7. Potential expression of the ORFs m106, m107 and m108 was abolished with
the deletion of these ORFs giving rise to the ∆m106 and ∆m107-m108 virus mutants. The
deletion of the ORFs m106, m107 and m108 included also the ORFs m106.1, m106.2, m107.1,
m107.2 and m107.3. To investigate a potential role of the stable intron RNA in epithelial cell
tropism, 3.3 kb were deleted of the DNA sequence including the ORF m106.4, in the mutant
denoted ∆intron. To exclude possible influences on viral growth, the kanamycin resistance
cassette was removed by Flp-mediated recombination from the genomes of the mutant viruses.
Infectious virus was reconstituted from the mutant BACs. MEF and C127I were infected in
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Figure 5.7: Schematic illustration of the m106-m108 region and the generated deletion viruses. Black
bars indicate the deletions in the virus mutants according to the annotated ORFs. The nucleotide position
(bp) of the deletions in the genome is given in parenthesis. Virus mutants that could grow in C127I epithelial
cells are marked with a tick, virus mutants that were impaired to grow in C127I cells are marked with a
cross. The illustration is not drawn to scale.
parallel with ∆m106∆kan, ∆intron∆kan or ∆m107-m108∆kan using a MOI of 0.01. Wild
type MCMV and the ∆m106-m108 virus mutant were used as controls. Supernatants from
three independent experiments were harvested six days after infection and viral titres were
determined by plaque assay.
The titres that were determined for MEF or C127I infected with the virus mutants
∆m106∆kan or ∆intron∆kan were comparable to the titres determined for the wild type
MCMV (Fig.5.8A). Given that the shorter intron RNA lacking almost half of its sequence is
non-functional and no m106 protein can be expressed from the deleted m106 ORF, the results
indicate that these factors do not determine viral growth in epithelial cells. Viral growth of
the ∆m106-m108 mutant was reduced in MEF and C127I compared to the growth of the wild
type MCMV. Although the titre obtained for MEF was approximately 1.5 orders of magnitude
lower compared to those of the wild type MCMV, the titre obtained for the C127I was ap-
proximately three orders of magnitude reduced compared to the titre of the wild type MCMV
(Fig.5.8A). The titre obtained from ∆m107-m108∆kan-infected MEF was two orders of mag-
nitude lower compared to those of the wild type MCMV. In contrast, the ∆m107-m108∆kan
virus did not produce detectable amounts of infectious virus. In a second experiment the
∆m107-m108∆kan virus did grow to detectable titers and yielded more than three orders of
magnitude lower titers in C127I compared to those of the wild type MCMV (data not shown).
Viral spread in the infected cultures was investigated after six days of infection (data not
shown). Here, small plaques were observed for C127I infected with the ∆m107-m108∆kan
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Figure 5.8: Viral growth of mutants with deletions in the m107-m108 region of the MCMV genome.
MEF and C127I were infected using a MOI of 0.01 in triplicate with wild type (wt) or MCMV mutants.
Supernatants were harvested six days after infection and viral titres (PFU/ml) were determined by plaque
assay on MEF. (A) The growth of the ∆m106∆kan, ∆intron∆kan and ∆m107-m108∆kan viruses was
analysed. The ∆m106-m108 virus genome still contains the kanamycin resistance cassette. Data show the
results of one experiment out of two independent experiments. (B) The kanamycin resistance cassette was
excised from the ∆m106-m108 BAC and the growth of the ∆m106-m108∆kan virus was analysed. Error
bars indicate standard deviation of the mean value.
or ∆m106-m108 viruses, whereas in MEF viral spread was comparable to wild type MCMV,
∆m106∆kan or ∆intron∆kan infected cultures. The latter also showed similar viral spread
in C127I. Thus, viral spread was consistent with the data obtained for the viral titres in the
respective cultures.
In order to compare virus mutants that only differ in the deleted genes the kanamycin
resistance cassette was also excised from the ∆m106-m108 BAC. Virus was reconstituted
from the ∆m106-m108∆kan BAC and viral growth on epithelial cells was investigated together
with the ∆m106∆kan, ∆intron∆kan and ∆m107-m108∆kan viruses (Fig.5.8B) In contrast to
the ∆m106-m108 virus, the ∆m106-m108∆kan virus grew similary to the wild type MCMV
in fibroblasts but was impaired to grow in C127I. The ∆m107-m108∆kan virus produced
infectious progeny in MEF but failed to do so in C127I.
To conclude, the reduced growth of the ∆m107-m108∆kan virus mutant in epithelial cells
pointed to the presence of factors encoded in the m107-m108 region that are required for viral
growth in epithelial cells. In the following, the virus mutants are designated without ∆kan.
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5.2.3 Does the 7.2 kb Stable Intron RNA Function as a Tropism
Factor for Epithelial Cells?
The aim of the following experiments was to pinpoint the cause of the impaired growth of
the ∆m107-m108 virus in epithelial cells. The 7.2 kb stable intron RNA was considered as
a potential epithelial cell tropism factor for the following reason: the in vivo growth analysis
of a virus mutant lacking the intron RNA sequence by another group revealed an impaired
growth in the salivary glands [Kulesza and Shenk, 2006]. Since MCMV replication in the
salivary gland is restricted to a specialised epithelial cell [Jonjic et al., 1989] it was speculated
that the 7.2 kb stable intron limits viral growth in these cells. The shortening of the intron
RNA sequence to half of its size did not inhibit viral growth in epithelial cells (Fig.5.8A, B).
Although changes of the secondary structure of the intron RNA are expected in this mutant,
it could theoretically retain its function as a potential epithelial tropism factor. According
to the published coordinates for the primary transcript, from which the intron is spliced, the
∆m107-m108 virus lacks at least 66 bp from the 5′- end for the primary transcript including
the potential 5′-transcription start site (Fig.5.9.A). Thus, the generation of the intron RNA
might be prevented during infection from the ∆m107-m108 virus thereby being a limiting
factor for viral growth in epithelial cells. In order to investigate this possibility, the 5′-end of
the primary transcript was re-analysed first.
Mapping the 5′-end of the Primary Transcript that Produces the 7.2 kb Intron
RNA
Total RNA was isolated from uninfected or wild type MCMV-infected MEF at 24 hours after
infection. This time point was considered as suitable since the 7.2 kb stable intron RNA
was shown to accumulate at late times of infection [Kulesza and Shenk, 2004]. For the
determination of the ends of the primary transcript rapid amplification of either 5′- or 3′-
cDNA ends (RACE) was performed.
To map the 5′-end of the primary transcript of the spliced 7.2 kb intron RNA, cDNA was
synthesised and amplified using first and second primers that were located within the m106
ORF. A major band of approximately 550 bp and a slightly lower migrating band of approx-
imately 450 bp were detected as well as a higher molecular weight (MW) smear (Fig.5.9B).
Sequence analysis of the major PCR product using the second gene specific primer identified a
473 bp sequence. The first 163 bp of the sequence completely mapped to the region between
the primer 106-2 and the predicted splice acceptor site (Fig.5.9C). The remaining sequence
mapped to the region starting at the predicted splice donor site and identified the 5′-end of
the m106 transcript at position 161,932. A poly(A) signal (AAUAAA) was identified at nt
position 153,899, downstream of the mapped m106 transcript. No TATA box was found in
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Figure 5.9: Mapping of the transcription start for the 7.2 kb stable RNA. (A) Position of the stable
intron RNA in relation of the deletions (black bars) of the virus mutants. The ORFs are indicated with open
arrows. The dashed line marks one end of the deletion in the ∆m107-m108 virus mutant, indicating the
lack of the 5′-end of the 7.2 kb intron RNA in this mutant. The nucleotide positions (bp) of the deletions
are given in parentheses. (B) Mapping the m106 transcription start by 5′-RACE. Total RNA was prepared
from uninfected (mock) or wild type MCMV-infected (wt) MEF at 24 h p.i. First, cDNA was synthesised
from total RNA using the gene specific primer 106-1. The cDNA was then PCR amplified with the second
gene specific primer 106-2 and an oligo dT anchor primer. PCR products were analysed by agarose gel
electrophoresis. Size markers are indicated to the left. (C) The MCMV m106 to m108 region. The location
of the primers used for the 5′-RACE experiment is shown. The genomic positions of the splice acceptor
(SA), splice donor (SD) and the and the 5′-end of the stable intron RNA are indicated. The illustration is
not drawn to scale.
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close proximity to the mapped m106 transcription start site. Instead a GC-rich sequence was
identified within 85 nt upstream of the m106 5′-end.
These results support the prediction that the generation of the 7.2 kb intron RNA from
the ∆m107-m108 genome is not possible, as 66 bp of the sequence of the primary transcript
including the apparent transcription start site are missing.
Analysing the Presence of the 7.2 kb Intron RNA in ∆m107-m108 Infected Cells
It was considered possible that an alternative transcription start site, that is present in the
∆m107-m108 virus, permits the production of a primary RNA and retains the splicing of the
7.2 kb stable intron RNA.
In order to investigate if the 7.2 kb intron RNA is produced in ∆m107-m108 infected cells,
Northern blot analysis was performed. MEF were infected with the ∆m107-m108, ∆m106
and ∆intron virus mutants. In addition, cells were infected with wild type MCMV and a
∆7.2kbSD virus mutant in which the splice donor of the 7.2 kb intron RNA was deleted.
Total RNA was prepared from infected cultures 24 hours after infection and was processed for
Northern blotting. Radiolabeled DNA probes were used for the detection of the 7.2 kb intron
RNA. An additional probe, located within the ORF m106, was applied to detect the primary
transcript producing the 7.2 kb intron RNA and a GFP-specific probe was used in order to
estimate the total amount of viral RNA present in the samples.
The GFP probe detected similar amounts of GFP-specific RNA in all samples except for the
∆m107-m108 infected cells, indicating that fewer cells were infected compared to the number
of cells infected with wild type MCMV or the other virus mutants (Fig.5.10C, compare lanes
2-4, 6 with lane 5). An approximately 7 kb RNA was detected with the intron probe in
cells infected with the wild type MCMV that apparently corresponds to the spliced 7.2 kb
intron RNA (Fig.5.10A, lane 2). The same probe also detected an approximately 8 kb RNA
that possibly represents the 8 kb intron RNA which is produced from the m106-m108 locus
in addition to the 7.2 kb intron RNA but does accumulate to a much lower level [Kulesza
and Shenk, 2006]. In addition, an approximately 5 kb RNA species was detected which is of
unknown origin (Fig.5.10A, lane 2). The strong intensity of the signal indicates, that it is not
due to unspecific binding of the intron probe, thus, it possibly represents an additional smaller
RNA produced from the same locus as the 7.2 kb intron RNA. Consisting with the detection
of the 7.2 kb intron RNA, the m106 specific probe detected a RNA that migrated to a size
of about 1 kb, which is suggested to represent the spliced transcript, in wild type infected
cells (Fig.5.10B, lane 2) [Kulesza and Shenk, 2006]. The calculated length of the mature
RNA is 1 kb based on the presence of the sequences from the m106 transcription start site
up to the identified poly(A) signal plus a poly (A) tail of about 200 nt. In ∆m106 infected
cells, no RNA corresponding to the 7.2 kb intron RNA was detected (Fig.5.10A, lane 3). The
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Figure 5.10: Analysis of MCMV-specific RNAs indicating the presence of a 7.2 kb intron RNA. (A)
MEF were infected with wild type MCMV (wt) or the indicated deletion mutants and total RNA was
prepared at 24 hours after infection. Northern blot hybridisation was performed on three different blots
with radiolabeled DNA probes. (A) Detection of the intron RNA with a specific probe. The arrows point to
the 7.2 and 8 kb intron RNAs. Size markers are indicated to the left. (B) Detection of the approximately 1
kb splice product (arrow) that is generated when the 7.2 kb intron is excised from the primary transcript.
(C) The GFP probe detects an approximately 1.4 kb RNA (black arrow). The sizes of the detected RNAs
in B and C were estimated relative to the position of the 18s rRNA (1,874 bases) and 28s rRNA (4,718
bases). (D) Location of the probes (red or green bars) within the m106 to m108 region. The genomic
position of the potential poly (A) signal of the primary transcript is indicated in parentheses. The ORFs
m106, m107 and m108 are illustrated as open arrows. The illustration is not drawn to scale.
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absence of the 7.2 kb RNA from ∆m106 infected cells indicated that splicing of the intron
RNA is not possible without the splice acceptor that is deleted in the ∆m106 BAC. This was
also confirmed with the absence of the 1 kb spliced transcript RNA (Fig.5.10B, lane 3). In
contrast, an approximately 3.8 kb RNA was detected with the intron probe in ∆intron infected
cells (Fig.5.10A, lane 4). Further, an approximately 1 kb RNA was detected with the m106
probe (Fig.5.10B, lane 4). This indicated that the deletion of 3.4 kb from 7.2 kb of the intron
sequence did not inhibit the splicing event but that a shorter 3.8 kb intron RNA is produced
instead that retains its stability at late times of infection.
An approximately 7 kb RNA was the only RNA species detected in ∆m107-m108 infected
cells (Fig.5.10A, lane 5). The weak signal detected from this RNA could be explained with
the low amounts of viral RNA isolated from ∆m107-m108 infected cells. The presence of
the 7 kb RNA, migrating with the same kinetics as the spliced 7.2 kb intron RNA, suggested
splicing of the primary transcript producing the 7.2 kb intron RNA although the transcription
start was deleted in this mutant (Fig.5.10A, lane 5). This is possibly due to the presence of
an alternative transcription start. If the 7.2 kb intron is produced, the spliced 1 kb transcript
should be detectable with the m106 probe. However, this RNA was not detected in RNA
isolated from ∆m107-m108 infected cells (Fig.5.10B, lane 5). Neither the intron probe nor
the m106 probe detected RNA that was prepared from cells infected with the ∆7.2kbSD
virus mutant, indicating that the 7.2 kb intron RNA could not be generated in this mutant
(Fig.5.10A, lane 6 and Fig.5.10B, lane 6).
To conclude, Northern blot analysis using a probe that hybridises to the 7.2 intron sequence
identified a RNA species in ∆m107-m108 infected cells that migrated with the same kinetics
as the RNA identified as the 7.2 kb intron RNA in wild type MCMV-infected cells. However,
no RNA corresponding to the spliced transcript was detected.
Analysis of the Growth Properties of the ∆7.2kbSD Virus in Epithelial Cells
To rule out any effects of the 7.2 kb RNA for the epithelial cell tropism of MCMV, the growth
of the ∆7.2kbSD virus in epithelial cells was investigated. In the corresponding BAC the splice
donor for the generation of the 7.2 kb intron RNA was deleted. In fibroblasts infected with the
reconstituted virus no 7.2 kb intron RNA was detected by Northern blotting indicating that
generation of the large intron RNA does not occur (Fig.5.10A, lane 6). The investigation of
the viral growth of the ∆7.2kbSD virus mutant in epithelial cells should clarify the role of the
7.2 kb RNA for the epithelial cell tropism of MCMV. Cells were infected with the ∆7.2kbSD
virus mutant as described for the cell tropism assay. Viral supernatants were harvested and
analysed by plaque assay.
In three independent experiments the ∆7.2kbSD virus grew to comparable titres in fibro-
blasts or epithelial cells (Fig.5.11). Analysis of the viral cell-to-cell spread showed comparable
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numbers of infected fibroblasts and epithelial cells (data not shown). This indicated that the
7.2 kb stable intron RNA is not essential for the growth in either cell type and thus a role in
epithelial cell tropism of MCMV can be excluded.
MEF C127I
Figure 5.11: Growth of the ∆7.2kbSD virus mutant. MEF and
C127I were infected using a MOI of 0.01 in triplicate with wild
type (wt) or MCMV mutants. Supernatants were harvested on
day 6 and viral titres (PFU/ml) were determined by plaque assay
on MEF. Data show the results of one representative experiment
out of three independent experiments. Error bars indicate stan-
dard deviation of the mean value.
5.2.4 Analysis of the m107 and m108 Genes as Viral Factors
Determining the Epithelial Cell Tropism of MCMV
Next, it was investigated whether the m107 or m108 genes play a role for the epithelial cell
tropism of MCMV. For this, the synthesis of RNAs and proteins from the ORFs m107 and
m108 were analysed.
Total RNA was isolated from uninfected or wild type MCMV infected MEF at 24 hours
after infection. This time point was considered as suitable for the investigation of a m108
transcript since it was shown previously that a m108 RNA is expressed at that time point
[Tang et al., 2006]. The 5′- and/or 3′-ends of the potential m107 or m108 transcripts were
determined using 5′- or 3′-RACE.
The primer 108-2 binds to the sequence that is predicted to comprise the ORF m108.
Using this primer in the m108 5′-RACE, a fragment of about 300 bp was amplified (Fig.5.12A,
lane 1). Analysis of this PCR product revealed a sequence of 275 bp that mapped exactly to
the m108 ORF. The m108 transcription start site was mapped five nucleotides upstream of
the predicted ATG of the m108 ORF to nucleotide position 162,775. For the detection of the
3′-end of the m108 transcript the primer 108-3 was used. Using this primer two fragments
of approximately 550 and 650 bp were amplified (Fig.5.12A, lane 2). Analysis of the PCR
products revealed that both sequences were identical except for 108 bp that were present in
the 620 bp sequence and absent from the 512 bp sequence.
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162,800  TGTGCCTGTC TCCCCGGACC CGCCTAGCAG ATGGTCTATA ACCTCACCGC GGACCGCCGA CATGCACGAG ATCGAGTCTC GAGAGCCCGT CCGAGACCTG
  
162,700  GCCCGGCGGC TCGTGCGGAT GTTCAACCTA GTGGCGCTCC TCGTCCTGGC CGGCCGCGCG AGGCCTTCGC CGAAGCGCAG GGGCCTCGGC TCGAGATAGC
  
162,600  GCGGCGTCCG TCGCACCGTA CGGCGTTCGA GATGCCGGTG GCGTCGAGCG GGTGTCCGAA GAGGGGTTTT CCCGGTCCGA TCGGCTCGAT GAGGGGGTCG
  
162,500  AGCACCGTCG GTATCGCCGT GACGAGCGAC CGCTCGTTCA CGAGCAACCG CCCGAAATGT GGGTCTTCCG CCTCGTTACG CACGTGTAAG TATACGGCGT
  
162,400  ACGGAGCTCC GTTCGTTTCT AACGGTAGCT CGTGTCGAGC GGTCGTCCGA TCCTCCGATC CTCCGAGGGC TGACGGACCT TCCCCGTTTT CAGGTCCGCT
  
162,300  TCGGTTACTT GATCGCATCG GACACGCGGA CGTGGTACGA GCACCCGTTC GCTTCGATCG AGCGGTCGTG GCGTTCGCGG CAATCAAATA ACACGGACGA
  
162,200  GCGGGTAATC GAAGCGAGCG GTCGGTCGCT ACGAGGGGTC GGTCGAAGCG AGAGATCACT CGTCGCGAGC GGTCACTCGA CGCGAGCACC GAGTCGCTAC
  
162,100  GGACGGTGAC TCGAGACGAG TGACCGGTCG ACGAGCGTCG GTCAGGCCGC CGATGGAGCA CCTCCCTACG TACTCCCTCC GAACCCGTCC CCGTCCGCCC
 
162,000  GCCCGTCCGT CCGTCCATGC GCCCATCCAG CCCCCGGGTT AAAAAGAAAG TCCGTGACCG GGTCGGCCGA AGGAACCCCA CCGGCACGGG GAAATAAAAT
  
161,900  GATCACGCTA CCACCGTGTG TCTCCGTACT CCGCTATTAT ACTTTGCGGC GTCGGACGTG ACCGCGCTAG GTAGGATACC TGGAGTGTAG GTATTCACCG
1 2
Figure 5.12: Detection of a m108 transcript. (A) 5′-/3′- RACE. Total RNA was prepared from wild type
MCMV infected MEF. First, cDNA was synthesised from total RNA using the gene specific primer 108-1.
The cDNA was then PCR amplified with the second gene specific primer 108-2 and an oligo dT anchor
primer (lane 1). For mapping of the 3′-end of a m108 transcript, cDNA was synthesised using the oligo dT
anchor primer. The cDNA was amplified with the 108-3 primer and the PCR anchor primer (lane 2). PCR
products were analysed by agarose gel electrophoresis. Size markers are indicated to the left. (B) Illustration
of the MCMV m107- m108 region. Predicted ORFs are illustrated with open arrows. The genomic position
of the 7.2 kb stable intron RNA and the location of the primers used for the RACE experiments are shown.
The genomic positions of the primers 108-2, 108-3, the splice acceptor (SA) and splice donor (SD) of the
identified 108 bp intron as well as the mapped transcription start site and the 3′-end are indicated. (C)
Genomic sequence of the m108 transcript. The putative translation start codons ATG and the stop codon
TAA are indicated in green and red, respectively. The mapped start site of the transcript is marked with
an arrow. The putative poly (A) signal is underlined. The 108 bp intron RNA sequence is indicated in blue
letters with the splice donor (SD) and splice acceptor (SA). The illustration is not drawn to scale.
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This result indicated the presence of an 108 bp intron which is spliced from a primary
transcript. Sequence analysis of the 108 bp intron splice donor site (exon-gcacgt/gtaagt-
intron) and splice acceptor site (intron-cag/gtccgct-exon) revealed the presence of consensus
splice donor or splice acceptor sequences [Proudfoot et al., 2002]. A conserved splicing signal
(CUAAC) required for branching of the intron RNA during the splicing process was identified
75 nt upstream of the splice acceptor within the intron sequence. The 3′-end of the transcripts
was mapped to the nucleotide position 161,889 and a poly (A) signal (AAAUAAAA) was found
21 nt upstream of the 3′-end.
The synthesis of a m107 transcript was analysed by mapping the 5′- and 3′-end using the
primers 107-1, 107-2 and 107-3. A PCR product, indicative of a m107 transcript, was not
found even when different PCR conditions were applied (data not shown). This suggests that
no m107 transcript is synthesised.
To summarise the data, a m108 transcript could be identified by mapping the m108 tran-
scription start site and the 3′-end. Further there is evidence for a 108 bp intron that is excised
from a m108 primary transcript. The existence of a m107 transcript was not evident.
Is the m108 Gene an Epithelial Cell Tropism Factor?
Since m108 gene expression could be demonstrated by identifying a m108 transcript, the
next aim was to investigate m108 protein expression. For this a virus was generated en-
coding a HA-tagged m108 protein. The sequence coding for the hemagglutinin(HA)-epitope
(YPYDVPDYA) was inserted at the 3′-end of the predicted m108 ORF upstream of the stop
codon. The integrity of the DNA sequence for the HA-tag in the BAC was checked by se-
quencing.
Lysates from cells infected with the m108HA virus for 24 hours were used for immunoblot-
ting with a HA-specific antibody. In addition, lysates from uninfected or wild type MCMV
infected cells were included as negative controls and a lysate from cells expressing a HA-protein
of a known molecular weight of 72 kDa was used as a positive control. Computer-based analysis
predicted a molecular mass of the putative m108 protein of approximately 20 kDa. No protein
of this size nor any other specific signals were detected by immunoblotting (data not shown).
Thus, by using this approach, the expression of a m108 protein could not be demonstrated.
To further investigate the role of a putative m108 protein for the epithelial cell tropism of
MCMV, additional virus mutants were constructed.
The m108mutATG virus was constructed to prevent translation of the m108 transcript
(Fig.5.13A, panel 1). Here, the first ATG of the m108 ORF was replaced by a stop codon
(TGA) using site-directed BAC mutagenesis. The integrity of the nucleotide exchange was
checked by sequencing of the BAC. Virus was reconstituted and the growth of the
m108mutATG virus in MEF and C127I cells was investigated as described in the cell tropism
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assay. Comparing the titres of the m108mutATG virus and of the wild type MCMV obtained
from infected MEF or C127I revealed a similar growth capacity of both viruses in these cell
types (Fig.5.13B, upper panel). Similar to the results obtained from previous experiments, the
∆m106-m108 and ∆m107-m108 viruses yielded at least two orders of magnitude lower titres
in C127I compared to those of the wild type MCMV or did not produce detectable amounts
of virus in this cell type (Fig.5.13B, upper panel). From this, it was concluded that the m108
protein is not required for viral growth in epithelial cells.
The first ATG of the m108 ORF is located 5 nt downstream of the mapped transcription
start site (Fig.5.12C). This indicated a very short 5′-untranslated region within the m108
RNA sequence. The analysis of the length of 5′-untranslated regions of mRNAs derived from
distinct taxonomic classes revealed an average length of 100 to 200 nt upstream of the start
codon [Pesole et al., 2000]. Further, it is assumed that the start codon is not recognized by
the ribosome when it is located only 10 nt or less downstream of the 5′-end of a transcript
[Kozak, 1978]. In frame with the first ATG a second ATG is present 198 nt further downstream
(nt 162,569) and a third ATG is located 255 nt downstream of the first ATG (nt 162,512)
(Fig.5.12C). It is possible that the second ATG in the m108 ORF, which is not mutated in the
m108mutATG virus, represents the start codon for translation and therefore a m108 protein
could still be expressed.
Therefore a second virus mutant, ∆m108, was generated in which the ORF m108 was
disrupted (Fig.5.13A, panel 2). The deletion covered 20 bp within the m108 sequence between
the third ATG codon and the splice donor of the m108 bp intron thereby deleting six amino
acids and introducing a frame shift. Infectious virus was reconstituted and growth of the
∆m108 virus was tested as described in the cell tropism assay.
In three independent experiments the wild type MCMV yielded titres in C127I that were
similar to those in MEF in three experiments (slightly higher or maximally one order of mag-
nitude lower) (Fig.5.13B, lower panel). The ∆m107-m108 virus was used as a control virus.
The titres of the ∆m107-m108 virus in MEF were somewhat lower compared to those of the
wild type MCMV in three independent experiments (maximally two orders of magnitude). In
C127I, the ∆m107-m108 virus yielded lower, but variable titres compared to the respective
titre of the wild type MCMV (Fig.5.13B, lower panel), ranging from at least one order of mag-
nitude lower to below the detection limit. In three independent experiments the ∆m108 virus
mutant yielded similar titres in MEF compared to those of the wild type MCMV (maximally
one order of magnitude lower) (Fig.5.13B, lower panel). In C127I, the virus mutant yielded
lower, but variable titres compared to those of the wild type MCMV (in two independent
experiments maximally one order of magnitude lower and in one experiment maximally two
orders of magnitude lower titres, respectively).
These data, together with the previous data obtained from the m108 RACE, strongly
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Figure 5.13: Analysis of the ORF m108 for MCMV growth in epithelial cells. (A) Analysis of MCMV
mutants. (1) The ATG start codon is replaced by the stop codon TGA in the m108mutATG virus genome.
(2) The ∆m108 virus genome lacks 20 bp of the m108 ORF. (3) The 5′-region, including the transcription
start site is deleted in the 108∆intron virus mutant. A primary transcript and thus the 108 bp intron RNA
is not expected to be generated. (4) The 3′-region of the m108 gene is deleted in the m108∆miRNAvirus
genome indicated as a black bar. The nucleotide positions in the genomes are given. Three miRNAs are
encoded from the m108 transcript and a single miRNA is encoded from the opposite strand. miRNAs are
indicated as asterisks [Do¨lken et al., 2007, Buck et al., 2007]. 5p and 3p describe the 5′ or 3′ hairpin
precursor sequences of the miRNAs. The illustration is not drawn to scale. (B) Viral growth of the deletion
mutants. MEF or C127I were infected with a MOI of 0.01 in triplicate with wild type (wt) or MCMV
mutants. Supernatants were harvested on day 6 and viral titres (PFU/ml) were determined by plaque assay
on MEF. Data show one experiment of two independent experiments (upper panel) or one experiment of
three independent experiments (lower panel). Error bars indicate standard deviation of the mean value.
The dashed line represents the detection limit of the virus plaque assay.
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suggest that if a m108 protein is produced it is dispensable for the growth of MCMV in
epithelial cells. Further, the ∆m107-m108 virus was impaired to grow in epithelial cells but
the growth in this cell type was variable.
Is the 108 bp Intron RNA a Limiting Factor for Viral Growth in Epithelial Cells?
Next, it was investigated whether the 108 bp intron RNA is required for the growth of MCMV in
epithelial cells. The deletion in the previously generated ∆m108 virus mutant led to changes in
the coding sequence but the splicing of the primary transcript should not be affected since the
DNA sequence was only changed upstream of the splice donor. Similar to the 7.2 kb stable
intron RNA the 108 bp intron RNA, which is produced from the m108 primary transcript,
could be stable and play a role as a factor determining the epithelial cell tropism of MCMV.
To investigate if the 108 bp intron RNA might be a tropism factor for epithelial cells, and
thus account for the impaired growth of the ∆m107-m108 virus mutant in epithelial cells, the
m108∆intron virus was constructed (Fig.5.13A, panel 3). In this virus mutant, the generation
of an intron RNA is expected to be prevented by the deletion of the 5′-region of the m108
ORF including the m108 5′- transcription start site. Thus, the m108 primary transcript would
be absent, and no intron RNA can be generated. Investigation of the viral titers in the cell
tropism assay showed that infection of C127I and MEF with this virus mutant yielded titers
that were comparable to those of the wild type MCMV (data not shown).
From these experiments it was concluded that the 108 bp intron RNA does not account
for the impaired growth of the ∆m107-m108 virus in epithelial cells and does not determine
the epithelial tropism of the MCMV.
As an alternative to investigate the role of a putative stable 108 bp intron RNA as a factor
determining epithelial cell tropism, a second virus mutant was constructed in which the splicing
of the 108 bp intron is prevented by the deletion of the 3′-region of the m108 ORF including
the splice acceptor for the generation of the 108 bp intron RNA, termed m108∆miRNA virus
(Corinna Benkartek, personal communication) (Fig.5.13A, panel 4). To investigate the viral
growth of this virus, MEF and C127I were infected as described in the cell tropism assay. In
this experiment infection with the m108∆miRNA virus was analysed by Fluorescence Activated
Cell Sorting (FACS) making use of the GFP expression of the viruses.
To investigate viral infection, the numbers of MEF and C127I infected with the
m108∆miRNA virus were determined. As controls, cells were infected with wild type MCMV
or the ∆m107-m108 virus mutant. The numbers of infected cells were analysed at day two
after infection to ensure comparable numbers of infected cells within the viruses in C127I or
MEF. The numbers of infected cells were again analysed at six days after infection to analyse
the spread of the viral infection of the viruses. Less MEF and C127I were infected with the
∆m107-m108 compared to the number of infected MEF and C127I with the wild type MCMV.
73
5 Results
In contrast, for the m108∆miRNA virus the number of infected MEF and C127I was similar
to the number of MEF and C127I infected with the wild type MCMV (C.Benkartek, personal
communication).
To conclude, first, the results obtained from determining numbers of cells infected with the
∆m107-m108 virus by FACS were comparable to the results obtained from determining the
viral titres of the∆m107-m108 virus. This highlights the FACS method as a suitable alternative
for the investigation of viral infection in cell culture. Second, the growth of the ∆m108intron
and the m108∆miRNA viruses, obtained from measuring viral titres or the number of infected
cells, was similar to those of the wild type MCMV. This indicated that a putative stable 108
bp intron RNA is not a limiting factor for virus production in epithelial cells.
Investigation of the miRNAs Expressed from the ORFs m107/m108 as Possible
Tropism Factors
In order to explain the lack of growth of the ∆m107- m108 virus in epithelial cells, other
possible factors were considered. It was experimentally shown that 18 micro RNAs (miRNAs)
are expressed from the MCMV genome [Do¨lken et al., 2007, Buck et al., 2007] in cultured
fibroblasts. Four miRNAs are encoded from the m107-m108 region (Fig.5.13A, panel 4). This
led to the speculation that these miRNAs might be required for viral growth in epithelial cells.
Three miRNAs potentially originate from the m108 primary transcript (Fig.5.13A, panel 4).
The deletion in the m108∆miRNA virus mutant described above also comprise the sequences
of all the four miRNAs. As mentioned before the m108∆miRNA mutant was able to grow in
epithelial cells to a similar extent as in fibroblasts indicating that the miRNAs expressed from
the m107-m108 locus do not account for the limited virus production of the ∆m107-m108
virus in epithelial cells.
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5.3 Identification of a Viral Gene Involved in
MCMV-Induced Cell Rounding
Cells infected with CMV show cytopathic effects. Cell rounding is one of these cytopathic
effects. Cell rounding induced by HCMV has been analysed, whereas this effect caused by
MCMV has not yet been studied. However, neither the mechanism leading to the round cell
shape caused by CMV nor the benefit for the virus, if any, has been determined.
5.3.1 MCMV M25 plays a Major Role in Changing Cellular
Morphology after CMV Infection
The aim of this study was to identify the viral gene products that cause changes of cellular
morphology during MCMV infection. To this end, MEF were infected with the MCMV mutants
described in chapter 5.1 and were screened for conspicuous phenotypes. The infection of MEF
with a virus mutant that carried a deletion spanning the ORFs M24 to m25.2 did not lead
to typical cell rounding (Fig.5.14C, upper right panel). Cells infected with the mutant virus
were still outstreched, forming protrusions at 48 hours after infection. In contrast, most cells
infected with wild type MCMV showed a round cell shape (Fig.5.14C, upper left panel).
The large deletion comprised four predicted ORFs (Fig.5.14A). The ORFs M24, M25,
m25.1 and m25.2 have been predicted for the MCMV Smith strain [Rawlinson et al., 1996].
To identify the responsible gene for cell rounding, individual virus mutants were generated in
which the single ORFs M24, M25, m25.1 were deleted using the BAC mutagenesis method
(Fig.5.14A, (lane 4-6)).
The kanamycin resistance cassette was excised from the ∆M25 BAC by Flp-mediated
recombination to keep the possibility of using the same selection marker to target a second
gene for deletion in the same genome or for later in vivo application (Fig.5.14A (lane 6)).
Since the m25.2 ORF is partially overlapping with both the m25.1 ORF and the M26
ORF, the importance of the m25.2 ORF for the induction of cell rounding was investigated
by deleting sequences of the M24 ORF to the m25.1 ORF (Fig.5.14A, (lane 3)). The m25.2
ORF was not targeted in this virus. A restoration of function to induce cell rounding in
this virus would then be linked to the m25.2 ORF. Sequences in the middle of each ORF,
rather than the complete ORF were deleted to avoid the disruption of adjacent poly (A)
signals or promoter sequences necessary for the expression of neighbouring ORFs. The correct
integrity of the mutant BACs was confirmed by restriction enzyme analysis (Fig.5.14A,B).
Exploiting viral GFP expression as means to detect infected cells, the induction of cell round-
ing was observed in cells infected either with wild type MCMV or mutants still expressing
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Figure 5.14: Generation and screening of
MCMV mutants. (A) Physical map of the
deletion mutants.The location of the genomic
region containing the genes M24-M26 within
the MCMV HindIII and AseI restriction maps is
shown. The genome structure of the deletion
viruses is indicated. The kanamycin resistance
cassette (KnR) replacing the individual ORFs
and the FRT site remaining in the ∆M25 BAC
are marked as boxes. Numbers refer to nu-
cleotide positions in the MCMV Smith strain
[Rawlinson et al., 1996]. Sizes of characteris-
tic DNA fragments (in kb) expected after AseI
digestion of the BACs are indicated in bold.
The illustration is not drawn to scale. (B)
Agarose gel showing the DNA fragments after
AseI treatment of the virus genomes. Relevant
fragments are marked with dots. Size markers
are indicated to the left. (C) Screening of the
virus mutants. MEF were infected with wild
type MCMV (wt) or mutants using a MOI of
3. Infected cells were visualized 48 hours post
infection by fluorescence microscopy. Magnifi-
cation, x 200.
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M25 (Fig.5.14C, (left panels)). The majority of cells infected with these viruses displayed a
round cell shape and a decreased cell size. In contrast, cells infected with the virus mutants
lacking the M25 gene did not change their shape (Fig.5.14C, (right panels)). Here the major-
ity of cells maintained a fibroblast-like morphology. Infected cells remained outstretched and
formed protrusions. Thus, for all virus mutants that were tested, those that were lacking the
M25 ORF, did not cause cellular rounding in fibroblasts.
In order to analyse if the failure to induce cell rounding is limited to primary cells or is cell
type specific, NIH 3T3 fibroblasts or C127I epithelial cells were infected with wild type MCMV
or the ∆M25 virus. A distinct plaque formation was not only observed in MEF but also in
NIH 3T3 and in C127I cells (Fig.5.15, (right panels). A plaque induced by wild type MCMV
consisted of a cluster of infected cells undergoing cell rounding. These cells lost contact to
neighbouring cells thereby forming a hole in the cell monolayer (Fig.5.15, (left panels). In
contrast, ∆M25 virus infected cells did not change their morphology or interrupted the cell
monolayer, but instead remained in contact with neighbouring cells. Thus, the phenotype is
also present in a fibroblast cell line, in addition to primary fibroblasts, and in epithelial cells.
The M25 ORF has been investigated in earlier studies [Dallas et al., 1994, Wu et al.,
1999]. A transcript was found and protein expression from the M25 transcript has been
detected, but the function of the M25 protein remained elusive. Searching the non-redundant
protein database for similarity to the M25 amino acid sequence of the Smith strain (Refseq.
NC 004065) revealed that the M25 amino acid sequence has a conserved domain at the
C-terminus (Fig.5.24). Homology to this domain was found in the HCMV proteins UL25 and
UL35 that constitute the UL25 gene family. The alignment of the M25 amino acid sequence
and the UL25 amino acid sequence of two HCMV isolates, TB40/E and AD169, revealed
26% homology that mapped to amino acid 494 to 880 at the M25 C-terminus whereas 23%
homology was discovered between M25 and UL35.
It is possible that the conserved region of the protein contains domains that are necessary for
the interaction with proteins required for the induction of cell rounding. In order to investigate
whether the C-terminal conserved region or the non-conserved region at the N-terminus of
M25 influence the induction of cell rounding, two additional MCMV mutants were generated.
The M25 protein variant expressed from the M25∆C virus lacks the M25 C-terminus. The
amino acids 490 - 932, covering the complete conserved region, were deleted in the genome
of this virus (Fig.5.16A and Fig.5.24). The M25 protein variant that would be made from the
M25∆N virus lacks the N-terminal amino acids 75-407. DNA sequences were deleted covering
the first ATG downstream of the M25 transcription start site that was mapped by Dallas et
al. [Dallas et al., 1994] (Fig.5.24). In the M25∆N virus, M25 protein synthesis is possibly
initiated at the 10th ATG (aa 421) that is the next start codon downstream of the deletion.
Neither the M25∆C nor the M25∆N virus induced cell rounding concluding that both regions
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Figure 5.15: MCMV-induced cyto-
pathic effect. Mouse embryonic
fibroblasts, NIH 3T3 fibroblasts or
C127I epithelial cells were infected
with wild type MCMV or the ∆M25
virus using a MOI of 1. Images show
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at 72 hours after infection.
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Figure 5.16: Phenotypic analysis of the M25∆N and M25∆C viruses (A) Scheme of the amino acid
sequence of the M25 variants synthesised from the wild type MCMV, M25∆N or M25∆C virus mutants.
The amino acids 75-407 are deleted from the genome of the M25∆N virus and the amino acids 490-932
are deleted from the genome of the M25∆C virus. The dashed line indicates the deletion in the respective
mutant BAC. The amino acids present in the M25 variants are given in numbers referring to the M25
ORF predicted by Rawlinson et al. [Rawlinson et al., 1996]. The illustration is not drawn to scale. (B)
Mouse embryonic fibroblasts were infected with wild type MCMV or the M25 mutants using a MOI of
3. The morphology of infected cells was examined 48 hours post infection by fluorescence microscopy.
Magnification, x 200.
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within the M25 ORF are essential for this process (Fig.5.16B).
Taken together, these results indicate a key role for the M25 protein in altering cellular
morphology after CMV infection.
5.3.2 Re-Insertion of the M25 Gene
If M25 is a key factor for the induction of cell rounding, the re-insertion of the M25 gene into
a ∆M25 BAC should enable the corresponding virus to induce morphological changes in cells.
To address this hypothesis experimentally, a plasmid containing the M25 gene was inserted
into the ∆M24-m25.2 BAC resulting in the M25R BAC (Fig.5.17A). For this, the parental
∆M24-m25.2 BAC was recombined with the plasmid pOriM25 containing the full length 2.7 kb
M25 ORF with additional 840 bp at the 5′-end and 748 bp at the 3′-end predicted to comprise
the M25 ORF promoter and poly (A) signal, respectively. The additional nucleotides flanking
the M25 ORF also contained sequences of the M24 gene and the m25.1 gene. However,
expression of these genes is not possible since the 3′-end of the ORF M24 and the 5′-end
of the M25 ORF were missing. The M25R induced morphological changes in infected cells
similar to the wild type MCMV (Fig.5.17B). These data reinforce the statement that changes
of cellular morphology and plaque formation are dependent on the presence of the M25 gene.
In conclusion, based on the deletion of single ORFs and the generation of a rescuant virus,
the ability to induce cell rounding was ascribed to the presence of the M25 gene.
5.3.3 Analysis of the Growth Properties of the ∆M25 Virus
HCMV disrupts the actin cytoskeleton at sites of cell entry [Jones et al., 1986]. Treatment
of cells with Cytochalasin B, a toxin that inhibits the formation of actin filaments, before
infection with HCMV increases the production of infectious virus particles. Three orders
of magnitude higher titers have been measured when cytochalasin B has been added prior
to HCMV infection [Jones et al., 1986]. Under these conditions more virus particles are
believed to reach the nucleus through the actin meshwork and to initiate viral gene expression
resulting in the production of more virus particles. Since morphological changes within the
cell are associated with rearrangements of the cytoskeleton the absence of cell rounding in
∆M25 virus-infected cells might be due to the failure to interact with the actin cytoskeleton.
Consequently, if the above outlined scenario holds also true for MCMV, ∆M25 growth should
be impaired.
The growth properties of the ∆M25 virus were analysed and compared to those of the wild
type MCMV by analysing the presence of viral proteins characteristic for the three stages of
viral gene expression and by determining the viral titers.
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Figure 5.17: Phenotypic analysis of the M25R virus. (A) To construct the M25R virus, the kanamycin
resistance gene was excised from the∆M24-m25.2 BAC by Flp-mediated recombination. A 4.3 kbp fragment
of the plasmid pOriM25 consisting of the M25 ORF and containing 840 bp of the sequences upstream of the
M25 start codon and 748 bp downstream of the M25 stop codon, predicted to provide suitable promoter
elements and the polyadenylation signal was integrated into the ∆M24-m25.2 ∆KnR BAC using FLP-
mediated recombination, giving rise to the M25R BAC. The M25R genome lacks the ORFs M24, m25.1
and m25.2. The direction of the M25 ORF is indicated with a black arrow. (B) Mouse embryonic fibroblasts
were infected with the M25R virus or the ∆M24-m25.2 virus using a MOI of 3. The morphology of infected
cells was examined 48 hours post infection by fluorescence microscopy. Magnification, x 200.
To identify a difference in the cascade of viral gene expression as a possible consequence
of an impaired disruption of the actin cytoskeleton during cell entry, the expression of an
immediate early protein (IE1), early protein (E1) or a late protein (20/352/4) was analysed.
Cell lysates were prepared from ∆M25 virus or wild type MCMV infected NIH 3T3 cells and
probed by Western blotting using IE1-, E1 or 20/352/4 -specific antibodies. Proteins of
the different kinetic classes were present in lysates from both wild type MCMV and ∆M25
virus-infected cells (Fig.5.18A). The abundance of IE1, E1 or 20/352/4 proteins detected in
lysates from ∆M25 virus-infected cells in this experiment was even slightly higher compared
to the abundance of IE1, E1 or 20/352/4 proteins in lysates from cells infected with wild
type MCMV. In other experiments, the abundance of the viral proteins was slightly reduced
in ∆M25 virus-infected cells compared to wild type MCMV-infected cells but the proteins of
the different kinetic classes were always present. Hence, the absence of the M25 gene did not
alter the kinetic pattern of viral gene expression and although specific classes of proteins were
present cell rounding was not induced.
Next, the growth kinetics of the ∆M25 virus were analysed in NIH 3T3 and
MEF (Fig.5.18B). Infection with a low MOI of 0.1 as well as a high MOI of 3 yielded slightly
lower titres of the ∆M25 virus compared to those of the wild type MCMV. In this specific
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Figure 5.18: Growth analysis of the ∆M25 virus. (A) Kinetics of viral gene expression in cells infected
with the ∆M25 virus or wild type MCMV. NIH 3T3 cells were infected with a MOI of 1 with the ∆M25
virus or the wild type MCMV (wt). Cells were harvested at the indicated time points and lysates were
separated on a 10% SDS-polyacrylamide gel and analysed by immunoblotting using antibodies specific for
the immediate-early protein IE1, the early protein E1, and a late protein (mAb 20/352/4). Membranes were
re-probed with a GAPDH specific antibody as a control for loading equal amounts of total protein. Mock,
lysates from uninfected cells. (B) NIH 3T3 or MEF were infected with wild type or the ∆M25 virus using
a MOI of 0.1 or 3. Supernatants were harvested at the indicated time points and titers were determined by
plaque assay on MEF. The dashed line represents the detection limit of the virus plaque assay. Error bars
indicate standard deviations of the mean value of triplicate cultures.
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experiment, the ∆M25 virus produced progeny virus slightly faster in NIH 3T3 cells compared
to the wild type MCMV when a MOI of 0.1 was used for infection. In two additional exper-
iments, the faster growth of the ∆M25 virus was not observed but the ∆M25 virus yielded
similar titres in both cell types compared to those of the wild type MCMV or titres that were
about one order of magnitude lower, respectively (data not shown).
These data demonstrate that the absence of M25, and thus cell rounding, did not severely
affect viral growth and had no influence on viral gene expression suggesting that the virus does
not strictly rely on this process for replication in vitro.
5.3.4 Morphological Changes are Induced at Early Stages of
Infection and are M25 Dependent
MCMV-induced cell rounding has not yet been described or illustrated in detail. Therefore,
the cellular morphology of wild type MCMV-infected cells was recorded by laser scanning
microscopy. MEF were fixed at different time points during the course of one replication cycle
of 24 hours and at subsequent time points. TRITC-phalloidin was used to label actin filaments
and GFP expression of the virus allowed the identification of infected cells.
The onset of alterations in cellular shape in wild type MCMV-infected cells was observed
at five hours after infection (Fig.5.19). From this time point on GFP expression was observed
allowing the identification of infected cells. Uninfected cells were outstretched with a fibroblast-
like morphology. Long actin filaments were visible spanning the cell body (Fig.5.19, 5 h p.i.,
white arrows). In contrast, at this time point (5 h p.i.) infected GFP-positive cells appeared
already more round. These cells were characterised by pronounced cortical actin (Fig.5.19,
5 h p.i., white triangle). Infected cells could clearly be distinguished from uninfected cells
by their altered morphology. Two types of cells infected with wild type MCMV were present
between 8 to 12 hours after infection: Most cells showed alterations in their shape becoming
circular, whereas some cells were already completely round. This may be explained by the
different infectious doses per individual cell. Assuming that the kinetics of cell rounding are
influenced by the number of infectious virus particles taken up and thus the level of M25
protein expression per cell, different stages of cell rounding can be expected. Alternatively,
the cells might be infected asynchronously. At final stages of infection, 24, 48 and 72 hours
after infection, tiny and completely round cells were found. All infected cells changed their
cell shape from outstretched into spherical. The actin filaments were visible as a spherical ring
localised to the cortex of an infected cell (Fig.5.19, 48 h p.i., white triangle).
Next, the cellular morphology of ∆M25 infected cells was analysed. To monitor cellular
morphology in the absence of the M25 gene, MEF were infected with the ∆M25 virus as
described for the wild type MCMV. In contrast to the infection with wild type MCMV, drastic
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Figure 5.19: Kinetics of wild type MCMV-induced cell rounding. MEF were infected with a MOI of 1
with wild type MCMV expressing GFP. Cells were fixed at the indicated time points and actin filaments
were visualised by TRITC-Phalloidin. Cellular morphology was analysed by laser scanning fluorescence
microscopy. Actin filaments are marked with a white arrow and cortical actin with a white triangle. Bar,
20 µm. Numbers indicate hours post infection.
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Figure 5.20:Morphology of ∆M25-infected cells at different time points of infection. MEF were infected
with ∆M25 virus expressing GFP using a MOI of 1. Cells were fixed and treated as described in Fig.5.19.
Cellular protrusions are exemplarily marked with a white triangle. Arrows indicate uninfected cells. Bar, 20
µm. Numbers indicate hours post infection.
84
5.3 Identification of a Viral Gene Involved in MCMV-Induced Cell Rounding
alterations in the cellular morphology of ∆M25-infected cells were not observed. In the time
frame of 5 to 12 hours after infection, ∆M25 infected cells retained the typical morphology
of uninfected fibroblasts with actin filaments and protrusions (Fig.5.20, 8-12 h p.i., white
triangles). Cells remained outstretched and could not be distinguished from uninfected cells.
In contrast to wild type MCMV-infected cells, ∆M25 infected cells still formed protrusions
between 24 to 72 h post infection. The morphology of ∆M25-infected cells was similar to
those of uninfected cells (Fig.5.20, 48-72 h p.i., compare infected and uninfected cells).
Taken together, these data demonstrate that MCMV-induced cell rounding is a process
starting at five hours after infection or earlier, finally leading to completely circular and tiny
cells. The absence of cell rounding in ∆M25 infected cells during a full infection cycle of 24
hours indicated that M25 has a large impact on rearrangements of the cytoskeleton and that
M25 function is not substituted by other viral factors during the viral replication cycle.
5.3.5 Investigation of M25-Induced Cell Rounding Outside the
Context of the Viral Genome
Next, M25-induced cell rounding was investigated in the absence of other viral factors. The
presence of M25 during viral infection was found to be essential for changes in cellular mor-
phology. In other words, no other viral protein substituted for M25. However, it was still
unclear whether additional viral proteins were required for M25 to exert its function. As a
proof of M25 specificity to induce cell rounding, cellular morphology was investigated in M25
transfected cells (Fig.5.21).
For this experiment the M25 ORF was cloned into the pIRES2AcGFP1 vector. The
pIRES2AcGFP1 vector contains an internal ribosome entry site (IRES) between the multi-
ple cloning site and the ORF encoding the green fluorescent protein (AcGFP1) (Fig.5.21A).
The IRES permitted the synthesis of both the AcGFP1 protein and the protein of interest from
a single bicistronic mRNA. Expression of GFP allowed the detection of transfected cells.
The pIRESM25CHA vector was constructed by PCR amplification of the full length M25
ORF and subsequent ligation of the PCR product into the pIRESAcGFP1 vector. An HA-tag
was added to the M25 C-terminus to detect the M25 protein with an HA-specific antibody.
The C-terminal HA-tag could theoretically have a negative influence on M25 protein func-
tion by altering the folding of the protein. Considering this possibility, a second plasmid was
constructed in which an HA-tag was added to the M25 N-terminus directly upstream of the
start codon. The M25 ORF contains more than 10 ATGs in frame. Translation initiation is to
some extent determined by the nucleotide context around the ATG [Kozak, 1999]. For adding
an HA-tag to the N-terminus, the 5th ATG was chosen since this particular ATG was claimed
to be the initiation codon according to Dallas et al., possibly because it is surrounded by a
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Figure 5.21: Cloning of the M25 ORF into the pIRES2AcGFP1 vector. (A) Cloning of the full length
M25 ORF into the pIRES2AcGFP1 vector. The full length M25 ORF was amplified by PCR from wild
type MCMV BAC DNA with primers containing EcoRI or PstI restriction sites. Either the PstI- or the
EcoRI - primer contains the sequence for the Hemagglutinin-tag to be added to the M25 N- or C-terminus.
The nucleotide positions of the M25 ORF, refer to the MCMV Smith strain. (B) (Top) Images show
NIH 3T3 fibroblasts transfected with either pIRES2AcGFP1 or the pIRESM25NHA construct 48 hours
after transfection. (Bottom) 48 hours after transfection the cellular morphology of GFP positive cells was
analysed. Error bars indicate standard deviation of the mean value, n= number of total analysed cells
strong context [Dallas et al., 1994].
NIH 3T3 fibroblasts were transfected with each of the M25 constructs or the empty pIRES
vector as a control. GFP expression was first observed around 24 hours after transfection. 48
hours after transfection was chosen as a time point for the assessment of cellular morphology.
GFP and M25 are translated from the same transcript thus the presence of the M25 protein is
expected at the same time GFP is present. At 48 hours after transfection sufficient amounts
of intracellular GFP allowed the detection of transfected cells. Further, at this time point the
changes of the cellular morphology in M25 expressing cells compared to cells transfected with
the empty vector were most obvious. Most fibroblasts transfected with the M25 constructs
appeared round whereas most of the fibroblasts that had been transfected with the pIRES
vector remained outstretched (Fig.5.21B).
To quantify round cells after transfection, the number of cells transfected with the individual
plasmids having a fibroblast morphology and those with a circular shape were counted. The
percentage of round cells was at least twice as high for the M25 constructs compared to
the vector control (Fig.5.21B). The M25 expression from both vector constructs induced cell
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rounding to a similar extend indicating that the presence of the HA-tag and its position did
not influence the function of M25. The percentage of round cells transfected with the empty
vector could represent cells undergoing stress. It is also possible that the transfection process
induced cell death resulting in cell rounding.
M25 expression in the absence of additional viral proteins induced cell rounding in fibroblasts
concluding that M25 alone is sufficient to provoke morphological changes.
5.3.6 The M25-Derived 105 kDa Protein is the Predominate Species
Expressed During Early Stages of MCMV-Infection
In the following experiment a possible correlation of M25 protein expression with the observed
kinetics of virus-induced cell rounding was investigated. M25 protein expression has been
previously analysed by immunoblotting cell lysates of MCMV-infected cells using a monoclonal
antibody directed against an M25 epitope [Wu et al., 1999]. A 105 kDa protein species is
expressed at nine hours after infection followed by the detection of 130 kDa and 95 kDa proteins
after 18 hours. Since the M25 dependent onset of morphological changes was observed five
hours after infection using fluorescence microscopy, it was hypothesised that the responsible
M25 protein is present at this time. To investigate this hypothesis, M25 protein expression
was re-analysed. For this, a MCMV virus was constructed that expressed an HA-tagged M25.
An antibody directed against the HA-tag could then be used for the detection of the M25
protein. The MCMV M25HA BAC was constructed using BAC mutagenesis with the HA-tag
being inserted directly upstream of the M25 stop codon.
NIH 3T3 fibroblasts were infected with the M25HA virus or wild type MCMV. M25 pro-
teins could be already detected after five hours of infection (Fig.5.22, lane 2). The most
abundant species at this early stage of infection was a protein migrating with approximately
105 kDa followed by a protein species migrating with approximately 80 kDa. In addition,
a protein of approximately 130 kDa and proteins of lower molecular weights were detected
in low abundance. The 130 kDa protein species and additional 52- and 48 kDa-M25 pro-
teins have been identified before, in preparations from purified MCMV virions [Wu et al.,
1999, Kattenhorn et al., 2004]. Thus, the low abundance of the 130 kDa protein and the
lower molecular weight proteins might result from incoming intracellular virus particles since
a high MOI of five was used for infection. The appearance of the approximately 105 kDa
protein is likely to be newly synthesised from an early viral transcript. Compared to overall
GAPDH protein levels the concentration of the three major proteins, 130, 105 and 80 kDa
increased at 18 hours after infection possibly caused by the ongoing synthesis of viral proteins
(Fig.5.22, lane 7). Similar concentrations of the 130, 105 and 80 kDa proteins were detected in
lysates starting from 24 hours after infection (Fig.5.22, lane 9-11). The abundance of the low
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Figure 5.22: Expression kinetics of M25-encoded proteins. Expression of HA-tagged M25 proteins at
different time points of the MCMV infection cycle. NIH 3T3 fibroblasts were infected with the M25HA
virus using a MOI of 5. Cell lysates were harvested at the indicated time points. The time point 0 indicates
cells harvested immediately after infection. Proteins were separated in a 10% SDS-polyacrylamide gel and
an HA-specific antibody was used to detect M25 proteins by immunoblotting. Membranes were reprobed
with an anti-GAPDH antibody to demonstrate the loaded protein amounts. Lysates from mock infected
cells or from wild type MCMV infected cells were harvested 24 hours post infection (p.i) and served as
controls. Arrows point to the 130, 105 and 80 kDa protein species. Protein size markers are indicated to
the right.
molecular weight proteins also increased with time. These proteins are likely to be M25 protein
species since uninfected or wild type MCMV-infected cells, harvested after 24 hours, did not
show any background signal.
The expression profile of the M25 revealed that several M25 proteins are synthesised
throughout the MCMV infection cycle. Correlation of the M25 protein expression to the
induction of morphological changes at early stages of infection reinforces the suggestion of
their participation in virus-induced cell rounding.
5.3.7 Analysis of M25 Transcripts
The detection of a major 105 kDa M25 protein species at early stages of infection, after 5 hours
of infection, by immunoblotting argued for a related transcript. Dallas et al. detected a single
approximately 3 kb M25 transcript only at late stages, after 16 hours of infection by Northern
blot analysis of total RNA from MCMV infected cells [Dallas et al., 1994]. Considering the
possibility that, in the previous publication, an early M25 RNA was not detected due to a
low infection dose the presence of an early M25 transcript was re-investigated. Northern blot
analysis was performed using total RNA of MEF infected with a high MOI of 3 with wild type
MCMV or ∆M25 virus as a control. Cells were harvested at 6 or 24 hours after infection
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and total RNA was prepared. For hybridisation a radiolabeled M25-specific DNA probe was
used (Fig.5.23A). A transcript of approximately 2.8 kb was present at six hours after infection
whereas two transcripts of approximately 3.1 kb and 2.8 kb were detected at 24 hours after
infection (Fig.5.23B). A high specificity of the probe was ensured since no signal was present
in total RNA from ∆M25 infected fibroblasts. These data support the assumption that a M25
transcript is present at early times which maybe translated into the 105 kDa M25 protein.
In order to further characterise the identified transcripts, their 5′ and 3′-ends were mapped
by 5′-/3′-rapid amplification of cDNA ends.
For the identification of the 5 ′-end of the M25 transcript the M25 specific primer (M25-1)
was used to synthesise cDNA form the RNA pool. The second M25-specific primer (M25-2)
was used for the amplification of cDNA by PCR (Fig.5.23C). A PCR product of approximately
200 bp was amplified from RNA prepared from cells infected for six hours whereas a product
of approximately 500 bp was obtained from RNA at 24 hours after infection (Fig.5.23C).
Besides the main product of about 500 bp, minor products of about 200 bp and 300 bp
were also detected. The 200 bp product possibly originated from the same RNA transcript
detected at six hours after infection that was still present at 24 hours after infection. Sequence
analysis of the 200 bp product, detected at six hours after infection, mapped the 5 ′-end to nt
position 26504 of the MCMV genome. The 5 ′-endof the 500 bp transcript was mapped to nt
position 26191 (Fig.5.23A and Fig.5.24). For identification of the 3 ′-end of the M25 transcript
cDNA was synthesised from total RNA with the M25 specific primer (M25-3). PCR products
of approximately 400 bp were detected at 6 hours and 24 hours after infection (Fig.5.23C).
Sequence analysis of the 400 bp products revealed identical 3 ′-ends at nt position 28956. Both
identified transcripts probably share the same poly (A) signal. A TATA box was identified 22
nt upstream of the 5 ′-end of the longer RNA (nt 26191) (Fig.5.24). Both, the 5 ′/ 3 ′-ends
and the TATA box are located within the predicted M25 ORF [Rawlinson et al., 1996]. A
single poly (A) signal was identified 18 nt upstream of the 3′-end of the RNAs (Fig.5.23A and
Fig.5.24).
Taken together, further analysis of the M25 transcripts confirmed the presence of two M25
transcripts that were identified by Northern blotting. Using the 5′/3′ RACE technique, the
5′/3′-ends of two M25 transcripts were mapped that differed in their 5′-ends but shared the
same 3′-end.
5.3.8 Identification of Proteins Expressed from M25 Transcripts
The expression of multiple M25 protein species and the presence of several potential M25
translation initiation codons raised the question of which ATGs are used for translation. Of
particular interest was the origin of the approximately 105 kDa protein since it was the pre-
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Figure 5.23: Detection of M25 transcripts. (A) Location of primers (bold arrows) used in the 5′-RACE or
3′-RACE and of the probe (black bar) used for Northern blotting. The M25 ORF is depicted as a gray
arrow. The transcription start/end sites identified in this study and the poly(A) signal are indicated referring
to the Smith strain. Potential start codons (ATG) of the transcripts are indicated. The illustration is not
drawn to scale. (B) Northern blot analysis. Total RNA was isolated from infected cultures at 6 or 24 h p.i.
and subjected to Northern blot hybridization using a radiolabeled M25 specific probe indicated in (A). The
positions of RNA marker bands are indicated to the left. (C) 5′-/ 3′-end mapping of the M25 transcripts.
Total RNA was harvested from wild type MCMV-infected cultures at 6 or 24 hours post infection. The
5′/3′-ends of the M25 transcript were mapped using the primers indicated in (A). PCR products were
separated by agarose gel electrophoresis and visualized by ethidium bromide staining.
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                      M  S   Q  F  V  Q   H  V  A   D  R  G   L  G  V   V  H  Q  R   L  A  R   G  V  E   P  R  A  D ·  
26001 CCCCGGCCGG CGGCATGAGC CAGTTCGTAC AGCACGTCGC TGACCGTGGC CTCGGCGTCG TCCACCAGCG GCTCGCACGC GGCGTCGAAC CGCGAGCCGA
      
        F  P  R   R  I  H   L  R  I  R   T  L  P   R  D  G  D   V  Q  L   Y  K  I   T  R  A   G  V  C  V   P  A  V     
26101 TTTTCCCCGT CGAATCCATC TCCGCATCCG AACCCTGCCC AGAGATGGAG ACGTGCAACT ATATAAAATC ACGAGAGCCG GGGTCTGCGT GCCAGCCGTC
   L  F  P  V   P  A  R   P  F  R   P  R  T  P   V  R  E   P  P  L   T  R  T  M   N  R  R   S  S  K  D  R  R  M ·
26201 CTATTCCCCG TGCCGGCGCG TCCCTTTCGA CCTCGAACGC CTGTCCGAGA ACCCCCACTC ACCCGAACGA TGAACCGTCG ATCCTCCAAG GACCGTCGTA
 
 ·  F  V  T   D  D  S   S  D  D  D   D  D  D   V  M  I   M  D  P  P   E  T  T   S  S  S   S  S  A  L   A  T  A ·
26301 TGTTCGTCAC CGACGACTCG TCGGATGATG ACGACGACGA TGTGATGATC ATGGACCCCC CGGAGACGAC GTCGTCGTCG TCATCGGCGC TGGCGACGGC
 · A  G  I   R  G  V  P   H  A  P   A  S  N   S  A  T  A   A  A  A   S  E  S   T  Y  K  P   L  S  I   P  S  E
26401 GGCGGGGATA CGGGGCGTTC CCCATGCCCC CGCCTCCAAC TCCGCCACGG CGGCGGCGGC CTCCGAGAGC ACATACAAGC CATTGAGCAT CCCGTCTGAG
  E  L  N  G   E  E  E   E  R  D   E  E  D  M   S  R  D   G  P  R   R  H  S  Q   D  D  D   F  T  Y   A  D  P  A ·
26501 GAACTAAACG GCGAAGAGGA GGAGAGAGAC GAAGAAGACA TGTCACGCGA CGGACCCCGC CGGCACAGCC AGGACGACGA CTTTACTTAT GCGGACCCGG
 ·  D  V  R   L  R  A   M  M  G  N   R  Y  G   G  Q  S   R  S  A  A   T  A  G   A  A  S   R  N  D  S   G  S  V ·
26601 CCGATGTGAG ACTGCGGGCG ATGATGGGCA ATAGGTACGG CGGACAGAGT CGGAGTGCGG CGACAGCGGG AGCAGCGTCC CGGAATGATA GTGGAAGCGT
 · S  P  V   T  L  F  D   E  D  G   Y  A  I   I  P  D  P   P  T  S   R  D  D   S  R  H  V   V  V  D   D  D  D
26701 GTCGCCCGTG ACCCTTTTTG ATGAGGACGG ATACGCGATA ATCCCCGACC CACCTACTTC GCGCGACGAT TCGCGACACG TCGTCGTGGA CGACGACGAC
  D  G  D  Y   D  S  H   Y  G  V   M  T  V  A   P  S  P   P  K  L   P  R  K  S   R  P  S   T  K  K   S  A  E  E ·
26801 GACGGAGATT ATGATTCACA CTACGGCGTG ATGACAGTCG CTCCGAGCCC ACCCAAACTG CCACGCAAGA GTCGACCTTC GACCAAAAAA TCGGCGGAGG
 ·  K  Q  S   S  T  A   G  R  S  R   G  R  S   T  A  R   R  T  P  K   K  A  Q   E  T  A   P  A  A  A   A  G  S ·
26901 AAAAGCAATC TTCCACCGCC GGCCGGTCCA GAGGCCGCTC GACCGCACGC CGGACCCCGA AGAAGGCTCA AGAGACCGCT CCGGCGGCCG CGGCGGGCTC
 · G  A  R   Q  K  Q  R   Q  Q  Q   Q  Q  Q   P  P  R  R   Q  S  Y   H  P  P   P  D  Y  P   P  P  P   P  P  V
27001 CGGAGCTCGC CAAAAACAAC GCCAGCAGCA GCAACAACAG CCTCCACGCC GCCAATCTTA CCACCCTCCA CCCGATTATC CTCCCCCACC TCCGCCCGTA
  Q  A  T  V   S  R  P   L  P  R   T  P  N  A   N  D  D   D  D  D   D  D  N  D   E  P  G   P  S  N   T  R  R  G ·
27101 CAGGCGACTG TGTCGCGTCC TCTCCCCAGG ACCCCGAACG CCAACGACGA CGATGACGAC GATGACAACG ACGAGCCGGG TCCGAGCAAC ACACGCCGCG
 ·  K  T  P   C  R  R   V  D  H  T   E  N  N   H  L  Y   E  T  P  I   S  A  T   A  M  V   I  D  I  E   D  D  E ·
27201 GCAAAACGCC CTGCCGTCGT GTCGATCACA CGGAGAATAA TCATCTATAC GAGACCCCGA TATCCGCCAC CGCCATGGTG ATCGATATCG AAGATGACGA
 · D  E  E   T  G  G  A   A  D  D   A  S  I   V  V  E  D   D  D  E   E  E  E   N  D  C  E   E  I  C   D  G  E
27301 GGACGAAGAG ACCGGCGGCG CCGCCGACGA CGCGTCTATC GTCGTCGAAG ATGATGATGA AGAAGAGGAG AACGATTGCG AGGAGATCTG CGACGGGGAA
  E  E  P  A   A  A  A   A  A  A   A  A  S  S   S  T  P   H  R  T   Q  P  L  P   V  P  P   S  S  P   R  I  T  R ·
27401 GAAGAGCCGG CAGCAGCAGC AGCAGCAGCG GCGGCATCGT CGTCGACTCC TCATCGCACC CAGCCTCTGC CCGTCCCACC GTCGTCTCCG CGCATCACGC
 ·  E  L  G   F  L  P   G  V  V  S   G  Q  D   A  R  F   I  A  A  C   L  H  H   S  H  A   P  Q  V  D   I  I  N ·
27501 GCGAGCTCGG GTTCCTGCCC GGTGTAGTGA GCGGTCAGGA CGCCAGATTC ATCGCGGCGT GCCTCCACCA CTCGCACGCG CCGCAGGTCG ACATCATAAA
 · T  C  Y   P  M  P  P   Y  T  L   D  A  L   S  E  P  V   L  T  K   K  A  L   R  C  A  G   V  L  R   P  V  I
27601 CACCTGCTAT CCGATGCCGC CGTACACCCT AGACGCGCTA TCTGAGCCGG TCCTGACCAA GAAGGCGCTG CGCTGCGCGG GGGTGCTGCG GCCCGTCATC
  K  L  A  I   L  V  N   Y  Y  C   V  G  I  G   R  L  A   R  A  R   A  L  S  K   D  L  M   T  P  P   R  I  E  T ·
27701 AAGCTAGCCA TCCTGGTGAA TTACTACTGC GTAGGGATCG GGCGTCTGGC CCGTGCTCGC GCGCTGTCCA AAGATCTGAT GACCCCGCCG CGCATCGAGA
 ·  L  R  R   R  L  E   G  L  L  P   Q  Q  T   S  P  S   P  P  M  C   L  R  V   L  G  R   L  N  I  T   A  A  Q ·
27801 CGCTGCGCCG CCGTCTGGAG GGCCTCCTGC CCCAGCAGAC GTCGCCCAGC CCTCCGATGT GCCTGCGGGT GCTCGGCCGC CTGAACATCA CCGCGGCGCA
 · H  K  A   S  C  D  T   I  D  Q   L  M  K   P  M  Q  E   R  E  R   R  R  Q   K  T  Q  C   A  Q  L   F  R  S
27901 GCACAAGGCC AGCTGCGATA CGATCGACCA ACTGATGAAA CCGATGCAGG AACGCGAGCG CCGCCGACAG AAGACGCAGT GCGCACAGTT GTTCCGCAGC
  K  N  L  L   F  S  P   P  R  F   T  R  E  G   A  K  T   L  Y  M   R  N  I  K   I  L  N   S  D  E   E  D  T  T ·
28001 AAGAACCTGC TGTTCAGTCC CCCGCGTTTC ACCCGCGAGG GGGCGAAGAC CCTGTACATG CGGAACATCA AGATCCTGAA CAGCGACGAG GAGGATACGA
 ·  L  N  L   V  M  T   L  N  P  H   P  T  R   E  D  V   L  N  D  A   I  F  C   L  S  L   G  N  F  V   Y  N  F ·
28101 CGCTGAACCT AGTGATGACC CTGAATCCGC ATCCCACACG GGAAGATGTG CTGAACGACG CGATCTTTTG CCTGTCGCTG GGAAACTTTG TGTACAACTT
 · S  R  A   L  E  E  L   R  G  M   I  R  C   Q  F  E  D   L  T  E   T  L  Y   A  A  Y  Y   Q  C  P   I  M  R
28201 CTCGCGCGCG CTCGAAGAAC TGCGCGGAAT GATCAGATGC CAGTTCGAGG ACCTGACCGA GACCCTGTAC GCGGCCTACT ATCAGTGTCC CATAATGAGA
  D  D  Y  R   V  L  C   S  E  V   A  N  E  I   T  S  P   R  E  D   G  Q  G  L   S  A  L   C  R  R   S  L  A  F ·
28301 GACGACTACC GCGTGCTGTG CTCCGAGGTG GCGAACGAGA TCACGTCGCC CCGTGAAGAC GGACAGGGCC TGTCCGCGTT GTGCCGCCGC AGCCTCGCTT
 ·  A  R  R   C  Y  N   E  G  V  F   F  S  P   S  Y  V   K  Y  L  I   K  C  A   A  M  E   E  A  G  F   E  G  Y ·
28401 TCGCGCGCCG CTGCTACAAC GAAGGCGTGT TTTTCTCACC GTCGTACGTC AAGTATCTGA TCAAGTGCGC GGCCATGGAA GAGGCAGGCT TCGAAGGCTA
 · S  L  E   S  A  A  R   S  L  A   N  P  D   I  F  R  P   L  P  D   E  S  S   A  R  R  M   L  R  R   T  I  H
28501 CTCGCTCGAG TCGGCCGCGA GATCTCTGGC GAACCCAGAC ATCTTCCGCC CGCTGCCTGA CGAGAGTAGC GCCCGCCGCA TGCTGCGCCG CACGATACAC
  F  V  R  V   D  G  T   P  S  S   S  R  Q  I   P  T  T   H  I  P   T  H  A  N   Y  E  L   F  L  Q   A  S  R  M ·
28601 TTCGTGCGCG TCGACGGGAC ACCCTCGTCT TCCAGACAGA TCCCCACGAC CCACATCCCA ACACACGCCA ACTACGAGCT GTTCCTGCAA GCGTCTCGCA
 ·  I  V  P   Q  Q  Q   Q  S  R  R   S  S  T   P  P  P   S  S  S  P   P  P  P   A  A  G   G  P  K  Y   S  K  R ·
28701 TGATCGTTCC GCAGCAACAG CAGTCACGCA GAAGCAGCAC CCCGCCACCA TCATCCTCTC CTCCTCCCCC GGCCGCCGGA GGGCCAAAGT ACTCCAAGCG
 · T  F  L   *
28801 TACCTTTCTG TAATCTTAGA TTAATCAGCA GAATAACCAA CCCCAAAAGC ACTTAGCACT TAGCCACACG AATCGAGTAA GTAAGTTACC AATCTCATAC
28901 ACCCCCCCCA TGTACTTCTT TCTTCCATAA TTTCACTGAA TAAATAAAGA TCACAGACAA AAAAAGACAA GAGACATCGT GTGTTGTGTA ATTCGATTTA
*
[                                   ]
Figure 5.24: Nucleotide sequence of the MCMV M25 gene. The potential TATA box and the polyadenyla-
tion signal as well as the aa sequence that is conserved between MCMV M25 (aa 494-893) and HCMV UL25
are underlined. Methionines in the M25 aa sequence are marked in bold. The 2nd and the 6th Methionine
are encircled. The identified transcription start sites are indicated with arrows and the mapped 3′-end is
framed. A bold asterisk indicates the start of the predicted M25 ORF in the Smith strain (accession number
NC 004065) [Rawlinson et al., 1996]. A nuclear localisation signal was predicted consisting of the amino
acids PRKSRPS (aa 283-289) shown in parentheses. The M25 protein is predicted to be soluble.
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dominant species identified at early stages of infection at the same time as cell rounding was
induced.
The M25 ORF contains several potential start codons for translation. Translation of each
of the identified transcripts might be initiated at different ATGs generating proteins of different
molecular weights with different N-termini. A potential ATG for translation initiation of the
3.1 kb transcript is the 2nd ATG referred to the predicted M25 ORF in the Smith strain since
it represents the first ATG downstream of the 5′-end of the 3.1 kb transcript whereas the 6th
ATG is the first ATG downstream of the 5′-end of the 2.8 kb transcript and hence a potential
start codon.
First, a computational analysis, predicting the molecular weights of the potential proteins
initiated from the different translation initiation start sites was done. Molecular weights ranging
of 103 kDa for the longest possible M25 ORF, initiated at the 1st ATG, to 57 kDa for the
protein initiated at the 10th ATG were predicted. The predicted molecular weights did not
match with the size of the identified proteins, thus making it necessary to analyse individual
protein expression.
It was proposed that M25 protein synthesis is either initiated at the first or the 5th ATG of
the M25 ORF [Rawlinson et al., 1996, Dallas et al., 1994]. Therefore a transfection-based ap-
proach was used to determine the size of the proteins expressed from the previously cloned M25
plasmids pIRESM25NHA and pIRESM25CHA (Fig.5.21A ). The plasmid pIRESM25CHA con-
tains the full length M25 ORF and the HA-tag is fused to the C-terminus of the M25 sequence
whereas in the pIRESM25NHA plasmid an HA-tag is fused to the N-terminus upstream of the
5th ATG (Fig.5.25 (a-b)). Immunoblotting using an HA-specific antibody identified a protein
species in pIRESM25NHA transfected 293T cells that migrated with a lower molecular weight
than the 130 kDa protein species, detected in lysates from M25HA virus infected 3T3 cells
(Fig.5.26A). A protein species migrating at >130 kDa was identified in lysates prepared from
pIRESM25CHA transfected cells. The lower abundance of this protein in the pIRESM25CHA
lysate may result from a low transfection efficiency. Besides these two proteins, no additional
protein species were identified in the respective lysates. None of the M25 expressed proteins
correlated in size to the previously detected 130, 105, 80 kDa or low molecular weight-M25
proteins in M25HA virus infected cells concluding that neither the 1st ATG nor the 5th ATG of
the M25 ORF represents the initiaton codon for M25 protein synthesis during viral infection.
To identify the start codon for the production of the 105 kDa protein, additional M25
constructs were generated. The PCR-based quick mutagenesis protocol was used in order to
shorten the M25 ORF using the pIRESM25CHA vector as the template. Expression plasmids
starting with the 2nd ATG, 4th ATG, 6th ATG, 7th ATG, 9th ATG or 10th ATG of the M25
ORF were constructed. The 3rd ATG was excluded since it is only separated by 27 nt from
the 2nd ATG and no detectable difference in protein size was expected. The 5th ATG and
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Figure 5.25: Structure of the
M25 expression plasmids. The
pIRESATG vectors were constructed
by means of the PCR-based quick
mutagenesis protocol using
pIRESM25CHA as the template.
Amplification with M25 specific
primers and a standard primer
binding to the major IE promoter
led to vectors with shortened M25
ORFs (c-h) downstream of the
HCMV major immediate early
promoter (MIEP) and upstream
of an internal ribosome entry side
(IRES), the ORF AcGFP and
the SV40 early poly (A) signal.
Nucleotide positions of the ATGs
are indicated referring to the Smith
strain. The illustration is not drawn
to scale.
the 8th ATG are located three nucleotides downstream or in direct proximity to another ATG,
respectively and were not investigated separately for the aforementioned reasons. Figure 6.25
illustrates the M25 constructs.
Immunoblotting of lysates from transfected 293T cells revealed a single major protein
species expressed from each of the shortened M25 ORFs (Fig.5.26A). Protein synthesis starting
at the 2nd ATG of the M25 ORF resulted in a protein species migrating with the same molecular
weight as the 130 kDa protein synthesised from the M25HA virus. Protein expression starting
at the 6th ATG of the M25 ORF revealed a protein species correlating in the molecular weight
with the 105 kDa protein made from the M25HA virus. The protein that was synthesised
starting at the 4th ATG of the M25 ORF migrated to approximately 120 kDa similar to the
protein made from the pIRESM25NHA plasmid. Protein synthesis from the pIRESM25NHA
plasmid was initiated at the 5th ATG of the M25 ORF which is only 6 nt downstream of the
4th ATG. An approximately 95 kDa protein was produced when protein synthesis started at
the 7th ATG of the M25 ORF, an approximately 85 kDa protein species from the 9th ATG and
an approximately 60 kDa protein was detected in lysates from pIRESATG10 transfected cells.
Besides the main proteins originating from the different M25 ORFs, additional M25 specific
protein species migrating to approximately 80, 50 and 48 kDa were detected in all lysates
of transfected cells except from pIRESM25NHA and pIRESM25CHA transfected cells. The
80 kDa protein species was absent when translation started at the 10th ATG and no further
93
5 Results
AT
G 
6
AT
G 
4
3T3 293T3T3 293T3T3 293T3T3
AT
G 
2
AT
G 
2
   2           4           6          7          9           10p
IR
ES
M
25
CH
A
pI
RE
SM
25
NH
A
M
25
HA
-V
iru
s
250
150
100
75
50
140
70
100
kDa
kDa
pI
RE
SA
TGA
B M25
HA
-V
iru
s
Figure 5.26: M25 proteins expressed from M25 plasmids. (A) Lysates of 293T cells transfected with the
M25 constructs shown in Fig.5.25 were prepared 48 hours after transfection and separated on a 7.5%-18%
SDS-polyacrylamide gradient gel followed by immunoblotting with an anti-HA antibody. Lysate prepared
from 3T3 fibroblasts infected for 24 hours with the M25HA virus was used to compare the molecular weight
of the proteins. (B) Lysates used in (A) and lysates from transfected NIH 3T3 fibroblasts were separated
on a 8% SDS-polyacrylamide gel followed by immunoblotting with an anti-HA antibody. Protein markers
are indicated to the left.
ATG is present between the 9th ATG and the 10th ATG of the M25 ORF that could initiate
translation of the 80 kDa protein.
Whereas the major protein species seem likely to originate from the individual M25 ORFs,
the origin of the shorter M25 protein species remains elusive. Notably, M25-derived proteins
of lower molecular weight have also been identified from purified MCMV virions including M25
proteins migrating with 52 and 48 kDa [Kattenhorn et al., 2004]. These proteins species might
have resulted from translation initiation at downstream ATGs. Alternatively, the additional
M25 proteins present in the lysates from cells transfected with the shortened pIRESM25 con-
structs may have resulted from protein degradation. It is striking that the abundance of the
80 kDa protein is higher compared to the other small proteins which may indicate that this
protein is a major degradation product.
A single M25 transcript is expected to originate from the plasmids since viral co-factors
that potentially regulate the expression of the two M25 transcripts, detected during virus
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infection, are missing. Unlike the transcription of viral genes that is a highly regulated process
dependent on viral proteins, translation of viral mRNAs is restricted to the host cell machinery
[Mocarski et al., 2007]. An unfavourable ATG-context, meaning that the first ATG on the
transcript is not surrounded by a strong context sequence, i.e. the classical Kozak sequence
GCCRCCAUGG (R= A or G), leads to translation re-initiation at downstream ATG codons
by means of leaky scanning [Kozak, 1991, 2002]. This enables the production of separately
initiated proteins from a single mRNA. Thus, the first ATGs in the shorter constructs may
be surrounded by a weaker context as the ATGs in the pIRESM25NHA or pIRESM25CHA
constructs. Consequently, M25 proteins possibly originate from the downstream ATG codons.
In order to have a direct comparison of the M25 proteins expressed from pIRESATG2,
pIRESATG4 and pIRESATG6, lysates obtained from transfected NIH 3T3 cells and 293T
cells were separated by SDS-polyacrylamide electrophoresis side-by-side with the lysates from
M25HA virus infected NIH 3T3 cells (Fig 6.26B). M25 protein synthesis in NIH 3T3 as well
as 293T cells, initiated at the 2nd ATG of the M25 ORF, generated a protein comigrating
with the 130 kDa protein expressed from the M25HA virus and a protein comigrating with the
105 kDa protein was detected when M25 protein synthesis started at the 6th ATG. Protein
synthesis initiating at the 4th ATG yielded a protein with a molecular weight of approximately
120 kDa. The 50 and 48 kDa protein species could only be seen when the blot was overexposed
but were present in all lysates.
A comparison of proteins expressed from the M25 constructs to those expressed by the
M25HA virus revealed that synthesis of the 105 kDa protein is initiated at the 6th ATG of
the M25 ORF. The synthesis of the 130 kDa protein is initiated at the 2nd ATG whereas the
origin of the 80 kDa M25 protein could not be linked to a specific ATG of the M25 ORF.
These data provide experimental evidence for the potential initiation codons on the two M25
transcripts.
5.3.9 Subcellular Localisation of M25 Proteins
CMV induced cell rounding involves morphological alterations and cellular shrinkage. During
this process, the cytoskeleton must be triggered to disassemble or to rearrange its components,
e.g. filamentous actin. The MCMV M25 that was identified as a key factor for MCMV-
induced cell rounding could exert its function in two possible ways. A direct interaction of the
M25 proteins with actin filaments or other cytoskeletal components in the cytoplasm could
influence cellular morphology. On the other hand, M25 proteins may indirectly regulate the
rearrangement of the cytoskeleton. This could occur by interacting with adaptor proteins in
the cytoplasm which regulate the cytoskeleton or by protein-DNA interactions in the nucleus.
Determining the subcellular localization of a protein is an important first step toward
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Figure 5.27: Subcellular localization of M25 proteins. C127I epithelial cells were infected with the GFP-
negative M25HA-tagged virus using a MOI of 1. Cells were fixed at the indicated time points. An antibody
directed against the HA-tag was used to locate the M25 proteins within the cell. Uninfected (mock) and
wild type MCMV infected cells served as controls. The dashed line marks the nucleus. N = nucleus, C =
cytoplasm
understanding its function. To investigate in which cellular compartment M25 potentially
exerts its function, the subcellular localisation of M25 was analysed by immunofluorescence.
C127I epithelial cells were infected with the M25HA-tagged virus and an antibody directed
against the HA-tag was used to visualise M25 within the cell at different time points after
infection (Fig.5.27). After 12 h of infection the HA-signal was observed as a punctate pattern
that was localised to the nucleus. In addition, a diffuse signal in the cytoplasm was observed.
Both M25-specific signals are likely to originate from newly synthesised M25 proteins and not
from incoming particles for the following reasons. First, a low infection dose of one plaque
forming unit per cell was used and second at 12 h after infection incoming viruses will have
undergone uncoating and will have disassembled. The HA-signal was still associated with the
nucleus at 16 hours after infection. A localisation clearly outside of the nucleus was detected
at late stages of infection, after 24 hours. Here, the HA-signal was concentrated to one side
of the nucleus in addition to a dispersed signal in the cytoplasm (Fig.5.27).
The HA-signal detected in M25-HA infected cells could result from several proteins ex-
pressed from the two M25 transcripts. The signal detected at 12 hours after infection prob-
ably results from the 105 kDa protein that is the most abundant species at early stages of
infection (Fig.5.22) whereas several other M25 protein species are present in the same abun-
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dance like the 105 kDa protein at late stages of infection. The 130 kDa protein is the only
protein identified in purified virus particles by Wu et al. and is suggested to be incorporated
as a tegument protein [Wu et al., 1999]. The tegumentation of virus capsids takes place at
the Trans-Golgi-Network (TGN) by budding into transport vesicles constricted from the TGN-
cisternae [Eickmann et al., 2006]. The cytoplasmic signal detected at 24 hours after infection
possibly reflects the situation when the 130 kDa protein is present in the cisternae during the
ongoing tegumentation process. No HA-specific signal was detected in uninfected or wild type
MCMV infected cells.
These experiments showed that the subcellular localisation of M25 is linked to the different
stages of MCMV infection: at early stages of infection M25 is made in the cytoplasm and
is then translocated into the nucleus, whereas at late stages of infection, M25 localisation
is primarily found in the cytoplasm. This suggested that, for the induction of cell rounding,
protein-protein interactions of M25 in the cytoplasm as well as interactions of M25 proteins
with the DNA in the nucleus are possible.
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6 Discussion
6.1 Generation of a Library of Mouse Cytomegalovirus
Mutants
For the productive infection of endothelial cells and macrophages, MCMV requires specific
tropism factors that are dispensable for virus growth in fibroblasts. This suggests that also
the growth of MCMV in epithelial cells is dependent on specific tropism factors.
The fact that cell rounding occurs during CMV infection indicates that viral factors account
for this effect. The aim of this thesis was to identify viral factors that determine the epithelial
cell tropism of MCMV and the viral factors that induce cell rounding during MCMV infection.
Viral factors can be proteins, like the already identified tropism factors, but could potentially
also be non-protein factors like miRNAs, non-coding RNAs, intron RNAs or cis-active binding
sites for transcription factors.
To identify the factors of MCMV, responsible for the productive infection of epithelial cells
and induced cell rounding, a forward genetic procedure was used. To this end, a library of
MCMV mutants was generated employing site-directed mutagenesis of the MCMV genome
that was previously cloned as a BAC. Cells infected with these mutants were then screened for
the appearance of specific phenotypes followed by the identification of the responsible region
on the viral genome. In this way, the M25 gene could be identified to induce cell rounding in
fibroblasts and epithelial cells and the m107-m108 region to contain factors that influence the
productive infection of epithelial cells.
The forward genetic procedure has been successively used in the past to associate the
appearance of a phenotype with the deletion of a specific gene [Brune et al., 2001, Me´nard
et al., 2003, Dunn et al., 2003, Loewendorf et al., 2004, Zimmermann et al., 2005, Lilja et al.,
2008]. Whereas the work in some of these publications was based on random, transposon
insertion mutagenesis of the MCMV genome creating a large library of mutants, the present
study used the site-directed BAC mutagenesis technique [Messerle et al., 1997]. An advantage
of site-directed mutagenesis over the transposon-mediated mutagenesis is the deletion of large
areas of the viral genome in one step, accelerating the screening process of the corresponding
mutants. A region of interest can then be identified and narrowed down by the production of
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mutants containing smaller deletions. A limitation of the generation of a mutated library by
introducing large deletions is that genes, whose deletion might cause a phenotype, would not
be revealed if they hide within the core region of essential genes.
The BAC mutagenesis technique exploits bacterial genetics in that the gene of interest is
interrupted by the insertion of a selection marker via homologous recombination between a
linear PCR fragment and the BAC-containing viral genome in E.coli [Borst et al., 2007]. The
identification of expected DNA sequences, by cutting BAC DNA and viral DNA prepared from
the individual mutants in this study, indicated a correct integrity of the mutant genomes.
The MCMV genome has been predicted to contain a total of 170 ORF, based on the
genome sequence of the Smith strain [Rawlinson et al., 1996]. Recent work confirmed the
majority of these ORFs by detecting their transcripts [Tang and Maul, 2006]. However, for
most ORFs the potentially expressed protein has not been characterised and thus the function
is unknown. All herpesvirus genomes contain a core of conserved genes. In HCMV, the core
region encompasses the ORFs UL44 to UL115 [Mocarski et al., 2007]. This includes the
essential genes encoding the viral replication machinery e.g. the viral DNA polymerase and
proteins necessary for virion maturation such as tegument proteins and glycoproteins. The core
functions and the position of the respective genes M44-M115 is retained in MCMV [Rawlinson
et al., 1996]. In the regions flanking the herpesvirus core genes, predicted MCMV genes have
sequence homology to HCMV genes or are unique to MCMV.
For the selection of the genes to be deleted the region that is conserved among CMV or
that is unique for MCMV was chosen since the majority of genes in this region has been found
to be non-essential for the infection of fibroblasts in vitro [Brune et al., 2006]. This cell type
is commonly used as a standard for virus production in cell culture. Further, four out of five
cytomegalovirus cell tropism factors that have been previously identified are located outside
the core conserved region [Brune et al., 2001, Me´nard et al., 2003, Hahn et al., 2004, Wang
and Shenk, 2005b]. MCMV M36, M45, m139, m140 and m141 genes promote the production
of virus progeny in endothelial cells or macrophages. The HCMV UL131-UL128 genes are
necessary for the productive infection of endothelial and epithelial cells. This approach was
recently supported by the identification of Rh01, a factor that is essential for the growth of
rhesus CMV in epithelial cells [Lilja et al., 2008]. The Rh01 gene is located in the region that
is unique for rhesus CMVs.
A library of 18 MCMV deletion mutants was created that lack either a single gene or
multiple genes. The deletions targeted a total of 105 predicted viral genes, referring to the
published sequence of the Smith strain [Rawlinson et al., 1996]. The reconstitution of infectious
virus from all 18 virus mutants in fibroblasts indicated that the deleted genes were not essential
for the production of progeny virus in fibroblasts. These results are in agreement with the
previous observation of M. Wagner [Brune et al., 2006] and extended the set of genes that are
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dispensable for virus productivity in fibroblasts by the region containing the ORFs m106-m108.
The growth of individual virus mutants was analysed in fibroblasts and epithelial cells using a
cell tropism assay. As revealed by this assay, the titres from the virus mutants in fibroblasts
were not uniform. It is possible that genome size negatively influenced the packaging of the
genome into the viral capsid possibly affecting infectivity. However, both the virus mutant
∆m01-m17 that has the smallest genome and the ∆M33 mutant that has the largest genome
yielded similar titers in fibroblasts compared to those of wild type MCMV. This indicated that
the presence or absence of specific gene functions rather than the genome size determined the
productivity of each individual mutant.
An overall genome size of about 230 kb that is conserved between several MCMV isolates
suggests that the maximal size of a MCMV genome packaged into a capsid cannot exceed
230 kb to ensure viral fitness [Smith et al., 2008]. The Smith strain that was manipulated
in the present study has a size of 230,278 bp. The added BAC vector contains 8396 bp and
the marker gene, GFP, 1526 bp (M.Messerle, personal communication). Thus, the complete
MCMV-BAC has a size of 240,200 bp. However, due to selection pressure against oversized
genomes, it has been observed that only the viral genome is packaged, due to spontaneous
excision of the BAC vector sequences in eukaryotic cells by homologous recombination [Wagner
et al., 1999]. The size of the mutant BAC genomes generated in the present study were in
the range of 224,812 bp (∆m01-m17) to 240,359 bp (∆M33). The analysis of viral DNA
prepared from fibroblasts infected with mutants with a genome size exceeding 230,000 bp,
revealed that the BAC vector sequences were missing. This confirmed that the BAC vector
was excised due to selection pressure against oversized genomes.
6.2 Searching for Mouse Cytomegalovirus Epithelial Cell
Tropism Factors
Productive infection of epithelial cells is thought to be important for CMV entry into the host
and for host-to-host transmission. Infectious virus has been found in body fluids such as saliva,
breast milk and urine possibly secreted from secretory epithelial cells [Mocarski et al., 2007].
Virus shedding from salivary gland epithelial cells has been shown during the persistent phase
of infection [Jonjic et al., 1989]. Salivary glands, and thus epithelial cells, exhibit a reservoir
of latent MCMV genomes, since reactivation of CMV from these organs has been observed
[Reddehase et al., 1994]. Thus, epithelial cells may be necessary to enable CMV to replicate at
mucosal sites of entry, to influence transmission by releasing virus into the bloodstream or by
passing the virus onto traversing leukocytes and to secrete virus for host-to-host transmission.
However, sites of primary CMV infection are not well characterised and the factors that
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promote the productive infection of a certain cell type, e.g. epithelial cells, so called tropism
factors, were unknown.
The aim of the present study was to investigate whether factors of MCMV exist that
are required for the productive infection of epithelial cells. To this end, a library of mouse
cytomegalovirus mutants was created and their growth properties on epithelial cells were inves-
tigated. Comparative analysis of their titers and their spread in epithelial cells and fibroblasts
to those of wild type MCMV identified five mutants that showed a reduced growth in epithelial
cells. Specifically, a reduced capacity for production of viral progeny and spread in epithelial
cells was ascribed to the deletion of the ORFs M28-M31, m29-M31, M35-M37, M45 and
m107-m108.
Evidence that deletion of these genes limited viral productivity in epithelial cells was ob-
tained from comparing the titres of 18 virus mutants to those of the wild type MCMV in a cell
tropism assay. Five virus mutants, ∆M28-M31, ∆m29-M31, ∆M35-M37, ∆M45 and ∆m106-
m108, were identified that yielded lower titres in epithelial cells compared to those of wild type
MCMV or the titres remained below the detection limit (Fig.5.6). Further, the spread of the
mutant viruses in epithelial cells was restricted to single cells surrounding the primary infected
cell (Fig.5.5). In contrast, wild type MCMV established a broad infection of surrounding cells.
However, the comparison of the titres of the virus mutants and wild type MCMV obtained
from fibroblasts revealed that the ∆M35-M37, ∆M45, ∆M28-M31 or ∆m29-M31 mutants
also yielded lower titres in fibroblasts. The titres were at least 1.5 orders of magnitude lower
compared to the titres of wild type MCMV. This indicated that the deletion of these genes
affected growth in fibroblasts and in epithelial cells and so these genes were not considered to
be specific for the growth in epithelial cells. In contrast, the ∆m106-m108 virus yielded three
orders of magnitude lower titres in epithelial cells and only one order of magnitude lower titres
in fibroblasts compared to those of the wild type MCMV. For this reason, the ∆m106-m108
mutant was considered to lack viral factors that are required primarily for the productive in-
fection of epithelial cells and was therefore further characterised. Additional virus mutants in
which the m106 ORF, and a DNA sequence giving rise to a stable intron RNA were targeted
for deletion, and these viruses yielded similar titres in epithelial cells and fibroblasts, excluding
these factors as potential candidates. In contrast, the ∆m107-m108 mutant showed reduced
productivity in epithelial cells. miRNAs that are expressed from this region in addition to
putative proteins expressed from the overlapping m107/m108 ORFs were also shown not to
account for the limited virus productivity.
Combining all the deletions that were introduced into the m107-m108 region revealed
that sequences of 252 and 103 bp were not targeted for deletion and thus could encode
potential epithelial tropism factors. The 252 bp sequence is partly located in the predicted
m107 5′-untranslated region and partly inside the m107 ORF whereas the 103 bp sequence
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is located inside the predicted m107-m108 ORFs. Since potential m107 and m108 proteins
were dispensable for the growth in epithelial cells, this led to the speculation that cis-acting
elements within the m107-m108 DNA sequence may determine the epithelial cell tropism of
MCMV.
Screening of a Library of MCMV Mutants
The overall titres obtained from epithelial cells infected with the 18 individual mutants or wild
type MCMV were at least 1.5 times lower than those obtained from fibroblasts. A possible
explanation for this might be an impaired release of virus particles.
GFP expression, as a marker for immediate early gene expression in epithelial cells infected
with the growth deficient ∆M28-M31, ∆m29-M31, ∆M35-M37, ∆M45 or ∆m107-m108
mutants showed that these mutants had successfully entered epithelial cells. This supported the
working hypothesis of the present study that the cell tropism of a virus is not only determined
by cellular receptors permitting viral attachment and viral entry but also by viral factors that
interact with other cellular factors at the post-entry step. The hypothesis was based on the
work of others. Heparan sulphate, integrins and two other unknown proteins have been shown
to bind HCMV at the cell surface of various cell types [Compton et al., 1993, Wang et al.,
2005, Nowlin et al., 1991]. However, the expression and binding to the attachment receptor
did not result in IE protein synthesis in every cell type that was tested, indicating that the virus
had also to overcome other cellular barriers to start viral gene expression [Nowlin et al., 1991].
A number of viral genes have been identified from different CMV species that are required at a
post-entry step for viral growth in a specific cell type [Brune et al., 2001, Me´nard et al., 2003,
Lilja et al., 2008]. The corresponding proteins control cellular functions in order to establish
a productive infection in the cell [Mack et al., 2008, Cicin-Sain et al., 2008].
Viral entry into the cell is a prerequisite for viral gene expression. A HCMV UL132-UL128
deletion mutant failed to initiate IE1 expression and consequently did not replicate in primary
endothelial cells, although IE1 gene expression and wild type virus-like titers had been observed
in fibroblasts [Hahn et al., 2004]. A recent study attributed this phenotype to the failure to
form a glycoprotein complex, containing the UL128/UL130/UL131 proteins, that is required
to enter endothelial cells by fusion in endocytic vesicles. Entry of fibroblasts occurs directly by
fusion at the plasma membrane and therefore depends on other viral factors [Ryckman et al.,
2008]. The above mentioned study is, up to date, the only report of cell tropism factors of
CMVs that are essential for viral entry into a specific cell type prior to viral gene expression.
The impaired growth of the∆M28-M31,∆m29-M31,∆M35-M37,∆M45 or∆m107-m108
mutants in epithelial cells correlated with greatly reduced spread in epithelial cells compared
to wild type MCMV. As a read out system, extracellular progeny virus was measured and
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cell-to-cell spread was followed until day six after infection. Alternatively to impaired virus
entry, the deletion of gene expressing cell tropism factors could also block the release of virus
particles. Infectious virus particles could be retained inside the cell due to impaired transport
of virions to the plasma membrane. Consequently, this would result in decreased progeny virus
in the supernatants.
The analysis of viral gene expression could provide information at which step of the infection
cycle a virus mutant is blocked. To find out whether differences in viral gene expression between
the virus mutants and wild type MCMV existed, the kinetic expression of viral genes in epithelial
cells should be investigated. However, MCMV-infected GFP-positive cells indicated that at
least the IE genes were expressed since the GFP gene is inserted in the IE2 locus that is
transcribed from the major immediate early promoter at immediate early stages of infection.
Thus possibly early or late viral gene expression could be blocked.
The Genes Selected for Deletion Encode Already Known Cell
Tropism Factors
Several genes that have been previously associated with cell- or tissue tropism are among
the genes that were targeted for deletion in the present study. The MCMV M45 and M36
genes have been previously identified as determinants of productive infection of endothelial
cells and/or macrophages [Brune et al., 2001, Me´nard et al., 2003]. Infection of epithelial cells
with the ∆M45 or ∆M35-M37 mutants yielded titres that remained under the detection limit.
This indicated that the productive infection of epithelial cells also requires the M45 protein.
The M45 protein inhibits TNFα-stimulated caspase-independent cell death by interacting with
the regulatory receptor interacting protein (RIP)1 [Mack et al., 2008, Upton et al., 2008].
Different cell type-dependent expression levels of RIP1 are suggested to determine sensitivity
to caspase-independent cell death. In this way, endothelial cells might be more sensitive
to caspase-independent cell death than fibroblasts. It is conceivable that epithelial cells are
sensitive to this RIP1-mediated cell death similar to endothelial cells and are protected by the
M45 protein. In case of the ∆M35-M37 mutant, the lack of the M36 protein is speculated
to cause the phenotype, since the M36 protein is required for MCMV growth in macrophages
[Cicin-Sain et al., 2008], but this has to be further investigated.
The deletion of the M43 or the m139-m141 genes has previously been shown to negatively
affect virus production in macrophages [Me´nard et al., 2003]. However, since the ∆m42-M43
or ∆m139-m141 mutants did not yield lower titres in epithelial cells compared to those of wild
type MCMV indicated that these genes are dispensable for virus productivity in epithelial cells.
Four genes that have positional homologs in MCMV, RhCMV Rh01 and HCMV UL128,
UL130, UL131, have been described as epithelial cell tropism factors [Lilja et al., 2008, Wang
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and Shenk, 2005b, Ryckman et al., 2008]. The respective viruses only productively infected
epithelial cells in the presence of these factors. However, similar titres of the ∆m01-m17 and
∆m128-m138 MCMV mutants and wild type MCMV obtained from epithelial cells suggested
that these genes are only positional homologs and have other functions during MCMV infection.
In fact, the chemokine homolog MCK-2 is translated from an mRNA that is expressed by the
MCMV m129-m131 genes [Fleming et al., 1999]. An MCK-2 mutant failed to produce high
titers in the salivary glands and was cleared more rapidly from spleen and liver during acute
infection compared to wild type MCMV [Saederup et al., 2001, Fleming et al., 1999]. The
majority of cells in the salivary gland are epithelial cells suggesting that the lower titres are
due to an impaired of the virus mutant to grow in epithelial cells. The growth properties
of a ∆m129-m131 mutant have not been analysed in epithelial cells until now. The present
study adds content to the aforementioned findings in that the phenotype of the ∆m129-m131
mutant in salivary glands is most likely not due to a failure to productively infect epithelial
cells.
A ∆m132 mutant has been shown to produce lower titres in salivary glands. Therefore the
m132-encoded protein was named salivary gland growth protein sgg1 [Manning et al., 1992].
Consistent with the finding from Lagenaur and co-workers, who observed that the sgg1 mutant
was able to enter epithelial cells of the salivary gland [Lagenaur et al., 1994], the ∆m128-m138
mutant infected epithelial cells and grew to similar titres in these cells compared to those of
wild type MCMV. Therefore it can be excluded that the impaired growth of the∆m132 mutant
in the salivary gland is determined by the failure to productively infect epithelial cells.
The present study is the first report that associates the predicted MCMV m106-m108
genes with MCMV epithelial cell tropism. The ∆m106-m108 mutant showed the most
significant growth defect in epithelial cells of all of the mutants tested, and was therefore
further investigated.
Analysis of the m106-m108 Region for Epithelial Cell Tropism
Factors
In order to identify the factor that causes the growth defect of the ∆m106-m108 mutant
in epithelial cells, additional mutants were generated. Deletions were introduced into the
predicted m106 ORF or the overlapping m107/m108 ORFs or into the large non-coding region
between the m106 and m107/m108 ORFs. The finding that the ∆m106 mutant was not
impaired to grow in epithelial cells indicated that the predicted m106 ORF is dispensable for
viral growth in epithelial cells.
Kulesza and Shenk identified a 7.2 kb intron RNA that is produced from the large non-
coding region between the ORF m106 and m107/m108 [Kulesza and Shenk, 2006]. The
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detection of this intron RNA and its appearance throughout the virus life cycle suggested that
it is a stable intron RNA. A mutant virus that is unable to produce the intron RNA failed to
produce similar titers in the salivary glands during the persistent phase of infection [Kulesza
and Shenk, 2006]. The salivary gland phenotype raised the hypothesis that the intron RNA
might be an epithelial tropism factor and thus is responsible for the reduced growth of the
∆m106-m108 mutant in epithelial cells. However, the observation that the ∆intron mutant,
in which half of the intron RNA sequence was deleted, yielded similar titres in epithelial cells
compared to those of the wild type MCMV suggested either that the intron RNA is not
produced and is therefore dispensable for growth in epithelial cells, or that the intron RNA
is still produced in this mutant and the deletion did not inhibit its function as an epithelial
tropism factor.
The finding that the infection of epithelial cells with the ∆m107-m108 mutant, from which
the predicted overlapping genes m107 and m108 had been deleted, yielded reduced titers
compared to those of the wild type MCMV, suggested that one of these ORF determines the
epithelial cell tropism of MCMV.
The synthesis of potential m107 and m108 proteins would require the presence of a
transcript. A m108 transcript was detected at 24 hours after infection and its 5′- and 3′-
ends could be mapped. In contrast, a m107 transcript could not be detected. This suggested
that there is no m107 transcript and no m107 protein. Consistent with these results no
mRNA transcribed from the m107 gene could be detected using microarray analysis or reverse
transcriptase PCR from total RNA prepared from fibroblasts at 24 hours after infection,
whereas a m108 transcript could be detected under the same conditions [Tang et al., 2006].
The potential MCMV m107/m108 ORFs were predicted by analysis of the viral DNA sequence
but not by analysing viral gene expression in cells [Rawlinson et al., 1996, Brocchieri et al.,
2005]. It is possible that transcription from the m107 gene only occurs at immediate early or
early stages of infection and thus a transcript would not be detectable in fibroblasts 24 hours
after infection. Alternatively, cell type specific m107 gene expression is conceivable. This
possibility has to be investigated by analysing m107 gene expression in epithelial cells.
Possible roles of potential m107 and m108 proteins as limiting factors for growth in
epithelial cells were investigated in this study by the generation of several mutants in which the
overlapping m107/m108 ORFs were targeted for deletion. These viruses produced infectious
virus in epithelial cells similar to the wild type MCMV indicating that potential m107 or m108
proteins are dispensable for the growth in epithelial cells.
Sequences that were deleted in the ∆m107-m108 mutant contained not only the ORFs
m107/m108 but also parts of the 5′−/3′- non-coding regions of the predicted m107/m108
genes. The 7.2 kb intron RNA was reported to be spliced from a primary transcript whose
5′-end was predicted to be in the region that is deleted in the ∆m107-m108 mutant [Kulesza
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and Shenk, 2006]. Thus, potentially, the intron RNA is an epithelial tropism factor that
retained its function as a shorter RNA in the ∆intron mutant but could not be produced in
the ∆m107-m108 mutant. Mapping the 5′-end of the putative primary transcript confirmed
the previously published splice donor and splice acceptor sites of the intron RNA and identified
the 5′-end of the primary transcript within the region that was deleted in the ∆m107-m108
mutant. In order to investigate if the 7.2 kb intron RNA is an epithelial tropism factor, a mutant
was generated in which the sequence of the splice donor was deleted and the absence of the
7.2 kb intron RNA was confirmed by Northern blotting. The finding that the ∆7.2kbintron
mutant grew to similar titres in fibroblasts and epithelial cells clarified that the intron RNA
is not an epithelial cell tropism factor. This was also supported by the fact that the ∆m106
mutant grew to similar titres in epithelial cells and fibroblasts although the splice acceptor
of the intron RNA was deleted and thus the intron was not produced, as could be shown by
Northern blotting.
In additon to the 7.2 kb intron RNA, Kulesza and Shenk also speculated that a 8 kb intron
RNA is produced from the 106-m108 region that shares the splice acceptor but differs in the
splice donor site. This 8 kb intron RNA accumulates to a much lower level than the 7.2 kb
intron RNA and could possibly be produced from a splicing event of a m108 primary transcript.
Consistent with the published data from Kulesza and Shenk, a 8 kb RNA could be detected by
Northern blot analysis with the same probe used for the detection of the 7.2 kb intron RNA.
Further, the presence of a m108 transcript was confirmed by analysis of its 5′- and 3′-ends.
There was no evidence of a splicing event of the m108 transcript producing the 8 kb intron
RNA. Instead, a 108 bp intron RNA was identified to be spliced from the m108 transcript.
Thus, the present study confirmed the data from Tang and Maul who identified the expression
of a 108 transcript and adds content to these data in that the m108 transcript coordinates
were determined and post-transcriptional modifications, namely splicing of an 108 bp intron,
were identified.
The fact that proteins and the 7.2 kb intron RNA did not account for the reduced growth
of the ∆m106-m108 mutant in epithelial cells, suggested that other factors than proteins cause
the defect. During productive HCMV infection, 14 miRNAs have been identified [Fannin Rider
et al., 2008] and 18 miRNAs are expressed during lytic infection of MCMV [Do¨lken et al.,
2007, Buck et al., 2007]. miRNAs are small RNA molecules. They can be transcribed in
clusters of miRNAs leading to a polycistronic primary transcript or as individual miRNAs Kim
[2005], Sarnow et al. [2006], Scaria et al. [2006]. miRNAs originate often from intron RNAs
of protein-coding or from non-protein-coding genes but can also be located in the 5′-/ 3′-
untranslated regions of a transcript. The function of miRNAs is to control protein synthesis.
The mode of action is achieved by a partial or complete binding to the target mRNA. Only
little is known about the targets for viral miRNAs and their function.
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The HCMV expressed miRNA miR-UL112-1 was reported to downregulate the ligand MICB
for the activating receptor on natural killer cells. The virus benefits from consequential less
killing of virus-infected cells by NK cells [Stern-Ginossar et al., 2007]. Whereas most of
the herpesvirus miRNAs have been attributed to viral gene expression, immunmodulation or
maintenance of latency, their exact mechanisms remain elusive and no viral miRNA has been
yet identified that functions as a cell tropism factor [Fannin Rider et al., 2008]. However,
since viral gene expression has been found to be species and cell-type specific [Lafemina and
Hayward, 1988, Goodrum et al., 2002, Jurak and Brune, 2006], one might also envision a cell
type-specific viral miRNA expression.
Do¨lken and coworkers have detected four MCMV miRNAs that are produced in fibroblasts
during the early late phase of gene expression and are localised within the m107/m108 region
[Do¨lken et al., 2007, Buck et al., 2007]. The functional relevance of these miRNAs has not
been investigated to date. In the present study, a possible role for the miRNAs as epithelial
tropism factors was addressed and a virus mutant was constructed lacking either the 5′-arm or
both 5′/ 3′-arms of each miRNA hairpin precursor. No differences were found in the number
of infected epithelial cells compared to those infected wild type MCMV. This indicated that
the previously detected miRNAs were dispensable for viral growth in epithelial cells and thus
are likely to fulfil other functions.
Essential vs. Accessory Factors that Promote Cell Type-Specifc Viral
Growth
Infection of epithelial cells with the ∆m106-108 or ∆m107-108 virus yielded reduced titres
compared to those of the wild type MCMV. The reduction however was not uniform within
different experiments. The difference of the titres from the of ∆m106-108 or ∆m107-108
virus, obtained from epithelial cells varied between 1 and 3 orders of magnitude compared to
those of the wild type MCMV. In some cases the virus mutants did not produce detectable
amounts of progeny virus in epithelial cells. The titres of the ∆m106-108 or ∆m107-108 virus
obtained from fibroblasts were uniformly 1.5 to 2-fold lower compared to those of wild type
MCMV. Thus, the alterations in the measured titers of the ∆m106-108 and ∆m107-108 virus
mutants indicated that the phenotype displays some variability.
Contrary to the previously published tropism factors, in the present study, no viral pro-
tein could be attributed to the observed phenotype. Instead the deletion of regulatory DNA
sequences is suggested to account for the observed phenotype. Therefore, and with respect
to the last paragraph, it is tempting to conclude that growth in epithelial cells is determined
by a yet undetermined viral factor that is not essential but rather accessory for the productive
infection and spread of MCMV in epithelial cells.
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cis-acting Elements as Potential Factors that Determine Viral
Productivity in Epithelial Cells
Proteins, miRNAs and the large intron RNA, expressed from the m107-m108 region were found
to be dispensable for the growth of MCMV in epithelial cells. Since infection of epithelial cells
with the∆m107-m108 mutant yielded reduced titres compared to those from wild type MCMV,
factors other than the aforementioned must account for the impaired growth.
Specific regions within the m107-m108 region were targeted for deletion and the corre-
sponding virus mutants were analysed for their growth properties in epithelial cells. All of these
sequences have been shown dispensable for the growth of MCMV in epithelial cells. Sequences
of 103 and 252 bp within the m107-m108 region have not yet been targeted and analysed.
Thus, they might contain viral factors for the productive infection of MCMV in epithelial cells.
It is tempting to speculate that cis-acting elements, located within these sequences, could
account for the phenotype. Cis-acting elements are specific DNA sequences that are binding
sites for transcription factors thereby regulating the expression of adjacent genes.
The detection of a binding site for a transcription factor does not necessarily identify the
regulated gene. Thus, it can only be speculated which of the adjacent genes, upstream or
downstream of the putative cis-acting element within the m107-m108 region, are target genes
to be regulated. These are for example the essential genes M112/M113 which are located
downstream of the ORFs m107-m108.
Comparable analysis of the MCMV genome with the HCMV genome revealed sequence
similarity of the MCMV M112/113 ORFs and the HCMV ORFs UL112/113 [Rawlinson et al.,
1996]. Further, the M112/113 proteins showed a comparable expression pattern and localisa-
tion to those encoded from the HCMV ORFs UL112/113 [Ciocco-Schmitt et al., 2002]. Both,
the M112/113 and UL112/113 proteins regulate viral gene expression. A combination of viral
proteins, including those expressed from the HCMV UL112/113 locus have been shown to en-
hance the expression of viral genes required for replication e.g. encoding the DNA polymerase
[Iskenderian et al., 1996]. The M112/113 proteins interact with their own transcriptional
activator IE3, thereby preventing the repressive effect of IE3 on the major IE promoter and
ensuring IE gene expression [Tang et al., 2005].
M112/113 gene expression might be differentially regulated in epithelial cells and
fibroblasts. The following scenario is conceivable: In addition to enhancers and repressors
that regulate M112/113 gene expression in fibroblasts, expression of the M112/113 genes in
epithelial cells could depend on transcription factors that bind to cis-acting sequences lo-
cated within the m107-m108 region. These cis-acting sequences then represent factors that
determine the productive infection of MCMV in epithelial cells.
Taken together, the tropism of MCMV for epithelial cells might be determined by cis-
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regulatory elements in the m107/m108 region of the virus genome which bind to epithelial
cell-specific transcription factors that are required for the expression of adjacent genes in
epithelial cells.
6.3 Identification of a Viral Gene Involved in
MCMV-Induced Cell Rounding
Cell rounding is a cytopathic effect of cytomegaloviruses that is induced at early stages of
infection [Kim and Carp, 1971, Furukawa et al., 1973, Albrecht et al., 1980, 1983]. The viral
factors required for the induction of these morphological changes induced by MCMV remained
unknown until now. The present study identified M25 as the first viral gene shown to be a
key factor in MCMV-induced cell rounding and showed that M25 transcripts and proteins were
present at early stages of infection correlating with the onset of virus-induced cell rounding.
The results of three experimental approaches provided clear evidence that the M25 gene is
both necessary and sufficient for the induction of cell rounding. First, MCMV virus mutants
lacking the M25 gene failed to induce cell rounding. ∆M25-infected cells maintained a typical
fibroblast morphology with finger-like protrusions at early stages of infection, whereas wild
type MCMV-infected cells demonstrated a decreased cell size and reduced protrusions. At final
stages of infection, ∆M25-infected cells still formed protrusions whereas wild type MCMV-
infected cells obtained a completely round cell shape with accumulated cortical actin. Second,
the re-insertion of the M25 gene into the MCMV ∆M25 genome restored the ability to induce
morphological changes to the reconstituted virus. Third, the expression of the M25 gene from
an expression vector, outside the context of the viral genome, was sufficient to induce cell
rounding in fibroblasts.
Having identified M25 as a key factor in MCMV induced cell rounding, two different
experiments showed that M25 transcripts and proteins were present at early stages of MCMV
infection correlating with the onset of induced cell rounding. Northern blot analysis demon-
strated the presence of an M25 early transcript in RNA extracted from wild type MCMV-
infected cells at six hours after infection and a second M25 transcript expressed during late
stages, after 24 hours of infection. Immunoblotting of M25 proteins revealed the expression of
multiple proteins from the M25 ORF. A 105 kDa protein was the predominant protein species
at early times of infection, whereas the expression of additional M25 proteins was detected
at later stages. These results support the view that cytomegalovirus-induced cell rounding is
caused by an early viral protein [Albrecht et al., 1983].
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In Vitro Growth Properties of the ∆M25 Virus
Wild type MCMV-like growth properties of the ∆M25 virus indicates that cell rounding is a
direct consequence of the lack of the M25 protein and not due to delayed replication kinetics.
The infection of cells with virus mutants either lacking multiple genes including M25
(∆M24-m25.2) or the single M25 ORF (∆M25) or parts of the M25 sequence
(M25∆conserved or M25∆non-conserved) did not manifest in a tiny and rounded cell shape.
It was considered possible that the absence of the M25 gene leads to delayed growth of the
viral mutants in vitro and thus makes the lack of cell rounding an effect of the delayed growth
kinetics of a slower replicating virus. This was proven not to be the case. Consistent with
the study from Zhan et al. that revealed similar titres of a virus mutant with a transposon
inserted in the M25 locus to those of the wild type MCMV [Zhan et al., 2000], in the present
study only slightly lower titres were measured in general of the ∆M25 virus compared to
those of the wild type MCMV. Viral proteins of different kinetic classes were present in ∆M25
virus-infected cells concluding that the respective genes were correctly expressed. The results
obtained from independent experiments were however not uniform. A higher abundance of
viral proteins were detected in ∆M25-infected cells compared to wild type MCMV was found
in one experiment whereas in a second experiment the protein abundance was higher in wild
type MCMV infected cells. Analysis of the growth properties of the ∆M25 virus revealed no
difference in one experiment but slightly lower titres of the ∆M25 virus compared to those of
wild type MCMV in additional experiments.
This could be explained by the limitations in determining the exact values of the titres of
the viruses used in these experiments. The actual value of the titre of a virus can be measured
with a certain accuracy only. In the above described experiments the titre of one virus might
be closer to the true value and the titre of the second virus might be more distant from the
true value. Hence, the infection of cells with either of these viruses will manifest in a different
number of infected cells. Based on long experimental experience, it is estimated that the true
value of a MCMV titre can be determined within the range of about one order of magnitude
by the applied method. Although a variability between single experiments existed it did not
change the main statement of the experiments.
The correct synthesis of viral proteins of specific kinetic classes and the maintenance of a
typical fibroblast cell shape in ∆M25-infected cells indicated that viral growth is not strictly
dependent on the presence of the M25 gene and cell rounding is not an effect of an altered
viral gene expression. The results obtained in this study suggest that the induction of cell
rounding is conserved as an accessory viral mechanism since viral gene expression and virus
particle production did not strictly depend on this process.
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Characterisation of M25 Transcripts
The observation that two M25 transcripts are present during MCMV infection, one transcript
at early stages and the other at late stages of infection indicated that the 105 kDa-M25 protein
at five hours after infection results from an early transcript.
Previous analysis of M25 transcripts by Dallas et al. and Zhan et al. identified a single M25
RNA at 16 hours and 24 hours after MCMV infection [Dallas et al., 1994, Zhan et al., 2000].
The expression of this transcript was blocked in the presence of PAA treatment indicating
that viral DNA synthesis is required for its generation [Dallas et al., 1994]. The present study
detected M25 proteins at five hours after infection suggesting the presence of a corresponding
mRNA. Supporting this hypothesis, a 2.8 kb M25 mRNA was detected at six hours after
infection in Northern Blot analysis. This mRNA was also identified at 24 hours after infection
together with a second 3.1 kb M25 mRNA. The detection of the late M25 transcript is
consistent with the results of others [Dallas et al., 1994, Zhan et al., 2000]. In contrast, the
early M25 transcript was identified for the first time in the present study.
Mapping the M25 transcript ends and transcript start sites revealed that both transcripts
share the same 3′-end but differ in their 5′-ends.
The 5′-end of the early M25 transcript was mapped to the M25 ORF, 313 nt downstream of
the 5′-end of the late transcript. The same 3′-end position was identified for both transcripts.
Thus both transcripts were initiated within the M25 ORF and the late transcript covers the
complete sequence of the early M25 transcript. The calculated size of the transcripts, of
2.7 kb and 2.4 kb, and poly(A) tailing matched approximately the observed sizes of the
transcripts detected in Northern blotting. Analysis of the DNA sequence for the M25 gene and
its flanking regions identified a single core promoter element, a TATA-box, 31 nt upstream of
the late transcript start and a single poly(A) signal downstream of the transcript end suggesting
that both M25 transcripts share the same poly(A) signal.
Although there is no evidence of a GC-box characteristic for TATA-less promoters, a sec-
ond, yet unidentified, TATA-less promoter might drive transcription of the early transcript.
Initiation of transcription is highly regulated through binding of transcription factors to en-
hancer and repressor elements proximal or distal to the core promoter element thereby in-
fluencing the formation of the transcription initiation complex and so the activity of the
RNA polymerase II.
Repressors possibly bind to proximal promoter elements and prevent transcription of the
larger transcript during the early phase of viral gene expression but do not influence the
transcription of the short M25 transcript. At late stages of viral gene expression the repressor
may dissociate from the promoter region allowing the synthesis of both transcripts.
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Kinetics of M25 Protein Expression
Analysis of M25 protein expression revealed the presence of multiple protein species expressed
from the M25 ORF. Four major proteins of approximately 130, 105, and 80 kDa were detected.
The detection of this M25 protein pattern in M25HA-virus infected cell lysates is consistent
with the M25 protein pattern identified in previous publications [Farrell and Shellam, 1990,
Wu et al., 1999]. In the present study, at five hours after infection the 105 kDa-M25 protein
was detected in a high abundance together with low amounts of the 130 and 80 kDa proteins.
The abundance of these proteins in infected cells did not change until 18 hours after infection.
From this time point on the abundance of all three protein species, especially those of the 130
and 80 kDa proteins increased reaching the highest abundance at 36 hours after infection.
Whereas the presence of M25 proteins in the late phase of infection are consistent with the
results from Wu et al., the onset of M25 protein expression and the presence of additional M25
proteins during the early phase of viral gene expression are controversial. In the present study,
the 105 kDa protein species was synthesised with early kinetics, starting already at five hours
after infection, whereas Wu et al. detected the 105 kDa protein at nine hours after infection
in lysates of wild type MCMV-infected cells [Wu et al., 1999]. The discrepancy between the
results obtained in this study and the published data for the detection of the 105 kDa protein
could be attributed to the different infection doses used in the experiments. In the current
study, a high infection dose of five PFU/cell was used for infection whereas the infection dose
utilised in the earlier publications is not mentioned but was possibly lower than five PFU/cell.
The more virus particles are present and able to express their genes, the higher the expected
expression of viral proteins.
The virus isolate, investigated in the previous publications is the MCMV K181 strain and
not the MCMV Smith strain used in the present study. The alignment of the M25 amino acid
sequence from both strains revealed 99% similarity. This supports the finding of the same
pattern of M25 proteins in both MCMV isolates but it is possible that functional differences
between other viral proteins of the strains K181 and the Smith strain influence M25 gene
expression and could also explain the temporal differences of M25 protein expression.
In addition to the 105 kDa protein, in this study, low levels of a 130 and 80 kDa-M25
proteins were also detected at early stages of infection. The low abundance of the 130 kDa-
M25 protein may originate from incoming virus particles since the 130 kDa-M25 protein species
has been detected in purified virions [Wu et al., 1999, Kattenhorn et al., 2004]. The increase
of the 130 kDa protein abundance at late stages of infection, after 18 hours, indicated that it
is made from a mRNA that is synthesised with late kinetics. Indeed, the generation of a 130
kDa-M25 protein in wild type MCMV infected cells is prevented when the expression of late
viral genes is blocked [Wu et al., 1999]. It is very likely that the 2.8 kb M25 mRNA detected in
wild type MCMV infected cells at 6 hours and 24 hours after infection results in the synthesis
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of the 105 kDa-M25 protein whereas translation of the 3.1 kb M25 mRNA identified at 24
hours after infection results in the 130 kDa protein.
The origin of the 80 kDa-M25 protein that was present in a low abundance at early stages
of infection remains unclear. Protein expression from different M25 plasmids did not result
in a 80 kDa-M25 species whereas the synthesis of the 105 and 130 kDa-M25 proteins was
initiated at specific start codons. Thus, the 80 kDa-M25 protein is likely a degradation or
cleavage product of the 130 or 105 kDa-M25 proteins.
Identification of the Translation Initiation Sites for the Synthesis of the 105 and
130 kDa-M25 Proteins
Protein synthesis from different M25 constructs provided evidence that the 105 and 130 kDa-
M25 proteins were synthesised starting from different ATGs and resulting in two distinct
N-terminal domains.
Several proteins were shown to be expressed from the M25 gene and several potential
translation initiation sites are present in frame within the M25 ORF. The 6th ATG within
the M25 ORF is the potential translation initiation codon of the early 2.8 kb M25 tran-
script since it is the first ATG downstream of the 5′-end of the transcript. The 2nd ATG of
the M25 ORF is the first start codon of the late 3.1 kb transcript where protein synthesis
could possibly start. The predicted sizes of the proteins that would result from the various
ATGs within the M25 ORF did not match with the size of any of the detected M25 proteins
suggesting that the proteins were posttranslationally modified. Analysis of protein expression
from successively shortened M25 ORF constructs revealed that translation initiated at the 6th
ATG predominantly produced an approximately 105 kDa protein, and a 130 kDa protein is the
major product when translation is initiated at the 2nd ATG. The 5th ATG that is proposed to
be the translation initiation codon for M25 proteins [Dallas et al., 1994] was excluded, based
on the results of the present study, since the protein produced from the 5th ATG did not match
to any of the M25 proteins detected during infection. Translation initiation sites generating
the 80 kDa protein could not be identified suggesting that this proteins did not originate from
unique translation events.
Replacing the 2nd and 6th methionine with similar non-polar amino acids followed by the
analysis of M25 protein expression would be an alternative method to show at which ATG
the synthesis of the M25 protein variants starts. A second alternative would be to apply a
translation assay coupled with a primer-extension assay as described [Kozak, 1997]. In this
system, the M25 mRNA would be analysed using an in vitro translation system containing
ribosomes and inhibitors to block elongation. The 80s ribosomal subunit would bind to the
favoured physiological ATG. This ATG start site would then be identified using a primer
extension inhibition assay in which a radiolabeled M25 specific primer would anneal to the
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M25 mRNA downstream from all potential initiator codons and would be extended by reverse
transcriptase up to the bound ribosome.
The 105 kDa-M25 Protein is a Potential Effector of Cell Rounding
Comparing wild type MCMV-induced cell rounding to ∆M25-induced cell rounding over the
course of a complete MCMV replication cycle revealed that cell rounding is not induced in the
absence of the M25 gene.
The onset of cell rounding was observed in cells infected with wild type MCMV at five hours
after infection and completely round and tiny cells were present at 24 hours after infection.
The finding that ∆M25-infected cells did not round up during the course of a viral replication
cycle suggested that MCMV-induced cell rounding is dependent on the M25 protein and no
other viral protein substitutes for the M25 protein.
The presence of the 80, 105 and 130 kDa proteins in M25HA-virus infected cell lysates at
five hours after infection made them potential candidates for the induction of cell rounding.
Previous studies revealed that viral protein synthesis is required for virus-induced cell rounding
[Furukawa et al., 1973, Hirai et al., 1977]. Cell rounding was inhibited in the presence of
the protein synthesis inhibitor cycloheximide when added to cells one hour before or after
infection with HCMV whereas the drug did not prevent cell rounding when added two hours
after infection or later [Furukawa et al., 1973]. The fact that UV-light affects the ability of
viral particles to induce cell rounding [Hirai et al., 1977] supports the hypothesis that a newly
synthesised viral protein is required. UV-irradiation of infectious particles prevents the de-novo
synthesis of viral proteins due to DNA damage of the viral DNA. The number of rounded cells
and the presence of HCMV early antigens decreased after infection with UV-irradiated virus
particles in a dose-dependent manner whereas the amount of nuclei-associated HCMV DNA
was not affected [Hirai et al., 1977]. The 105 kDa-M25 protein fulfils the requirements of two
criteria to be a candidate for the induction of cell rounding: First, its presence at five hours
after infection correlates with the onset of cell rounding observed at the same time. Second,
the 105 kDa protein is not present in MCMV virions, thus must be newly synthesised during
infection.
Subcellular Localisation of M25 Proteins
The finding that M25 proteins were localised in distinct cellular compartments at different
stages during infection led to the speculation that the distinct N-terminal domains of the 105
and 130 kDa-M25 proteins determines their localisation and their function.
The M25 signal was followed in epithelial cells infected with a M25HA-tagged virus by
immunofluorescence. M25 proteins were associated with the nucleus at early stages of infection
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and accumulated outside, at one site of the nucleus, in the cytoplasm during late stages of
infection. Additionally, at both early and late times after infection, a diffuse M25 signal was
detected in the cytoplasm. Comparison of the data obtained from M25 immunofluorescence
with those of M25 protein synthesis suggests that the signal observed at early stages of infection
is due to the 105 kDa protein whereas the signal detected at late stages of infection could
reflect the presence of both the 105 as well as the 130 kDa protein.
The work of others suggests that the 130 kDa-M25 protein is a tegument protein. At early
stages of infection, the 105 kDa protein was detected exclusively in the nuclear fraction of
MCMV-infected cells whereas the 130 kDa protein was the major protein in the cytoplasmic
fraction and both proteins were present to some degree in both the nuclear and cytoplasmic
fractions at late stages of infection [Wu et al., 1999]. In addition, the 130 kDa protein but
not the 105 kDa protein was detected in purified virions by the same authors. Further, a M25-
specific antibody labeled with gold particles localised to electron dense material in the nucleus
and to individual virions and multicapsid structures in the cytoplasm. In the cytoplasmic
virions, the immunogold particles localised to the viral tegument.
Further evidence for a 130 kDa-M25 tegument protein was provided since a monoclonal
antibody raised against MCMV antigens reacted with a structural MCMV protein of 130 kDa
size [Dallas et al., 1994]. Screening of a MCMV cDNA library with this monoclonal antibody
identified a reactive clone. The insert of this clone exclusively hybridised to a fragment of the
MCMV genome that was mapped to be the M25 ORF. Considering all these points, it is most
likely that the 130 kDa structural protein detected by the monoclonal antibody is a component
of the viral tegument. Many tegument proteins are phosphorylated. Consistent with this, the
M25 protein sequence contains several serines, threonines and tyrosine throughout the sequence
that were predicted to be phosphorylated.
The tegumentation of virus capsids is thought to take place at the Trans-Golgi-Network
(TGN) by budding into transport vesicles constricted from the TGN-cisternae [Eickmann et al.,
2006]. The cytoplasmic staining of M25, observed at late stages of infection resembles the
localisation of at least three other known HCMV tegument proteins, pp150, pUL24 and pUL43
during the late phase of infection [Sanchez et al., 2000, Adair et al., 2002].
Co-localisation studies using markers for Golgi and tegument proteins in addition to the
detection of M25 would reveal whether the M25 staining observed in this study at late stages
of infection reflects the tegumentation of viral capsids.
The 105 kDa-M25 protein is possibly a nuclear protein. The size of the 105 kDa protein
indicates that it must have been actively transported into the nucleus. Only proteins smaller
than 60 kDa can diffuse through the nuclear pore [Nigg, 1997]. This implies the presence of
a nuclear localisation signal (NLS) that is required for the nuclear import by cargo proteins.
A NLS with similarity to the NLS of the SV40 large T antigen was predicted within the M25
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protein indicating the possibility of active nuclear import. However, the function of this signal
has yet to be experimentally verified. A passive translocation to the nucleus by interaction of
M25 with cytoplasmic proteins that actively translocate to the nucleus is also possible. Further
studies on the localisation of the M25 protein variants synthesised from the M25 plasmids,
especially the 105 and 130 kDa proteins, would help to understand whether additional viral
proteins are required or cellular proteins are sufficient to translocate the M25 proteins to the
nucleus.
The unique 89 amino acids present at the N-terminus of the 130 kDa protein that are
missing in the 105 kDa protein could influence the properties of the protein. An accumulated
sequence of threonines and serines within this N-terminal segment is predicted to be phospho-
rylated, and thus could have an impact on the localisation and the function of the 130 kDa
M25 protein. The additional N-terminal amino acids could also alter the secondary structure
of the protein possibly exposing interaction domains not present in the 105 kDa M25 protein.
For instance, one of the two predicted M25 homologs in HCMV, the ORF UL35, encodes two
proteins that are synthesised from two different transcripts. The N-terminus of the 22 and 75
kDa UL35 proteins has been suggested to determine their localisation and function [Liu and
Biegalke, 2002]. The 22 kDa protein is localised in the nucleus and inhibits activation of the
MIEP, whereas the 75 kDa protein is localised exclusively in the cytoplasm, is packaged in
virions and is important for particle formation [Liu and Biegalke, 2002, Schierling et al., 2005].
The analysis of morphological changes induced by the M25ATG2 or M25ATG6 proteins,
in fibroblasts will help to identify whether the 130 kDa or the 105 kDa M25 protein is crucial
for the induction of cell rounding, possibly determined by their N-termini.
M25-induced Cell Rounding Outside the Context of the Viral
Genome
Having shown that M25 is able to induce morphological changes during MCMV infection it
was considered possible that M25 could also induce cell rounding without the help of additional
viral proteins.
Indeed, M25 protein expression was sufficient to induce morphological changes in trans-
fected cells. The GFP-expression from the bicistronic M25 transcript made it easy to identify
transfected cells and allowed the characterisation of their cellular morphology. The transfec-
tion of two vectors expressing N- or C-terminally HA-tagged M25 variants yielded in each
case about two times more rounded cells than transfection of the empty vector concluding
that a direct interaction between the M25 protein and cellular factors without additional viral
proteins is sufficient to induce cell rounding. The presence of round cells after transfection of
the empty vector is possibly related to stress-induced rounding due to the transfection proce-
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dure. Rounded cells were also observed when other transfection reagents were tested. The
cloning of M25 into a retrovirus vector and the infection of cells with these M25-expressing
retroviruses would be an alternative method to the transfection approach that could possibly
reduce the background of rounded cells.
M25 Homologs in HCMV
Based on the sequence conservation of the C-terminal domain between the MCMVM25 protein
and the HCMV UL25 and UL35 proteins, it was speculated whether these proteins may also
share functional homology.
The UL25 and UL35 are the only members of the HCMV UL25 gene family [Chee et al.,
1990]. Similar to the proteins expressed from the MCMV M25 ORF, several proteins are
expressed from the HCMV UL25 and UL35 ORFs that localise to the nucleus or are detected
in the cytoplasm of infected cells and individual UL25 and UL35 proteins have been identified
in purified virions [Baldick and Shenk, 1996, Battista et al., 1999, Zini et al., 1999, Liu and
Biegalke, 2002, Schierling et al., 2005].
No differences in cellular morphology between fibroblasts infected with a UL35 deletion virus
and wild type HCMV have been described suggesting that the UL35 protein is functionally
distinct from the M25 protein [Schierling et al., 2005]. The infection of fibroblasts with a
HCMV ∆UL25 virus resulted in cell rounding similar to cell infected with wild type HCMV
suggesting that the M25 protein is not a functional equivalent to the UL25 protein (personal
communication, Corinna Benkartek).
During evolution of MCMV and HCMV, functional domains might have been lost and/or
new functional domains were gained. Herpesviruses may have captured a number of their
genes from the cellular genome repertoire during co-evolution with their host [Shackelton and
Holmes, 2004]. Other viral genes are likely to have been passed vertically from viral ancestors.
If conserved domains, important for the function of a gene, are lacking after the transfer, these
genes may no longer retain their original function but might instead obtain new functions. This
happened to be the case for the HCMV UL72 protein that represents the ortholog of a cellular
dUTPase [Davison and Stow, 2005]. Due to the loss of conserved motifs this protein lacks
dUTPase activity. As members of the UL25 family, the M25, UL25 and UL35 proteins could
have a common origin in a viral ancestor or in the genome of a cellular host but have obtained
distinct functions during evolution of the viruses. This might explain why cell rounding is (still)
induced by the MCMV M25 gene products but not by the HCMV UL25 or UL35 proteins.
Perhaps M25 is unique to MCMV and provides a specialised function for the induction of
cell rounding in MCMV whereas in HCMV other factors may account for the same function.
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Possible Mechanisms of M25-induced Cell Rounding
Combining the obtained data from the present study and the published data about M25,
several scenarios are plausible to explain the M25-mediated cell rounding. The role of M25 in
two scenarios, that are described in the following, will be investigated in future experiments.
The M25 proteins may directly influence the regulation of the cytoskeleton. Exploiting the
GFP-expressing viruses and visualising actin filaments during infection led to the observation
that the absence of the M25 gene affects cellular morphology during infection. Three types of
cytoskeletal filaments, actin filaments, microtubules and intermediate filaments, determine the
spatial organisation and the structural framework of a cell. Factors that regulate the dynamics
of these cytoskeletal filaments represent putative M25 interaction partners. Cdc42, Rho and
Rac, members of the Rho GTPase family, are key regulators of the actin cytoskeleton and
determine the formation of cellular protrusions, e.g. filopodia and lamellipodia [Hall, 1998,
Mattila and Lappalainen, 2008].
Several members of the herpesviruses have been shown to directly or indirectly interact with
Rho GTPases. The expression of Rac1 and Cdc42 mutants did not influence
binding, internalisation and transport of HSV-1 particles but affected infectivity [Hoppe et al.,
2006]. Activation of Rho GTPases during HHV-8 entry results in a reorganisation of the actin
cytoskeleton [Sharma-Walia et al., 2004]. The activity of Rho GTPases is stimulated by integrin
engagement [DeMali et al., 2003]. RhoA protein levels decrease during HCMV infection, possi-
bly through integrin-mediated signalling [Wang et al., 2005] and integrins have been identified
as HCMV entry receptors mediating HCMV internalisation [Feire et al., 2004]. Cell rounding is
also induced via Rho GTPases by other pathogens that infect epithelial cells. Glycosylation of
Rho proteins by Clostridium difficile Toxin A and Toxin B causes actin re-organisation resulting
in rounded epithelial cells and fibroblasts [Gerhard et al., 2008, Halabi-Cabezon et al., 2008].
In the present study, filopodia and lamellipodia have been observed in fibroblasts infected
with the ∆M25 virus whereas wild type infected cells did not exhibit protrusions but in con-
trast altered their morphology towards a rounded cell shape. This points to a potential,
direct or indirect M25-mediated effect on the Rho GTPase proteins. M25 proteins might
induce cell rounding by affecting the activity of these Rho GTPases. Stimulation of these
Rho GTPases upon infection may in turn stimulate downstream effectors that are involved
in effecting changes in the actin cytoskeleton. Altered protein levels have been detected,
among others, of the actin regulators Connexin-43, Paxillin and the protein Eg5 upon HCMV
infection [Stanton et al., 2007]. It cannot be ruled out that, besides actin filaments, the break-
down of microtubules or intermediate filaments caused the cell rounding in CMV-infection.
Investigation of the MCMV-induced CPE and the ∆M25-induced CPE after treatment with
inhibitors of actin polymerisation or with microtubule disrupting agents will help to identify
the cytoskeletal filaments involved. Pull-down assays from cells expressing Rho GTPases using
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M25 as the bait or MCMV infection of cells expressing dominant-negative Rho GTPases would
help to understand the mechanism of M25-induced changes in cellular morphology.
In the second scenario, M25 proteins may indirectly induce cell rounding by interacting
with cellular factors that control the host cell cycle. The cell cycle is a complex and controlled
process that prepares a cell for its division during the mitotic phase. A hallmark of mitosis is
cell rounding. The molecular mechanisms of the morphological changes during mitosis are not
fully understood.
HCMV and MCMV can infect cells throughout the cell cycle [Salvant et al., 1998, Wiebusch
et al., 2008]. HCMV stimulates cellular proliferative pathways by activating synthesis-phase
promoting pathways and mitosis-phase promoting complexes [Salvant et al., 1998, Sanchez
et al., 2003 Dec]. Increased protein levels of a key regulatory factor, cyclin E, have been
measured during HCMV infection [Salvant et al., 1998]. Cyclin E is expressed in the G1 phase
of the cell cycle and associates with cyclin-dependent kinase 2. This complex is required for the
progression into the S-phase. The effect of HCMV on cyclin E is at the transcriptional level by
upregulating cyclin E mRNA [Salvant et al., 1998]. Both, HCMV or MCMV infection inhibits
cellular DNA synthesis resulting in a deregulated cell cycle in infected cells [Bresnahan et al.,
1996, Petrik et al., 2006, Wiebusch et al., 2008]. Although cellular DNA synthesis is inhibited,
other features of the S-phase such as an active nucleotide metabolism and the expression of
replication factors are induced to ensure proper viral replication. It is conceivable that the
cell cycle is further stimulated towards the mitotic phase. Notably, pseudo-mitotic cells have
been reported in HCMV-infected cells [Hertel et al., 2007]. In this regard, MCMV-induced cell
rounding might be the result of the interaction of M25 proteins with cell cycle regulators.
Further experiments are required to investigate whether MCMV wild type infected cells
resemble mitotic cells.
Possible Contribution of Cell Rounding to Viral Dissemination
Cytomegloviruses manipulate target cells in various ways in order to disseminate efficiently.
These include virus-encoded chemokines that recruit leukocytes to sites of infection, the sup-
pression of cell death and the interferon response, as well as the subversion of host immune
responses. The induction of cell rounding may also contribute to viral dissemination within
the host.
The observation that plaque formation was not only present in a fibroblast cell line but
also in primary mouse embryonic fibroblasts suggested that cell rounding is not only an in
vitro effect but is probably also present in vivo. Notably, cell rounding and plaque formation
was also induced in epithelial cells indicating that virus-induced cell rounding is not restricted
to fibroblasts. In fact, circulating HCMV-infected endothelial cells have been found in the
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peripheral blood of immunosuppressed patients with lytic HCMV infection and have been
associated with CMV dissemination [Percivalle et al., 1993, Gerna et al., 1998, Salzberger
et al., 1997]. Thus, endothelial cells might round up upon CMV infection and move from
the vascular endothelium into the blood stream. These infected cells, circulating in the blood
stream, may provide a means for dissemination of the virus.
Bentz et al. report of an actin stress fibre breakdown in HCMV-infected endothelial cells
[Bentz et al., 2006]. The induction of these cytoskeletal alterations together with the degra-
dation of lateral junction proteins in HCMV-infected endothelial cells, described by the same
group, is suggested to increase the permeability of the endothelium upon infection with HCMV.
HCMV is further shown to increase the permeability of the endothelium which in turn in-
creased the number of na¨ıve monocytes that migrated through the infected endothelial cell
layer [Bentz et al., 2006]. A small percentage of these monocytes becomes infected during
their trans-endothelial passage. In an in vivo scenario these infected monocytes would migrate
into the surrounding tissue and disseminate the virus. These data imply that HCMV-induced
morphological changes of the endothelium play a role in dissemination of the virus.
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Primers used for the Generation of a Library of MCMV Mutants
Upper case letters designate the homology to the wild type MCMV Smith strain, lower case letters designate homology to the
pGP704-kan plasmid. [deleted MCMV genes] (genomic positions of the deletion)
[∆m01-m17] (479...16,951)
Delta1.for
5′- CAC GTG TTA GCA TAG GAA TCC AGA CGC GCG CTC GCC TGA gcgtcgtggaatgccttcgaattc -3′
Delta1.rev
5′- CTT TGA AAT CGG ACG ACC GAT CAG AAC GTC CGC CTT CGA GA aacaaggacgacgacgacaagtaa -3′
[∆m18-m23.1] (19,225...24,975)
m18.for
5′- CCG CTC TGC GCG AGC CGG TGG TCG TCT CCA CAG GCC CTC CGT TCA ATA AA aggacgacgacgacaagtaa -3′
m23.1.rev
5′- AAA GGC CGA GGG ACG CCC ACC CAC GAC CGA CCC ATC GTC TCG AGC TCG AA caggaacacttaacgcctga -3′
[∆M24-m25.2] (25,685...30,751)
M24.for
5′- CCG ATC TCG ATG GGG CCT GCC GTG CAG TGA ATC GGA TAA AAA TAT CTG AA aggacgacgacgacaagtaa -3′
m25.2.rev
5′- CTA CGA CCC GGC GCC CTA CGG GGG ACT ATA TAG GCT TGC CAA CAC TAT GA caggaacacttaacgcctga -3′
[∆M28-M31] (34,489...38,826)
A4.for
5′-CTG GCG GGA TAA CTG CAA GAG AGG GGA AAA GCG GTC GAT CCC AGC CGT CA ctacaggacgacgacgacaagtaa -3′
A4.rev
5′-CGG GGA GAT CAG CGA GAG GCG GAT GGG GCT CTG CGG GCG CCA GAC CGT CA gtgacacaggaacacttaacggctga -3′
[∆m29-M31] (36,339...38,442)
m29.for
5′- CCG CTC GGA GCG GCG CTT TTC GCT GGA GCA CGC GAG CAT TTT ATT CAT AA aggacgacgacgacaagtaa -3′
M31.rev
5′- TGC CGC CGT CCA CGA CGT ACA TGC TCT CGA CGT TGA TAC CGG CCT CGA AA caggaacacttaacgcctga -3′
[∆M33] (41,656...42,586)
M33.for
5′- TAA ATG ATT GAT ATC CGT CTA TCT TCG GTG TCC GGT GTC TAT CCC CAC AA aggacgacgacgacaagtaa -3′
M33.rev
5′- CGC CGA CTG AAG AGC TTG CCA GTT ATG CAT TGC ATG AAG CGT TTG TTG AA caggaacacttaacggctga -3′
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[∆M35-M37] (45,969...50,165)
M35.for
5′- CGA CGG AGG AAG ACC CCA GAC GCG ACA CGA GTC TGA TGA TAA ACG AGA GA aggacgacgacgacaagtaa -3′
M37.rev
5′- AGC TGT CAA GAT GCC TTC ACG TTG GTC AGT ACC TGG TTC GGC AAG GTT AA caggaacacttaacggctga -3′
[∆m39-m40] (53,319...52,841)
m40.rev (KnR is inserted in reverse orientation)
5′- GGG CCT GGT TCG CGT ACA ACA TCT ACG CCG TTA GAC GTG AAT TCG TTC GA aggacgacgacgacaagtaa -3′
m39.for
5′- TGC ACG GTG GGA GAA AGT GCC TCG TCC GAG TAC CAT TTC TTC CTG AGA AA caggaacacttaacggctga -3′
[∆m42-M43] (54,471...57,001)
m42.for (KnR cassette is inserted in reverse orientiation)
5′- GGA CAC ACA GAC TCC GAC CGT GAT GGC GGT CCA CTG AAA CTC TTT ATC CA caggaacacttaacggctga -3′
M43.rev
5′- GAC GGA ACA TCA CCA GCG TCC CCG CGC CGT TCT CTA TGT ATC CCG AAC GA aggacgacgacgacaagtaa -3′
[∆M45] (59,674...62,907)
M45.for
5′- AAG CCG ATG GCG ACG GGC AGC GAC TGC GCA TGG TCG ACG AAC GGC TGT CT aggacgacgacgacaagtaa -3′
M45.rev
5- GAG GCC AGC AGA CCG CCA CCA CCG CTG CCG GGG GAG CCT TCG GGG TGG GT caggaacacttaacgcctga -3′
[∆m106-m108] (153,916...162,771)
A2.for
5′- GTT TTC TGA CAT GAG TCT GTG TGT TTA TTT ATT AAT TAT CTG TCA GTT CA ctacaggacgacgacgacaagtaa -3′
A2.rev
5′- CTG GGC GCC GAG GCC AGT AAT GTG CCT GTC TCC CCG GAC CCG CCT AGC AG gtgacacaggaacacttaacggctga -3′
[∆M116] (167,452...168,980)
M116.for
5′- CGC TCA GGA CGA ACG GCC CGT ATT TCG CGG GGC AGT ACC TGC GAG TGC AT aggacgacgacgacaagtaa -3′
M116.rev
5′- CTC CGT GAC CTC CAA GCA GCC GAG CAT ACC CAA ACA GCC CAA GCT GGA TA caggaacacttaacgcctga -3′
[∆m117-m120] (169,217...174,574)
A3.for
5′- GTG TCC GAG AGG TTA AAT AGT TGA TGG GGG TGA CGG GGA AAA ACT CGC TAC ctacaggacgacgacgacaagtaa -3′
A3.rev
5′- GTA CGA GTC CGT GAC CGC GTC CCT CCC GCT CTT TCT CGT CTA CCC GAC CA gtgacacaggaacacttaacggctga -3′
[∆M121] (175,903...177,674)
M121.for
5′- ATG CGT ATC GAT TTC CGG TTC ACC TGA GAC CAC GGG GAG AAG GTC GAC CA aggacgacgacgacaagtaa -3′
M121.rev
5′- TGT TGG CGC GCG GTG GCG GTG GTG CAG AGA GTG CCG CTC AAG TGA CTA AC caggaacacttaacgcctga -3′
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[∆m128-m138] (168,085...193,943)
A1.for
5′- CCG GGG GCG TGA GGG ACG CGA CTG CTC ACG GTT CTG TTT GTC TGT AGA T ctacaggacgacgacgacaagtaa -3′
A1.rev
5′- CAG AGC GCG AGC TCA AGT CGC CAT CAT CTC TCG GTC GGC AGA GCC GAG GCG gtgacacaggaacacttaacggctga -3′
[∆m139-m141] (194,494...199,182)
m139.for
5′- GCC TCT TCG CCT CGC TCA CGT TCG ACA GGG CCA CGC CGT CCT GCA ACC GC aggacgacgacgacaagtaa -3′
m141.rev
5′- ATG GAG AGG CCG GTG ACG GCG AAC GCC ATC TCC GCG TAC AAG CGG GTG AT caggaacacttaacgcctga -3′
[∆m144-m158] (203,001...217,799)
Delta6.for
5′- AGC GCC GTC CGA ACC TCC TAC GCG TCT TCC TCT GTT CCT TG aggacgacgacgacaagtaa -3′
Delta6.rev
5′- CTA CCG TCT CCT CGA ATG GCA GAG AGG CGA TCT CGT ACC TCT AAC C aggaacacttaacggctga -3′
[∆m159-m170] (218,173...229,997)
Delta7S1.for
5′- AAC TGG AAA ATA TAG TTA GCA CCG TTA GAG AGG GCG ACA GAT TTC GAT CA ctacaggacgacgacgacaagtaa -3′
DeltaS3.rev
5′- ATG TGC TCG GTT AAC GAG TTG GCC TTC GTC CGG CTG TCC GGC ACG ACT AC gtgacacaggaacacttaacggctga -3′
[HCMV ∆UL25] (on the basis of the HCMV TB40/E strain, Refseq EF999921 )
UL21.5-25ko.for
5′- TAA CGT GAT TGT GAA CGC GGT TAT CGT GTT TTT GCA GCG TGA CGG TGG AA gaaaagtgccacctgcagat -3′
UL21.5-25ko.rev
5′- TGA AGG CGT CCT GCT GAC GCA CGA CGC GTA AAA AGT CAA ACA ACG caggaacacttaacggctga -3′
Primer Sequences for the generation of Probes used for Northern Blotting
m106 probe
sonde m106.for 5′- GAC GCT GAT CGC GAC GAC GA -3′
sonde m106.rev 5′- GAT CGT CCC ATG TGG ACA CA -3′
intron probe
sonde intron.for 5′- GCG GTC GCG TAG ACT ATA CA -3′
sonde intron.rev 5′- GCA TCG TTG ATG ACG TGA CA -3′
M25 probe
sonde M25.for 5′-AAC GCC AAC GAC GAC GAT GA-3′ (original name: M25sequenzierung VI.for)
sonde M25.rev 5′-TGC GCG GCG GGG TCA TCA GA-3′ (original name: 5′ RACE M25 SP1.rev)
5′- /3′-RACE
M25 RACE
(M25-1) 5′- GGA TTA TCG CGT ATC CGT CC -3′
(M25-2) 5′- CTG TCC GCC GTA CCT ATT GC -3′
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(M25-3) 5′- GAG CCG GTC CTG ACC AAG AA -3′
m108 RACE
(108-1) 5′- CCG TAC GCC GTA TAC TTA CA -3′
(108-2) 5′- TTC GGG CGG TTG CTC GTG AA -3′
(108-3) 5′- CGG TCC GAT CGG CTC GAT GA -3′
m106 RACE
(106-1) 5′- GGT ATA GGA CGG GGA TTC AA -3′
(106-2) 5′- CGG CGA CGT TGT CAT CGA GA -3′
m107 RACE
(107-1) 5′- CGG TCC GAT CGG CTC GAT GA -3′
(107-2) 5′- GAC CGC TCG TTC ACG AGC AA -3′
Primers for the Generation of Additional Mutants within the M24-m25.2 Region of the
MCMV Genome
[∆M24-m25.1]
M24.for
5′- CCG ATC TCG ATG GGG CCT GCC GTG CAG TGA ATC GGA TAA AAA TAT CTG AA aggacgacgacgacaagtaa -3′
m25.1.rev
5′- GTC AAG ATC CGC AAG GGA TGG CGG ATG CCG CTG ACC TGG CCC AAG AAT TA caggaacacttaacgcctga -3′
[∆M24]
M24end.for
5′- TGG CGC CGA TGC CGA CGA AGC CCG GGA TCG AGT CGG CTA TGA GAT AGT AA aggacgacgacgacaagtaa -3′
M24start.rev
5′- TTC GGC CGT TTC TAC TGT TAT CGC GGG CCC CCG GAC GAC GCC ATC TAC TA caggaacacttaacgcctga -3′
[∆m25.1]
m25.1end.for
5′- AGG CAA CGT AAG GTG CTG TTC TCC CCA CAG AGA TCT TGT CCT GTG AAG AA aggacgacgacgacaagtaa -3′
m25.1.rev
5′- GTC AAG ATC CGC AAG GGA TGG CGG ATG CCG CTG ACC TGG CCC AAG AAT TA caggaacacttaacgcctga -3′
[∆M25]
M25start.for
5′- TCG CGA CAC GTC GTC GTG GAC GAC GAC GAC GAC GGA GAT TAT GAT TCA CA aggacgacgacgacaagtaa -3′
M25end.rev
5′- GAG TAG CCT TCG AAG CCT GCC TCT TCC ATG GCC GCG CAC TTG ATC AGA TA caggaacacttaacgcctga -3′
[∆M25non-conserved]
M25non-conserved.for
5′- CGT GCC AGC CGT CCT ATT CCC CGT GCC GGC GCG TCC CTT TCG ACC TCG AA aggacgacgacgacaagtaa -3′
M25non-conserved.rev
5′- TCG ATC ACC ATG GCG GTG GCG GAT ATC GGG GTC TCG TAT AGA TGA TTA TT caggaacacttaacggctga -3′
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[∆M25conserved]
A stop-codon (underlined) was added at the 3′- end of the 5′-M25conserved.for primer in order to preserve M25-protein expression
from the M25 gene in the mutant.
M25conserved.for
5′- GGC ATC GTC GTC GAC TCC TCA TCG CAC CCA GCC TCT GCC CGT CCC ACC G TAG aggacgacgacgacaagtaa -3′
M25conserved.rev
5′- CGT GTG GCT AAG TGC TAA GTG CTT TTG GGG TTG GTT ATT CTG CTG ATT AA caggaacacttaacggctga -3′
Primers for the generation of the pIRESM25CHA and pIRESM25NHA vectors
(EcoRI or PstI restriction sites, hemagglutinin tag)
pIRESM25CHA
M25CHA-PstI.for
5′- aactgcagaa CTA CGCGTAGTCCGGCACGTCGTACGGGTA CAG AAA GGT ACG CTT GGA GTA C-3′)
M25CHA-EcoRI.rev
5′- cggaattccggccgccATG AGC CAG TTC GTA CAG CAC GTC G -3′)
pIRESM25NHA
HANM25-EcoRI.rev
5′- ggaattcctgatcATG TACCCGTACGACGTGCCGGACTACGCG GAC CCC CCG GAG ACG ACG TCG TCG TCG TCA -3′
HANM25-PstI.for
5′- aactgcagaaTTA CAG AAA GGT ACG CTT GGA GTA C -3′
Primers for the Shortening of the M25 ORF within the pIRES2AcGFP1 Vector PstI restriction site)
Primer HMIEP 5′-GCG GAT CTG ACG GTT CAC TA-3′
ATG N◦2 5′- tgcactgcagCTC GAA CGC CTG TCC GAG AA -3′
(ATG N◦ 4/5) 5′- tgcactgcagCGT CAC CGA CGA CTC GTC GGA TGA -3′
(ATG N◦ 6) 5′- tgcactgcagGAG GAA CTA AAC GGC GAA GA -3′
(ATG N◦7/8) 5′- tgcactgcagCTT ATG CGG ACC CGG CCG ATG TGA GA -3′
(ATG N◦ 9) 5′- tgcactgcagCGA CGA CGA CGG AGA TTA TGA -3′
(ATG N◦10) 5′- tgcactgcagCGT GTC GAT CAC ACG GAG AA -3′
Primers for the Generation of Hemagglutinin-tagged viruses
(The sequence coding for the hemagglutinin-tag is underlined)
M25HA-tagged virus
M25CHA.for
5′- CTC CTC CCC CGG CCG CCG GAG GGC CAA AGT ACT CCA AGC GTA CCT TTC TG-
TAC CCG TAC GAC GTG CCG GAC TAC GCG TAG aggacgacgacgacaagtaa -3′
M25CHA.rev
5′- CGT GTG GCT AAG TGC TAA GTG CTT TTG GGG TTG GTT ATT CTG CTG ATT AA caggaacacttaacggctga -3′
m108HA-tagged virus
m108CHA.rev
5′- GAG CAC CCG TTC GCT TCG ATC GAG CGG TCG TGG CGT TCG CGG CAA TCA AA-
TAC CCG TAC GAC GTG CCG GAC TAC GCG TAG caggaacacttaacggctga -3′
m108CHA.for
5′- CTT CGA CCG ACC CCT CGT AGC GAC CGA CCG CTC GCT TCG ATT ACC CGC TC caggacgacgacgacaagtaa -3′
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Additional Mutants within the m106-m108 Region
[∆m106]
A1.for
5′- CCG GGG GCG TGA GGG ACG CGA CTG CTC ACG GTT CTG TTT GTC TGT AGA T ctacaggacgacgacgacaagtaa -3′
m106.rev
5′- CCC GCA TCT GTA CGC AAT TTT CTG GTC TCA CGG GAG TCG AGG TCT CAC GG caggaacacttaacggctga -3′
[∆intron]
RVSS25.for
5′- GCCGAATCTGTGGTTGTCCCCTCACACGCTTTGTTACGGTTCGGATAAA aggacgacgacgacaagtaa -3′
RVSS25.rev
5′- GAG CGC CTC GGG TAT GCT ATA TGT CCC CCT TTT TGT ACC TGT GTC ATT AA caggaacacttaacggctga -3′
[∆m107-m108]
m107.for
5′- TCC AGG TAT CCT ACC TAG CGC GGT CAC GTC CGA CGC CGC AAA GTA TAA TA aggacgacgacgacaagtaa -3′
A2.rev
5′- CTG GGC GCC GAG GCC AGT AAT GTG CCT GTC TCC CCG GAC CCG CCT AGC AG gtgacacaggaacacttaacggctga -3′
[∆7.2kb RNA]
delta7.2kbRNAsplicedonor.for
5′- ACG ATA AAA GAG GAC AGT AGA TAA AGA TTG ATT TAG TGT ACA CAC GTT GT aggacgacgacgacaagtaa -3′
delta7.2kbRNAsplicedonor.rev
5′- AGG CCG AGG AGG CGG CGG CGG AGG TGA CGG CGT CCC GAA GGC CCG GAG CT caggaacacttaacggctga -3′
[m108mutATG]
m108mutATG.for (nucleotides that have been exchanged, CAT → TCA are marked in bold letters)
5′-C TCG TGC ATG TCG GCG GTC CGC GGT GAG GTT ATA GAC TCA CTG CTA GGC G aggacgacgacgacaagtaa -3′
m108start.rev
5′- CAC GCC TAG GCT GGG CGC CGA GGC CAG TAA TGT GCC TGT CTC CCC GGA CC caggaacacttaacggctga -3′
[∆m108]
m108middle.for
5′- CAC ATT TCG GGC GGT TGC TCG TGA ACG AGC GGT CGC TCG TCA CGG CGA TA aggacgacgacgacaagtaa -3′
m108middleII.rev
5′- CGT CGA GCG GGT GTC CGA AGA GGG GTT TTC CCG GTC CGA TCG GCT CGA TG caggaacacttaacggctga -3′
[m108∆miRNA]
miRNAm108ko.for
5′- GTA CGT AGG GAG GTG CTC CAT CGG CGG CCT GAC CGA CGC TC -3′
miRNAm108-1ko.rev
5′- GTT ACG CAC GTG TAA GTA TAC GGC GTA CGG AGC TCC GTT C-3′
[m108∆intron]
m108middle.for
5′-CAC ATT TCG GGC GGT TGC TCG TGA ACG AGC GGT CGC TCG TCA CGG CGA TA-3′
m108start.rev
5′-CAC GCC TAG GCT GGG CGC CGA GGC CAG TAA TGT GCC TGT CTC CCC GGA CC-3′
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